Recent Publications
2023 (articles in alphabetic order)
1. (2023). Corrigendum for Cosme et al., volume 323, 2022, p. G410-G419. Am J Physiol Gastrointest Liver Physiol, 324 (1), G89. https://doi.org/10.1152/ajpgi.00139.2023_COR
2. AMOEDO, P., CEREJEIRA, A., MOREIRA, F., COELHO, A., BARROS, A. M., MOREIRA, E., MAGINA, S., SILVA-RAMOS, M. and AZEVEDO, F., (2023). Metastatic hidradenocarcinoma: a report of two rare cases. Eur J Dermatol, 33 (3), 241-244. https://doi.org/10.1684/ejd.2023.4478
3. BARROCAS, P., VIEIRA, A. C. F., ALMEIDA, H., TEIXEIRA, J., GOMES, M. J., CHEVALIER, E., SOARES-DA-SILVA, P. and VASCONCELOS, T., (2023). Over-blending effect of lubricants on capsules manufacturing: a simple and fast wettability technique to predict batch dissolution performance. Pharm Dev Technol, 28 (3-4), 363-370. https://doi.org/10.1080/10837450.2023.2196332
4. BESSA, C., LOUREIRO, J. B., BARROS, M., ISCA, V. M. S., SARDAO, V. A., OLIVEIRA, P. J., BERNARDINO, R. L., HERMAN-DE-SOUSA, C., COSTA, M. A., CORREIA-DE-SA, P., ALVES, M. G., RIJO, P. and SARAIVA, L., (2023). Counteracting Colon Cancer by Inhibiting Mitochondrial Respiration and Glycolysis with a Selective PKCdelta Activator. Int J Mol Sci, 24 (6), https://doi.org/10.3390/ijms24065710
5. BESSA-GONCALVES, M., BRAGANCA, B., MARTINS-DIAS, E., VINHAS, A., CERTAL, M., RODRIGUES, T., FERREIRINHA, F., COSTA, M. A., CORREIA-DE-SA, P. and FONTES-SOUSA, A. P., (2023). Blockage of the adenosine A(2B) receptor prevents cardiac fibroblasts overgrowth in rats with pulmonary arterial hypertension. Purinergic Signal, in press https://doi.org/10.1007/s11302-023-09952-z
6. CARDOSO, D., BEZERRA, S., SOARES-DOS-REIS, R., SA, M. J. and GUIMARAES, J., (2023). Optic neuropathy diagnosis in the emergency room - retrospective observational study of the last 18 years. Eur J Ophthalmol, in press 11206721231173005. https://doi.org/10.1177/11206721231173005
7. CORREIA, G. and MAGINA, S., (2023). Efficacy of topical vitamin C in melasma and photoaging: A systematic review. J Cosmet Dermatol, 22 (7), 1938-1945. https://doi.org/10.1111/jocd.15748
8. COSME, D., SOARES-DA-SILVA, P. and MAGRO, F., (2023). Long-term effect of Toll-like receptor-2, -4, -5, -7 and NOD2 stimulation on Na(+),K(+)-ATPase activity and expression in intestinal epithelial cells. Am J Physiol Cell Physiol, 324 (5), C1028-C1038. https://doi.org/10.1152/ajpcell.00208.2022
9. DE FREIXO FERREIRA, L., GUERRA, C. and VIEIRA-COELHO, M. A., (2023). Predictors of psychotherapy dropout in patients with borderline personality disorder: A systematic review. Clin Psychol Psychother, in press https://doi.org/10.1002/cpp.2888
10. DE SOUSA, H. T., GULLO, I. and MAGRO, F., (2023). Fibromuscular Expansion in Crohn's Disease Ileal Strictures: An Open Issue. Clin Gastroenterol Hepatol, 21 (5), 1378-1380. https://doi.org/10.1016/j.cgh.2022.06.023
11. FERNANDES, A. A., GRANGEIA, A., DIAS, L. and GUIMARAES, J., (2023). Expanding the genetic spectrum of ALKU syndrome: Compound heterozygosity for two deleterious variants in SMG8 gene. Am J Med Genet A, 191 (8), 2204-2208. https://doi.org/10.1002/ajmg.a.63242
12. FERREIRA-DUARTE, M., OLIVEIRA, L. C. G., QUINTAS, C., ESTEVES-MONTEIRO, M., DUARTE-ARAUJO, M., SOUSA, T., CASARINI, D. E. and MORATO, M., (2023). ACE and ACE2 catalytic activity in the fecal content along the gut. Neurogastroenterol Motil, 35 (9), e14598. https://doi.org/10.1111/nmo.14598
13. GASPAR, A. R., ANDRADE, B., MOSCA, S., FERREIRA-DUARTE, M., TEIXEIRA, A., COSME, D., ALBINO-TEIXEIRA, A., RONCHI, F. A., LEITE, A. P., CASARINI, D. E., AREIAS, J. C., SOUSA, T., AFONSO, A. C., MORATO, M. and CORREIA-COSTA, L., (2023). Association between blood pressure and angiotensin-converting enzymes activity in prepubertal children *. J Hypertens, 41 (4), 545-553. https://doi.org/10.1097/HJH.0000000000003345
14. GIRALT, L., PEREZ-FERNANDEZ, S., ADAN, A., FIGUEIRA, L., FONOLLOSA, A. and GROUP*, I. S., (2023). Clinical Features and Outcomes of Tubulointerstitial Nephritis and Uveitis Syndrome in Spain and Portugal: The IBERTINU Project. Ocul Immunol Inflamm, 31 (2), 286-291. https://doi.org/10.1080/09273948.2022.2026413
15. GOUVEIA, R., CRUZ, V. T., ANTAO, J. and ALMEIDA, L., (2023). Interpersonal Values of Patients Participating in Phase II-III Clinical Trials: Implications for Clinical Trial Representativeness. Pharmaceut Med, 37 (4), 319-329. https://doi.org/10.1007/s40290-023-00479-7
16. KOEPP, M. J., TRINKA, E., MAH, Y. H., BENTES, C., KNAKE, S., GIGLI, G. L., SERRATOSA, J. M., ZELANO, J., MAGALHAES, L. M., PEREIRA, A., MOREIRA, J. and SOARES-DA-SILVA, P., (2023). Antiepileptogenesis after stroke-trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate. Epilepsia Open, 8 (3), 1190-1201. https://doi.org/10.1002/epi4.12735
17. LOPES, C., SOUSA, C., FRAGA, A., GUIMARAES, J., VICENTE, S. and SA, M. J., (2023). Cognitive impairment in Neuromyelitis Optica Spectrum Disorder: A retrospective study using the Brief International cognitive Assessment for Multiple Sclerosis (BICAMS). Appl Neuropsychol Adult, in press 1-7. https://doi.org/10.1080/23279095.2023.2210242
18. MATHIAS, L. S., HERMAN-DE-SOUSA, C., CURY, S. S., NOGUEIRA, C. R., CORREIA-DE-SA, P. and DE OLIVEIRA, M., (2023). RNA-seq reveals that anti-obesity irisin and triiodothyronine (T3) hormones differentially affect the purinergic signaling transcriptomics in differentiated human adipocytes. Biochim Biophys Acta Mol Cell Biol Lipids, 1868 (4), 159276. https://doi.org/10.1016/j.bbalip.2022.159276
19. NORONHA-MATOS, J. B., PINTO-CARDOSO, R., BESSA-ANDRES, C., MAGALHAES-CARDOSO, M. T., FERREIRINHA, F., COSTA, M. A., MARINHAS, J., FREITAS, R., LEMOS, R., VILACA, A., OLIVEIRA, A., PELLETIER, J., SEVIGNY, J. and CORREIA-DE-SA, P., (2023). Silencing NTPDase3 activity rehabilitates the osteogenic commitment of post-menopausal stem cell bone progenitors. Stem Cell Res Ther, 14 (1), 97. https://doi.org/10.1186/s13287-023-03315-6
20. OLIVEIRA, A., SEIXAS, R., PEREIRA, F., AZEVEDO, M., MARTINHO, R., SERRAO, P. and MOREIRA-RODRIGUES, M., (2023). Insulin enhances contextual fear memory independently of its effect in increasing plasma adrenaline. Life Sci, 328 121881. https://doi.org/10.1016/j.lfs.2023.121881
21. PEDRO, B., MAVROPOULOU, A., OYAMA, M. A., LINNEY, C., NEVES, J., DUKES-MCEWAN, J., FONTES-SOUSA, A. P. and GELZER, A. R., (2023). Optimal rate control in dogs with atrial fibrillation-ORCA study-Multicenter prospective observational study: Prognostic impact and predictors of rate control. J Vet Intern Med, 37 (3), 887-899. https://doi.org/10.1111/jvim.16666
22. PEREIRA-SILVA, R., SERRAO, P., LOURENCA NETO, F. and MARTINS, I., (2023). Diffuse noxious inhibitory controls in chronic joint inflammatory Pain: Study of the descending serotonergic modulation mediated through 5HT3 receptors. Neurobiol Pain, 13 100123. https://doi.org/10.1016/j.ynpai.2023.100123
23. PINTO-CARDOSO, R., BESSA-ANDRES, C., CORREIA-DE-SA, P. and BERNARDO NORONHA-MATOS, J., (2023). Could hypoxia rehabilitate the osteochondral diseased interface? Lessons from the interplay of hypoxia and purinergic signals elsewhere. Biochem Pharmacol, 214 115646. https://doi.org/10.1016/j.bcp.2023.115646
24. PORTELA MOREIRA, I., HENRIQUES, T., VIEIRA-COELHO, M. A. and GUIMARAES, J., (2023). Dysfunction of norepinephrine and its metabolites in Alzheimer's dementia - A review with meta-analysis. Ageing Res Rev, 83 101784. https://doi.org/10.1016/j.arr.2022.101784
25. REINA-COUTO, M., ROBOREDO-MADEIRA, M., PEREIRA-TERRA, P., SILVA-PEREIRA, C., MARTINS, S., TEIXEIRA-SANTOS, L., PINHO, D., DIAS, A., CORDEIRO, G., DIAS, C. C., SARMENTO, A., TAVARES, M., GUIMARAES, J. T., RONCON-ALBUQUERQUE, R., PAIVA, J. A., ALBINO-TEIXEIRA, A. and SOUSA, T., (2023). Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients. Inflamm Res, 72 (3), 475-491. https://doi.org/10.1007/s00011-022-01682-z
26. SOUSA, T., PINHO, D., RECCHIUTI, A., ISOPI, E. and VERRI, W. A., JR., (2023). Editorial: Specialized proresolving mediators: Benefits within and beyond inflammation resolution in cardiometabolic, neurological and psychiatric disorders. Front Physiol, 14 1176700. https://doi.org/10.3389/fphys.2023.1176700
27. SOUSA-SOARES, C., NORONHA-MATOS, J. B. and CORREIA-DE-SA, P., (2023). Purinergic Tuning of the Tripartite Neuromuscular Synapse. Mol Neurobiol, 60 (7), 4084-4104. https://doi.org/10.1007/s12035-023-03317-8
28. TEIXEIRA-SANTOS, L., MARTINS, S., SOUSA, T., ALBINO-TEIXEIRA, A. and PINHO, D., (2023). The pro-resolving lipid mediator Maresin 1 ameliorates pain responses and neuroinflammation in the spared nerve injury-induced neuropathic pain: A study in male and female mice. PLoS One, 18 (6), e0287392. https://doi.org/10.1371/journal.pone.0287392
29. TEIXEIRA-SANTOS, L., VERISSIMO, E., MARTINS, S., SOUSA, T., ALBINO-TEIXEIRA, A. and PINHO, D., (2023). Effects of NADPH Oxidase Isoform-2 (NOX2) Inhibition on Behavioral Responses and Neuroinflammation in a Mouse Model of Neuropathic Pain. Biomedicines, 11 (2), https://doi.org/10.3390/biomedicines11020416
30. TRIGUINHO, A., FONTES-SOUSA, A. P., PIMENTA, J. and COTOVIO, M., (2023). Electrocardiographic Reference Values in Clinically Healthy Lusitano Horses. Vet Sci, 10 (8), https://doi.org/10.3390/vetsci10080518
31. VIEIRA-COELHO, M. A. and MARTEL, F., (2023). Inhibition of kidney potassium channels by fluoxetine: In vivo and in vitro studies. Fundam Clin Pharmacol, 37 (2), 226-234. https://doi.org/10.1111/fcp.12833
2022 (articles in alphabetic order)
1. AMOEDO, P., MATOS, P. and MAGINA, S., (2022). sQuiz your knowledge! Symmetrical palpebral plaques following blepharoplasty. Eur J Dermatol, 32 (6), 820-822. https://doi.org/10.1684/ejd.2022.4389
2. ANDRIKAKOU, P., REEBYE, V., VASCONCELOS, D., YOON, S., VOUTILA, J., GEORGE, A. J. T., SWIDERSKI, P., HABIB, R., CATLEY, M., BLAKEY, D., HABIB, N. A., ROSSI, J. J. and HUANG, K. W., (2022). Enhancing SIRT1 Gene Expression Using Small Activating RNAs: A Novel Approach for Reversing Metabolic Syndrome. Nucleic Acid Ther, 32 (6), 486-496. https://doi.org/10.1089/nat.2021.0115
3. ANTONIO, T., SOARES-DA-SILVA, P., PIRES, N. M. and GOMES, P., (2022). Salt-inducible kinases: new players in pulmonary arterial hypertension? Trends Pharmacol Sci, 43 (10), 806-819. https://doi.org/10.1016/j.tips.2022.06.008
4. CARVALHO, C. and VIEIRA-COELHO, M. A., (2022). Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms. Pharmacol Res, 181 106258. https://doi.org/10.1016/j.phrs.2022.106258
5. CEREJEIRA, A., CANELAS, G., VIDE, J., DURO, R., AZEVEDO, F. and MAGINA, S., (2022). Cavitary pulmonary tuberculosis during treatment with guselkumab. J Eur Acad Dermatol Venereol, 36 (6), e488-e490. https://doi.org/10.1111/jdv.17992
6. CERQUEIRA, N., NEVES, M., ROCHA, J., SOARES-DA SILVA, P. and PALMA, P. N., (2022). Inactivation Mechanism of the Fatty Acid Amide Hydrolase Inhibitor BIA 10-2474. Chembiochem, 23 (20), e202200166. https://doi.org/10.1002/cbic.202200166
7. CHAUDHURI, K. R., ODIN, P., FERREIRA, J. J., ANTONINI, A., RASCOL, O., KURTIS, M. M., STORCH, A., BANNISTER, K., SOARES-DA-SILVA, P., COSTA, R., MAGALHAES, D. and ROCHA, J. F., (2022). Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial. BMC Neurol, 22 (1), 88. https://doi.org/10.1186/s12883-022-02602-8
8. CHAVARRIA, D., BENFEITO, S., SOARES, P., LIMA, C., GARRIDO, J., SERRAO, P., SOARES-DA-SILVA, P., REMIAO, F., OLIVEIRA, P. J. and BORGES, F., (2022). Boosting caffeic acid performance as antioxidant and monoamine oxidase B/catechol-O-methyltransferase inhibitor. Eur J Med Chem, 243 114740. https://doi.org/10.1016/j.ejmech.2022.114740
9. CORREIA-SA, I., CARVALHO, C., V, A. M., CARVALHO, S., SERRAO, P., MARQUES, M. and VIEIRA-COELHO, M. A., (2022). Targeting cannabinoid receptor 2 (CB2) limits collagen production-An in vitro study in a primary culture of human fibroblasts. Fundam Clin Pharmacol, 36 (1), 89-99. https://doi.org/10.1111/fcp.12716
10. COSME, D., SOARES-DA-SILVA, P. and MAGRO, F., (2022). Effect of Toll-like receptor-2, -4, -5, -7, and NOD2 stimulation on potassium channel conductance in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol, 323 (5), G410-G419. https://doi.org/10.1152/ajpgi.00139.2022
11. DA COSTA AZEVEDO, J. N., CARVALHO, C., SERRAO, M. P., COELHO, R., FIGUEIREDO-BRAGA, M. and VIEIRA-COELHO, M. A., (2022). Catechol-O-methyltransferase activity in individuals with substance use disorders: a case control study. BMC Psychiatry, 22 (1), 412. https://doi.org/10.1186/s12888-022-04068-x
12. ESPANHOL, J. C. L. and VIEIRA-COELHO, M. A., (2022). Effects of lithium use on the white matter of patients with bipolar disorder - a systematic review. Nord J Psychiatry, 76 (1), 1-11. https://doi.org/10.1080/08039488.2021.1921264
13. FARINHA-FERREIRA, M., REI, N., FONSECA-GOMES, J., MIRANDA-LOURENCO, C., SERRAO, P., VAZ, S. H., GOMES, J. I., MARTINS, V., DE ALVES PEREIRA, B. and SEBASTIAO, A. M., (2022). Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior. Neuropharmacology, 109155. https://doi.org/10.1016/j.neuropharm.2022.109155
14. FERNANDES, H., BATALHA, V., BRAKSATOR, E., HEBEISEN, S., BONIFACIO, M. J., VIEIRA-COELHO, M. A. and SOARES-DA-SILVA, P., (2022). Voltage-clamp evidence of GABAA receptor subunit-specific effects: pharmacodynamic fingerprint of chlornordiazepam, the major active metabolite of mexazolam, as compared to alprazolam, bromazepam, and zolpidem. Pharmacol Rep, 74 (5), 956-968. https://doi.org/10.1007/s43440-022-00411-x
15. FERREIRA, J. J., POEWE, W., RASCOL, O., STOCCHI, F., ANTONINI, A., MOREIRA, J., GUIMARAES, B., ROCHA, J. F. and SOARES-DA-SILVA, P., (2022). Effect of Opicapone on Levodopa Pharmacokinetics in Patients with Fluctuating Parkinson's Disease. Mov Disord, 37 (11), 2272-2283. https://doi.org/10.1002/mds.29193
16. FIGUEIREDO, A., COSTA, L., MAURICIO, M. J., FIGUEIRA, L., RAMOS, R. and MARTINS-DA-SILVA, C., (2022). Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends. Clin Drug Investig, 42 (8), 631-642. https://doi.org/10.1007/s40261-022-01178-y
17. GOUVEIA, R., CRUZ, V. T. and ALMEIDA, L., (2022). Sociodemographic and psychological characteristics influencing patients' willingness to participate in clinical trials. BMJ Open Qual, 11 (4), https://doi.org/10.1136/bmjoq-2022-002044
18. GUERRA LEAL, B., BARROS-BARBOSA, A., FERREIRINHA, F., CHAVES, J., RANGEL, R., SANTOS, A., CARVALHO, C., MARTINS-FERREIRA, R., SAMOES, R., FREITAS, J., LOPES, J., RAMALHEIRA, J., LOBO, M. G., MARTINS DA SILVA, A., COSTA, P. P. and CORREIA-DE-SA, P., (2022). Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22. Front Cell Neurosci, 16 910662. https://doi.org/10.3389/fncel.2022.910662
19. HERMAN-DE-SOUSA, C., COSTA, M. A., SILVA, R. P., FERREIRINHA, F., RIBEIRO, S. and CORREIA-DE-SA, P., (2022). A2A receptor-induced overexpression of pannexin-1 channels indirectly mediates adenosine fibrogenic actions by favouring ATP release from human subcutaneous fibroblasts. Life Sci, 310 121080. https://doi.org/10.1016/j.lfs.2022.121080
20. JOSE-VIEIRA, R., FERREIRA, A., MENERES, P., SOUSA-PINTO, B. and FIGUEIRA, L., (2022). Efficacy and safety of intravitreal and periocular injection of corticosteroids in noninfectious uveitis: a systematic review. Surv Ophthalmol, 67 (4), 991-1013. https://doi.org/10.1016/j.survophthal.2021.12.002
21. LOUREIRO, A. I., FERNANDES-LOPES, C., BONIFACIO, M. J., SOUSA, F., KISS, L. E. and SOARES-DA-SILVA, P., (2022). Metabolism and disposition of opicapone in the rat and metabolic enzymes phenotyping. Pharmacol Res Perspect, 10 (1), e00891. https://doi.org/10.1002/prp2.891
22. LOUREIRO, A. I., ROCHA, F., SANTOS, A. T., SINGH, N., BONIFACIO, M. J., PINTO, R., KISS, L. E. and SOARES-DA-SILVA, P., (2022). Absorption, metabolism and excretion of opicapone in human healthy volunteers. Br J Clin Pharmacol, 88 (10), 4540-4551. https://doi.org/10.1111/bcp.15383
23. MARTINHO, R., SEIXAS, R., AZEVEDO, M., OLIVEIRA, A., SERRAO, P. and MOREIRA-RODRIGUES, M., (2022). Sotalol Treatment may Interfere With Retrieval, Expression, and/or Reconsolidation Processes Thus Disrupting Traumatic Memories in a Post-Traumatic Stress Disorder Mice Model. Front Pharmacol, 12 809271. https://doi.org/10.3389/fphar.2021.809271
24. MARTINS, B., MIRANDA, J., PINTO, M. J., COSTA, A., SILVA-PINTO, A., MELO, N., CEIA, F., COSTA, J. T. and GUIMARAES, J., (2022). Common variable immunodeficiency and its inflammatory neurological manifestations: A case report and literature review. Mult Scler Relat Disord, 67 104086. https://doi.org/10.1016/j.msard.2022.104086
25. MARTINS, C., MOURA, J., FIGUEIROA, S., GARRIDO, C., MARTINS, J., SAMOES, R., GUIMARAES, J., MELO, C., SOUSA, R., PALAVRA, F., FERREIRA, J., DA SILVA, A. M., SA, M. J. and SANTOS, E., (2022). Pediatric neuromyelitis optica spectrum disorders in Portugal: A multicentre retrospective study. Mult Scler Relat Disord, 59 103531. https://doi.org/10.1016/j.msard.2022.103531
26. MONNI, L., KRAUS, L., DIPPER-WAWRA, M., SOARES-DA-SILVA, P., MAIER, N., SCHMITZ, D., HOLTKAMP, M. and FIDZINSKI, P., (2022). In vitro and in vivo anti-epileptic efficacy of eslicarbazepine acetate in a mouse model of KCNQ2-related self-limited epilepsy. Br J Pharmacol, 179 (1), 84-102. https://doi.org/10.1111/bph.15689
27. MOREIRA-RODRIGUES, M. and GRUBISHA, M. J., (2022). Editorial: Molecular mechanisms of neuropsychiatric diseases. Front Mol Neurosci, 15 1102296. https://doi.org/10.3389/fnmol.2022.1102296
28. REICHMANN, H., EGGERT, K., OEHLWEIN, C., WARNECKE, T., LEES, A. J., KEMMER, M. and SOARES-DA-SILVA, P., (2022). Opicapone Use in Clinical Practice across Germany: A Sub-Analysis of the OPTIPARK Study in Parkinson's Disease Patients with Motor Fluctuations. Eur Neurol, 85 (5), 389-397. https://doi.org/10.1159/000523771
29. REINA-COUTO, M., SANTOS-OLIVEIRA, M., PEREIRA-TERRA, P., SILVA-PEREIRA, C., QUELHAS-SANTOS, J., DUARTE, A., MARTINS, S., SERRAO, P., DIAS, C. C., MORATO, M., GUIMARAES, J. T., RONCON-ALBUQUERQUE, R., PAIVA, J. A., ALBINO-TEIXEIRA, A. and SOUSA, T., (2022). Urinary Cysteinyl Leukotrienes as Biomarkers of Endothelial Activation, Inflammation and Oxidative Stress and Their Relationship with Organ Dysfunction in Human Septic Shock. Biomedicines, 10 (11), https://doi.org/10.3390/biomedicines10112845
30. REINA-COUTO, M., SILVA-PEREIRA, C., PEREIRA-TERRA, P., QUELHAS-SANTOS, J., BESSA, J., SERRAO, P., AFONSO, J., MARTINS, S., DIAS, C. C., MORATO, M., GUIMARAES, J. T., RONCON-ALBUQUERQUE, R., PAIVA, J. A., ALBINO-TEIXEIRA, A. and SOUSA, T., (2022). Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target. Front Physiol, 13 965611. https://doi.org/10.3389/fphys.2022.965611
31. REIS-FERREIRA, A., NETO-MENDES, J., BRAS-SILVA, C., LOBO, L. and FONTES-SOUSA, A. P., (2022). Emerging Roles of Micrornas in Veterinary Cardiology. Vet Sci, 9 (10), https://doi.org/10.3390/vetsci9100533
32. ROCHA, J. F., SANTOS, A., GAMA, H., MOSER, P., FALCAO, A., PRESSMAN, P., WALLACE HAYES, A. and SOARES-DA-SILVA, P., (2022). Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10-2474: A Double-Blind, Randomized, Placebo-Controlled Study in Healthy Volunteers. Clin Pharmacol Ther, 111 (2), 391-403. https://doi.org/10.1002/cpt.2290
33. SCHOFIELD, C., CHAUDHURI, K. R., CARROLL, C., SHARMA, J. C., PAVESE, N., EVANS, J., FOLTYNIE, T., REICHMANN, H., ZUROWSKA, L., SOARES-DA-SILVA, P. and LEES, A., (2022). Opicapone in UK clinical practice: effectiveness, safety and cost analysis in patients with Parkinson's disease. Neurodegener Dis Manag, 12 (2), 77-91. https://doi.org/10.2217/nmt-2021-0057
34. TEIXEIRA, A., RIBEIRO, C., GAIO, R., TORRES, T., MAGINA, S., PEREIRA, T., TEIXEIRA, M., ROCHA, J. C., LOBO, J. M. S., ALMEIDA, I. F., VIDAL, D. G., PEDROSA, E. S. H. F., DINIS, M. A. P. and ALMEIDA, V., (2022). Influence of psoriasis lesions' location and severity on psychosocial disability and psychopathology. Observational study and psychometric validation of the SAPASI Portuguese version. J Psychosom Res, 154 110714. https://doi.org/10.1016/j.jpsychores.2021.110714
35. VALE, L., CHARRUA, A., CAVALEIRO, H., RIBEIRO-OLIVEIRA, R., AVELINO, A., ANTUNES-LOPES, T., ALBINO-TEIXEIRA, A. and CRUZ, F., (2022). DU Is Induced by Low Levels of Urinary ATP in a Rat Model of Partial Bladder Outlet Obstruction: The Incidence of Both Events Decreases after Deobstruction. Adv Urol, 2022 6292457. https://doi.org/10.1155/2022/6292457
36. VASCONCELOS, I., ADAO, R., RADEMAKER, M. T., LEITE-MOREIRA, A. F., FONTES-SOUSA, A. P. and BRAS-SILVA, C., (2022). Urocortins as biomarkers in cardiovascular disease. Clin Sci (Lond), 136 (1), 1-14. https://doi.org/10.1042/CS20210732
37. VIEIRA, R., SOUSA-PINTO, B. and FIGUEIRA, L., (2022). Efficacy and Safety of Corticosteroid Implants in Non-infectious Uveitis: A Systematic Review with Network Meta-analysis. Ocul Immunol Inflamm, 30 (1), 215-222. https://doi.org/10.1080/09273948.2020.1787463
2021 (articles in alphabetic order)
1. ANDERMANN, E., ROSENFELD, W., PENOVICH, P., ROGIN, J., CENDES, F., CARRENO, M., RAMSAY, R. E., BEN-MENACHEM, E., GAMA, H., ROCHA, F., SOARES-DA-SILVA, P., TOSIELLO, R., BLUM, D. and GRINNELL, T., (2021). Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (>/=60 years) and younger (18-59 years) adults. Epilepsy Res, 169 106478. https://doi.org/10.1016/j.eplepsyres.2020.106478
2. ANTONIO, T., COSME, D., IGREJA, B., FRAGA, S., SERRAO, M. P., PIRES, N. M. and SOARES-DA-SILVA, P., (2021). The role of salt-inducible kinases on the modulation of renal and intestinal Na(+),K(+)-ATPase activity during short- and long-term high-salt intake. Eur J Pharmacol, 904 174153. https://doi.org/10.1016/j.ejphar.2021.174153
3. BONIFACIO, M. J., SOUSA, F. and SOARES-DA-SILVA, P., (2021). Opicapone enhances the reversal of MPTP-induced Parkinson-like syndrome by levodopa in cynomolgus monkeys. Eur J Pharmacol, 892 173742. https://doi.org/10.1016/j.ejphar.2020.173742
4. BORREGA, R., ARAUJO, C., AGUIAM, N., MAGRO, F., FONSECA, J. E., DANESE, S., LOPES, J. and GONCALVES, J., (2021). Systematic Review and Principal Components Analysis of the Immunogenicity of Adalimumab. BioDrugs, 35 (1), 35-45. https://doi.org/10.1007/s40259-020-00458-3
5. CAMPOS-MARTINS, A., BRAGANCA, B., CORREIA-DE-SA, P. and FONTES-SOUSA, A. P., (2021). Pharmacological Tuning of Adenosine Signal Nuances Underlying Heart Failure With Preserved Ejection Fraction. Front Pharmacol, 12 724320. https://doi.org/10.3389/fphar.2021.724320
6. CARROLA, G., LIMA-FONTES, M., FALCAO-REIS, F., FIGUEIRA, L. and CARNEIRO, A., (2021). Inflammatory Choroidal Neovascular Membranes: Clinical Profile, Treatment Effectiveness, and Visual Prognosis. J Ophthalmol, 2021 9982883. https://doi.org/10.1155/2021/9982883
7. CHARBIT-HENRION, F., PARLATO, M., HANEIN, S., DUCLAUX-LORAS, R., NOWAK, J., BEGUE, B., RAKOTOBE, S., BRUNEAU, J., FOURRAGE, C., ALIBEU, O., RIEUX-LAUCAT, F., LEVY, E., STOLZENBERG, M. C., MAZEROLLES, F., LATOUR, S., LENOIR, C., FISCHER, A., PICARD, C., ALOI, M., DIAS, J. A., HARIZ, M. B., BOURRIER, A., BREUER, C., BRETON, A., BRONSKY, J., BUDERUS, S., CANANZI, M., COOPMAN, S., CREMILLEUX, C., DABADIE, A., DUMANT-FOREST, C., GURKAN, O. E., FABRE, A., FISCHER, A., DIAZ, M. G., GONZALEZ-LAMA, Y., GOULET, O., GUARISO, G., GURCAN, N., HOMAN, M., HUGOT, J. P., JEZIORSKI, E., KARANIKA, E., LACHAUX, A., LEWINDON, P., LIMA, R., MAGRO, F., MAJOR, J., MALAMUT, G., MAS, E., MATTYUS, I., MEARIN, L. M., MELEK, J., NAVAS-LOPEZ, V. M., PAERREGAARD, A., PELATAN, C., PIGNEUR, B., PAIS, I. P., REBEUH, J., ROMANO, C., SIALA, N., STRISCIUGLIO, C., TEMPIA-CALIERA, M., TOUNIAN, P., TURNER, D., URBONAS, V., WILLOT, S., RUEMMELE, F. M. and CERF-BENSUSSAN, N., (2021). Corrigendum to: Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study. J Crohns Colitis, 15 (3), 517-518. https://doi.org/10.1093/ecco-jcc/jjaa164
8. CORREIA-SA, I. B., CARVALHO, C. M., SERRAO, P. V., MACHADO, V. A., CARVALHO, S. O., MARQUES, M. and VIEIRA-COELHO, M. A., (2021). AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-beta - An in vitro study. Eur J Pharmacol, 892 173738. https://doi.org/10.1016/j.ejphar.2020.173738
9. COSME, D., ESTEVINHO, M. M., RIEDER, F. and MAGRO, F., (2021). Potassium channels in intestinal epithelial cells and their pharmacological modulation: a systematic review. Am J Physiol Cell Physiol, 320 (4), C520-C546. https://doi.org/10.1152/ajpcell.00393.2020
10. COSTA, R., MARTINS, A., GUIMARAES, J. and COSTA, A., (2021). Sneddon syndrome: a rare cause of stroke hidden in plain sight. Acta Neurol Belg, in press https://doi.org/10.1007/s13760-021-01839-3
11. CUNHA, A. M., SILVA, M., PEDROSA, A. C., FALCAO-REIS, F. and FIGUEIRA, L., (2021). Nocardia Subretinal Abscess: A Rare and Challenging Case Report. Case Rep Ophthalmol Med, 2021 8876864. https://doi.org/10.1155/2021/8876864
12. CUNHA-REIS, D., CAULINO-ROCHA, A. and CORREIA-DE-SA, P., (2021). VIPergic neuroprotection in epileptogenesis: challenges and opportunities. Pharmacol Res, 164 105356. https://doi.org/10.1016/j.phrs.2020.105356
13. D'AMICO, F., SOLITANO, V., ALETAHA, D., HART, A., MAGRO, F., SELMI, C., NG, S. C., AL AWADHI, S., CHOY, E., SCHULZE-KOOPS, H., BOSSUYT, P., OLIVERA, P. A., KOTZE, P. G., GHOSH, S., PEYRIN-BIROULET, L. and DANESE, S., (2021). Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus. Autoimmun Rev, 20 (7), 102849. https://doi.org/10.1016/j.autrev.2021.102849
14. FERNANDES, S., SOSA-NAPOLSKIJ, M., LOBO, G. and SILVA, I., (2021). Impact of the COVID-19 pandemic in the Portuguese population: Consumption of alcohol, stimulant drinks, illegal substances, and pharmaceuticals. PLoS One, 16 (11), e0260322. https://doi.org/10.1371/journal.pone.0260322
15. FERREIRA-DUARTE, M., RODRIGUES-PINTO, T., MENEZES-PINTO, D., ESTEVES-MONTEIRO, M., GONCALVES-MONTEIRO, S., CAPAS-PENEDA, S., MAGRO, F., DIAS-PEREIRA, P., MORATO, M. and DUARTE-ARAUJO, M., (2021). 2,4,6-trinitrobenzenesulfonic acid-induced colitis in Rattus norgevicus: a categorization proposal. Exp Anim, 70 (2), 245-256. https://doi.org/10.1538/expanim.20-0113
16. FERREIRA-DUARTE, M., RODRIGUES-PINTO, T., SOUSA, T., FARIA, M. A., ROCHA, M. S., MENEZES-PINTO, D., ESTEVES-MONTEIRO, M., MAGRO, F., DIAS-PEREIRA, P., DUARTE-ARAUJO, M. and MORATO, M., (2021). Interaction between the Renin-Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of Colitis. Int J Mol Sci, 22 (9), https://doi.org/10.3390/ijms22094836
17. FIORINO, G., ESTEVINHO, M. M., LOPES, D. J. M., CHERSI, F., ALLOCCA, M., SOUTO, M. T., DANESE, S. and MAGRO, F., (2021). Inflammatory Bowel Disease in Migrant Populations: Should we Look Even Further Back? Curr Drug Targets, 22 (15), 1706-1715. https://doi.org/10.2174/1389450122666210203193817
18. GOMEZ RIVAS, J., SOMANI, B., RODRIGUEZ SOCARRAS, M., MARRA, G., PEARCE, I., HENNINGSOHN, L., ZONDERVAN, P., VAN DER POEL, H., VAN POPPEL, H., N'DOW, J., LIATSIKOS, E., PALOU, J. and A EUROPEAN SCHOOL OF UROLOGY COLLABORATIVE, G., (2021). Essentials for Standardising the Undergraduate Urology Curriculum in Europe: Outcomes of a Delphi Consensus from the European School of Urology. Eur Urol Open Sci, 33 72-80. https://doi.org/10.1016/j.euros.2021.09.003
19. GONCALO, A. M. G. and VIEIRA-COELHO, M. A., (2021). The effects of trazodone on human cognition: a systematic review. Eur J Clin Pharmacol, 77 (11), 1623-1637. https://doi.org/10.1007/s00228-021-03161-6
20. HAYES, A. W., WEBER, K., MOSER, P. and SOARES-DA-SILVA, P., (2021). Non-clinical toxicology evaluation of BIA 10-2474. Crit Rev Toxicol, 51 (1), 65-75. https://doi.org/10.1080/10408444.2020.1867821
21. HERMANN, L., FALCAO-REIS, F. and FIGUEIRA, L., (2021). Epidemiology of Uveitis in a tertiary care centre in Portugal. Semin Ophthalmol, 36 (1-2), 51-57. https://doi.org/10.1080/08820538.2021.1885721
22. JENNER, P., ROCHA, J. F., FERREIRA, J. J., RASCOL, O. and SOARES-DA-SILVA, P., (2021). Redefining the strategy for the use of COMT inhibitors in Parkinson's disease: the role of opicapone. Expert Rev Neurother, 21 (9), 1019-1033. https://doi.org/10.1080/14737175.2021.1968298
23. KUCHARZIK, T., ELLUL, P., GREUTER, T., RAHIER, J. F., VERSTOCKT, B., ABREU, C., ALBUQUERQUE, A., ALLOCCA, M., ESTEVE, M., FARRAYE, F. A., GORDON, H., KARMIRIS, K., KOPYLOV, U., KIRCHGESNER, J., MACMAHON, E., MAGRO, F., MAASER, C., DE RIDDER, L., TAXONERA, C., TORUNER, M., TREMBLAY, L., SCHARL, M., VIGET, N., ZABANA, Y. and VAVRICKA, S., (2021). ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease. J Crohns Colitis, 15 (6), 879-913. https://doi.org/10.1093/ecco-jcc/jjab052
24. LEITE-ALMEIDA, L., MORATO, M., COSME, D., AFONSO, J., AREIAS, J. C., GUERRA, A., CALDAS AFONSO, A., ALBINO-TEIXEIRA, A., SOUSA, T. and CORREIA-COSTA, L., (2021). Impact of physical activity on redox status and nitric oxide bioavailability in nonoverweight and overweight/obese prepubertal children. Free Radic Biol Med, 163 116-124. https://doi.org/10.1016/j.freeradbiomed.2020.12.005
25. LEUZINGER-DIAS, M., GODINHO, G., LIMA-FONTES, M., OLIVEIRA-FERREIRA, C., CAMISA, E., FALCAO-REIS, F., SILVA, M. and FIGUEIRA, L., (2021). A painful red eye in an intravenous drug abuser: When not everything is what it seems. Eur J Ophthalmol, 11206721211060151. https://doi.org/10.1177/11206721211060151
26. LOBO, L., ESTEVES-GUIMARAES, J., OLIVEIRA, P., SALAZAR, L., PEREIRA, A. and FONTES-SOUSA, A. P., (2021). Maternal Left Ventricular Diastolic and Systolic Function during Normal Pregnancy in Saint Bernard Dogs. Vet Sci, 8 (12), https://doi.org/10.3390/vetsci8120306
27. MAGALHAES, L. M., COSTA, R., VIEIRA, M., MOREIRA, J., GAMA, H. and SOARES-DA-SILVA, P., (2021). Safety of Eslicarbazepine Acetate in Elderly Versus Non-Elderly Patients with Focal Seizures: From Pooled Data of Clinical Studies to 8 Years of Post-Marketing Experience. Drug Saf, 44 (10), 1099-1107. https://doi.org/10.1007/s40264-021-01097-5
28. MAGINA, S. and FILIPE, P., (2021). Pathophysiology of moderate to severe plaque psoriasis: anti-IL-17 towards disease modification. Drugs Today (Barc), 57 (5), 347-357. https://doi.org/10.1358/dot.2021.57.5.3266244
29. MAGRO, F., DIAS, C. C. and MORATO, M., (2021). Aminosalicylates and COVID-19: Facts or Coincidences? Gastroenterology, 160 (5), 1884-1885. https://doi.org/10.1053/j.gastro.2020.05.092
30. MAGRO, F., ESTEVINHO, M. M., DIAS, C. C., CORREIA, L., LAGO, P., MINISTRO, P., PORTELA, F., FEAKINS, R., DANESE, S. and PEYRIN-BIROULET, L., (2021). Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis. J Crohns Colitis, 15 (4), 551-566. https://doi.org/10.1093/ecco-jcc/jjaa176
31. MAGRO, F., NUZZO, A., ABREU, C., LIBANIO, D., RODRIGUEZ-LAGO, I., PAWLAK, K., HOLLENBACH, M., BROUWER, W. P. and SIAU, K., (2021). COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology. United European Gastroenterol J, 9 (7), 750-765. https://doi.org/10.1002/ueg2.12115
32. MARTINHO, R., CORREIA, G., SEIXAS, R., OLIVEIRA, A., SILVA, S., SERRAO, P., FERNANDES-LOPES, C., COSTA, C. and MOREIRA-RODRIGUES, M., (2021). Treatment With Nepicastat Decreases Contextual Traumatic Memories Persistence in Post-traumatic Stress Disorder. Front Mol Neurosci, 14 745219. https://doi.org/10.3389/fnmol.2021.745219
33. MELO, F. J., PINTO-LOPES, P., ESTEVINHO, M. M. and MAGRO, F., (2021). The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review. Inflamm Bowel Dis, 27 (7), 1153-1165. https://doi.org/10.1093/ibd/izaa324
34. MENDES-BASTOS, P., NERO, P., FERREIRA, P., BERNARDO, A., BARCELOS, A., PIMENTEL DOS SANTOS, F. M., SOUSA, J., LOUREIRO, M. M., MAGINA, S., ALPALHAO, M., ANTUNES, J. and VIEIRA-SOUSA, E., (2021). A multidisciplinary approach in psoriatic disease: the different models of dermatology-rheumatology collaborations in Portugal. Acta Reumatol Port, 46 (4), 333-341.
35. MIEHLKE, S., GUAGNOZZI, D., ZABANA, Y., TONTINI, G. E., KANSTRUP FIEHN, A. M., WILDT, S., BOHR, J., BONDERUP, O., BOUMA, G., D'AMATO, M., HEIBERG ENGEL, P. J., FERNANDEZ-BANARES, F., MACAIGNE, G., HJORTSWANG, H., HULTGREN-HORNQUIST, E., KOULAOUZIDIS, A., KUPCINSKAS, J., LANDOLFI, S., LATELLA, G., LUCENDO, A., LYUTAKOV, I., MADISCH, A., MAGRO, F., MARLICZ, W., MIHALY, E., MUNCK, L. K., OSTVIK, A. E., PATAI, A. V., PENCHEV, P., SKONIECZNA-ZYDECKA, K., VERHAEGH, B. and MUNCH, A., (2021). European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J, 9 (1), 13-37. https://doi.org/10.1177/2050640620951905
36. MINISTRO, P., DIAS, C. C., PORTELA, F., FERNANDES, S., BERNARDO, S., PIRES, F., LAGO, P., ROSA, I., TRINDADE, E., ALVES, C., CORREIA, L. and MAGRO, F., (2021). Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?Clin Transl Gastroenterol, 12 (2), e00309. https://doi.org/10.14309/ctg.0000000000000309
37. MOLEIRO, A. F., AIRES, A. F., ALVES, H., VIANA PINTO, J., CARNEIRO, A., FALCAO-REIS, F., FIGUEIRA, L. and PINHEIRO-COSTA, J., (2021). The Role of Atopy in the Choroidal Profile of Keratoconus Patients. Clin Ophthalmol, 15 1799-1807. https://doi.org/10.2147/OPTH.S301330
38. PINHO, S., ROCHA, V. and VIEIRA-COELHO, M. A., (2021). Effectiveness of multimodal interventions focused on smoking cessation in patients with schizophrenia: A systematic review. Schizophr Res, 231 145-153. https://doi.org/10.1016/j.schres.2021.03.012
39. PINTO-LOPES, P., MELO, F., AFONSO, J., PINTO-LOPES, R., ROCHA, C., MELO, D., MACEDO, G., DIAS, C. C., CARNEIRO, F., MAGRO, F. and PORTUGUESE, I. B. D. S. G., (2021). Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease. Clin Transl Gastroenterol, 12 (3), e00320. https://doi.org/10.14309/ctg.0000000000000320
40. PIRES, N. M., IGREJA, B. and SOARES-DA-SILVA, P., (2021). Antagonistic modulation of SIK1 and SIK2 isoforms in high blood pressure and cardiac hypertrophy triggered by high-salt intake. Clin Exp Hypertens, 43 (5), 428-435. https://doi.org/10.1080/10641963.2021.1896728
41. REINA-COUTO, M., AFONSO, J., CARVALHO, J., MORGADO, L., RONCHI, F. A., DE OLIVEIRA LEITE, A. P., DIAS, C. C., CASARINI, D. E., BETTENCOURT, P., ALBINO-TEIXEIRA, A., MORATO, M. and SOUSA, T., (2021). Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment. Biomed Pharmacother, 133 110938. https://doi.org/10.1016/j.biopha.2020.110938
42. REINA-COUTO, M., PEREIRA-TERRA, P., QUELHAS-SANTOS, J., SILVA-PEREIRA, C., ALBINO-TEIXEIRA, A. and SOUSA, T., (2021). Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets. Front Physiol, 12 746494. https://doi.org/10.3389/fphys.2021.746494
43. ROCHA, J. F., EBERSBACH, G., LEES, A., TOLOSA, E., FERREIRA, J. J., POEWE, W., RASCOL, O., STOCCHI, F., ANTONINI, A., MAGALHAES, D., GAMA, H. and SOARES-DA-SILVA, P., (2021). The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -II. Front Neurol, 12 754016. https://doi.org/10.3389/fneur.2021.754016
44. ROSEIRA, J., SOUSA, H. T., MARREIROS, A., CONTENTE, L. F. and MAGRO, F., (2021). Short Inflammatory Bowel Disease Questionnaire: translation and validation to the Portuguese language. Health Qual Life Outcomes, 19 (1), 59. https://doi.org/10.1186/s12955-021-01698-9
45. SCHMIDT, S., POTHMANN, L., MULLER-KOMOROWSKA, D., OPITZ, T., SOARES DA SILVA, P. and BECK, H., (2021). Complex effects of eslicarbazepine on inhibitory micro networks in chronic experimental epilepsy. Epilepsia, 62 (2), 542-556. https://doi.org/10.1111/epi.16808
46. SOUSA, P., MINISTRO, P., ARMUZZI, A., DIGNASS, A., HOIVIK, M. L., BARREIRO-DE ACOSTA, M., VAVRICKA, S., SAAD-HOSSNE, R., KOTZE, P. G., PEYRIN-BIROULET, L. and MAGRO, F., (2021). Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease. Dig Liver Dis, 53 (12), 1571-1579. https://doi.org/10.1016/j.dld.2021.05.038
47. TAVARES DE SOUSA, H., GULLO, I., CASTELLI, C., DIAS, C. C., RIEDER, F., CARNEIRO, F. and MAGRO, F., (2021). Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype. Clin Transl Gastroenterol, 12 (4), e00330. https://doi.org/10.14309/ctg.0000000000000330
48. TAVARES, M., FARRAIA, M., SILVA, S., RIBEIRO, A. M., SEVERO, M., PACIENCIA, I., RIBEIRO, R., HESPANHOL, V., GUIMARAES, T., ALMEIDA, J., MAGRO, F., SARMENTO, A., OLIVEIRA, A. M. and MOREIRA, A., (2021). Impact of montelukast as add on treatment to the novel coronavirus pneumonia (COVID-19): protocol for an investigator-initiated open labeled randomized controlled pragmatic trial. Porto Biomed J, 6 (2), e134. https://doi.org/10.1097/j.pbj.0000000000000134
49. TEIXEIRA, A., TEIXEIRA, M., ALMEIDA, V., GAIO, R., TORRES, T., MAGINA, S., CUNHA, C., SOUSA LOBO, J. M. and ALMEIDA, I. F., (2021). Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis. Pharmaceutics, 13 (10), https://doi.org/10.3390/pharmaceutics13101539
50. TEIXEIRA-SANTOS, L., ALBINO-TEIXEIRA, A. and PINHO, D., (2021). An alternative method for oral drug administration by voluntary intake in male and female mice. Lab Anim, 55 (1), 76-80. https://doi.org/10.1177/0023677220950782
51. UNGAR, B., MALICKOVA, K., HANZEL, J., ABU ARISHA, M., PAUL, S., ROCHA, C., BEN SHATACH, Z., ABITBOL, C. M., HAJ NATOUR, O., SELINGER, L., YAVZORI, M., FUDIM, E., PICARD, O., SHOVAL, I., ELIAKIM, R., KOPYLOV, U., MAGRO, F., ROBLIN, X., CHOWERS, Y., DROBNE, D., LUKAS, M. and BEN HORIN, S., (2021). Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms. J Crohns Colitis, 15 (10), 1707-1719. https://doi.org/10.1093/ecco-jcc/jjab067
52. VIEIRA, R., SOUSA-PINTO, B. and FIGUEIRA, L., (2021). Beware of word truncation in PubMed: unexpected problems and potential solutions. BMJ Evid Based Med, 26 (1), 34-36. https://doi.org/10.1136/bmjebm-2019-111286
2020 (articles in alphabetic order)
1. ALVES, J. M., SEABRA, M., BRAZ, L. and GUIMARAES, J., (2020). Optic neuropathy: A 15-year retrospective observational study. Mult Scler Relat Disord, 44 102337. https://doi.org/10.1016/j.msard.2020.102337
2. AZEVEDO, J., VIEIRA-COELHO, M., CASTELO-BRANCO, M., COELHO, R. and FIGUEIREDO-BRAGA, M., (2020). Impulsive and premeditated aggression in male offenders with antisocial personality disorder. PLoS One, 15 (3), e0229876. https://doi.org/10.1371/journal.pone.0229876
3. BARBOSA, R. S. D. and VIEIRA-COELHO, M. A., (2020). Probiotics and prebiotics: focus on psychiatric disorders - a systematic review. Nutr Rev, 78 (6), 437-450. https://doi.org/10.1093/nutrit/nuz080
4. BESSA, J., ALBINO-TEIXEIRA, A., REINA-COUTO, M. and SOUSA, T., (2020). Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases. Clin Chim Acta, 509 310-335. https://doi.org/10.1016/j.cca.2020.07.041
5. BONIFACIO, M. J., SOUSA, F., AIRES, C., LOUREIRO, A. I., FERNANDES-LOPES, C., PIRES, N. M., PALMA, P. N., MOSER, P. and SOARES-DA-SILVA, P., (2020). Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474. Br J Pharmacol, 177 (9), 2123-2142. https://doi.org/10.1111/bph.14973
6. BRAGANCA, B. and CORREIA-DE-SA, P., (2020). Resolving the Ionotropic P2X4 Receptor Mystery Points Towards a New Therapeutic Target for Cardiovascular Diseases. Int J Mol Sci, 21 (14), https://doi.org/10.3390/ijms21145005
7. CATELAS, D. N., SERRAO, M. P. and SOARES-DA-SILVA, P., (2020). Effects of nepicastat upon dopamine-beta-hydroxylase activity and dopamine and norepinephrine levels in the rat left ventricle, kidney, and adrenal gland. Clin Exp Hypertens, 42 (2), 118-125. https://doi.org/10.1080/10641963.2019.1583245
8. CHAVES, C. B. and VIEIRA-COELHO, M. A., (2020). Clinical trials with monoclonal antibodies in schizophrenia. Schizophr Res, 222 511-513. https://doi.org/10.1016/j.schres.2020.05.026
9. CORREIA-SA, I., PAIVA, A., CARVALHO, C. M. and VIEIRA-COELHO, M. A., (2020). Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis?Pharmacol Res, 159 104862. https://doi.org/10.1016/j.phrs.2020.104862
10. CORREIA-SA, I. B., CARVALHO, C. M., SERRAO, P. V., LOUREIRO, A. I., FERNANDES-LOPES, C., MARQUES, M. and VIEIRA-COELHO, M. A., (2020). A new role for anandamide: defective link between the systemic and skin endocannabinoid systems in hypertrophic human wound healing. Sci Rep, 10 (1), 11134. https://doi.org/10.1038/s41598-020-68058-3
11. COSTA-PEREIRA, J. T., SERRAO, P., MARTINS, I. and TAVARES, I., (2020). Serotoninergic pain modulation from the rostral ventromedial medulla (RVM) in chemotherapy-induced neuropathy: The role of spinal 5-HT3 receptors. Eur J Neurosci, 51 (8), 1756-1769. https://doi.org/10.1111/ejn.14614
12. D'AMICO, F., POUILLON, L., ARGOLLO, M., HART, A., FIORINO, G., VEGNI, E., RADICE, S., GILARDI, D., FAZIO, M., LEONE, S., BONOVAS, S., MAGRO, F., DANESE, S. and PEYRIN-BIROULET, L., (2020). Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group. Dig Liver Dis, 52 (2), 138-142. https://doi.org/10.1016/j.dld.2019.11.004
13. DE OLIVEIRA, M., MATHIAS, L. S., DE SIBIO, M. T., NORONHA-MATOS, J. B., COSTA, M. A., NOGUEIRA, C. R. and CORREIA-DE-SA, P., (2020). Pitfalls and challenges of the purinergic signaling cascade in obesity. Biochem Pharmacol, 182 114214. https://doi.org/10.1016/j.bcp.2020.114214
14. DIAS, A. M., CORDEIRO, G., ESTEVINHO, M. M., VEIGA, R., FIGUEIRA, L., REINA-COUTO, M., MAGRO, F. and THE CLINICAL PHARMACOLOGY UNIT, S. J. H. U. C., (2020). Gut bacterial microbiome composition and statin intake-A systematic review. Pharmacol Res Perspect, 8 (3), e00601. https://doi.org/10.1002/prp2.601
15. ESTEVINHO, M. M., ROCHA, C., CORREIA, L., LAGO, P., MINISTRO, P., PORTELA, F., TRINDADE, E., AFONSO, J., PEYRIN-BIROULET, L., MAGRO, F. and GEDII, (2020). Features of Fecal and Colon Microbiomes Associate With Responses to Biologic Therapies for Inflammatory Bowel Diseases: A Systematic Review. Clin Gastroenterol Hepatol, 18 (5), 1054-1069. https://doi.org/10.1016/j.cgh.2019.08.063
16. FERREIRA-DUARTE, M., SOUSA, J. B., DINIZ, C., SOUSA, T., DUARTE-ARAUJO, M. and MORATO, M., (2020). Experimental and Clinical Evidence of Endothelial Dysfunction in Inflammatory Bowel Disease. Curr Pharm Des, 26 (30), 3733-3747. https://doi.org/10.2174/1381612826666200701212414
17. GOMES, N., SIBAUD, V., AZEVEDO, F. and MAGINA, S., (2020). [Cutaneous Toxicity of Immune Checkpoint Inhibitors: A Narrative Review]. Acta Med Port, 33 (5), 335-343. https://doi.org/10.20344/amp.12424
18. HAYES, A. W., PRESSMAN, P., MOSER, P. and SOARES-DA-SILVA, P., (2020). Regulatory safety pharmacology evaluation of BIA 10-2474. J Pharmacol Toxicol Methods, 102 106677. https://doi.org/10.1016/j.vascn.2020.106677
19. HERMAN-DE-SOUSA, C., PINHEIRO, A. R., PARAMOS-DE-CARVALHO, D., COSTA, M. A., FERREIRINHA, F., MAGALHAES-CARDOSO, T., RIBEIRO, S., PELLETIER, J., SEVIGNY, J. and CORREIA-DE-SA, P., (2020). Opposing Effects of Adenosine and Inosine in Human Subcutaneous Fibroblasts May Be Regulated by Third Party ADA Cell Providers. Cells, 9 (3), https://doi.org/10.3390/cells9030651
20. KIRKHAM, F., AUVIN, S., MOREIRA, J., GAMA, H., FALCAO, A. C., ROCHA, J. F. and SOARES-DA-SILVA, P., (2020). Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial. Epilepsy Behav, 105 106962. https://doi.org/10.1016/j.yebeh.2020.106962
21. MAGRO, F., LOPES, J., BORRALHO, P., LOPES, S., COELHO, R., COTTER, J., DIAS DE CASTRO, F., TAVARES DE SOUSA, H., SALGADO, M., ANDRADE, P., VIEIRA, A. I., FIGUEIREDO, P., CALDEIRA, P., SOUSA, A., DUARTE, M. A., AVILA, F., SILVA, J., MOLEIRO, J., MENDES, S., GIESTAS, S., MINISTRO, P., SOUSA, P., GONCALVES, R., GONCALVES, B., OLIVEIRA, A., CHAGAS, C., CRAVO, M., DIAS, C. C., AFONSO, J., PORTELA, F., SANTIAGO, M., GEBOES, K. and CARNEIRO, F., (2020). Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels. J Crohns Colitis, 14 (2), 169-175. https://doi.org/10.1093/ecco-jcc/jjz123
22. MARTINHO, R., OLIVEIRA, A., CORREIA, G., MARQUES, M., SEIXAS, R., SERRAO, P. and MOREIRA-RODRIGUES, M., (2020). Epinephrine May Contribute to the Persistence of Traumatic Memories in a Post-traumatic Stress Disorder Animal Model. Front Mol Neurosci, 13 588802. https://doi.org/10.3389/fnmol.2020.588802
23. MIRANDA-LOURENCO, C., DUARTE, S. T., PALMINHA, C., GASPAR, C., RODRIGUES, T. M., MAGALHAES-CARDOSO, T., REI, N., COLINO-OLIVEIRA, M., GOMES, R., FERREIRA, S., ROSA, J., XAPELLI, S., ARMSTRONG, J., GARCIA-CAZORLA, A., CORREIA-DE-SA, P., SEBASTIAO, A. M. and DIOGENES, M. J., (2020). Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling. Neurobiol Dis, 145 105043. https://doi.org/10.1016/j.nbd.2020.105043
24. NEIVA, R., CAULINO-ROCHA, A., FERREIRINHA, F., LOBO, M. G. and CORREIA-DE-SA, P., (2020). Non-genomic Actions of Methylprednisolone Differentially Influence GABA and Glutamate Release From Isolated Nerve Terminals of the Rat Hippocampus. Front Mol Neurosci, 13 146. https://doi.org/10.3389/fnmol.2020.00146
25. NORONHA-MATOS, J. B., OLIVEIRA, L., PEIXOTO, A. R., ALMEIDA, L., CASTELLAO-SANTANA, L. M., AMBIEL, C. R., ALVES-DO PRADO, W. and CORREIA-DE-SA, P., (2020). Nicotinic alpha7 receptor-induced adenosine release from perisynaptic Schwann cells controls acetylcholine spillover from motor endplates. J Neurochem, 154 (3), 263-283. https://doi.org/10.1111/jnc.14975
26. NUNES-CARNEIRO, D., MADANELO, M., SILVA, F., PESTANA, N., RIBEIRO, C., GIL-SOUSA, D., MARTINS, S., ALMEIDA, M., DIAS, L., MALHEIRO, J., CAVADAS, V., CASTRO-HENRIQUES, A., FRAGA, A. and SILVA-RAMOS, M., (2020). Remaining kidney volume indexed to weight as a strong predictor of estimated glomerular filtration rate at 1 year and mid-term renal function after living-donor nephrectomy - a retrospective observational study. Transpl Int, 33 (10), 1262-1273. https://doi.org/10.1111/tri.13683
27. PATINHA, D., ABREU, C., CARVALHO, C., CUNHA, O. M., MOTA, M., AFONSO, J., SOUSA, T., ALBINO-TEIXEIRA, A., DINIZ, C. and MORATO, M., (2020). Adenosine A2A and A3 Receptors as Targets for the Treatment of Hypertensive-Diabetic Nephropathy. Biomedicines, 8 (11), https://doi.org/10.3390/biomedicines8110529
28. PINTO-CARDOSO, R., PEREIRA-COSTA, F., PEDRO FARIA, J., BANDARRINHA, P., BESSA-ANDRES, C., CORREIA-DE-SA, P. and BERNARDO NORONHA-MATOS, J., (2020). Adenosinergic signalling in chondrogenesis and cartilage homeostasis: Friend or foe?Biochem Pharmacol, 174 113784. https://doi.org/10.1016/j.bcp.2019.113784
29. PORTELA, F., MINISTRO, P., DE DEUS, J., CRAVO, M., COTTER, J., DUQUE, G., FERREIRA, F., ROSA, B., FERREIRA, P. L., DIAS, C. C., MAGRO, F. and PORTUGUESE, I. B. D. S. G., (2020). Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory Therapy. Digestion, 101 (5), 631-637. https://doi.org/10.1159/000501823
30. REICHMANN, H., LEES, A., ROCHA, J. F., MAGALHAES, D., SOARES-DA-SILVA, P. and INVESTIGATORS, O., (2020). Correction to: Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study. Transl Neurodegener, 9 (1), 14. https://doi.org/10.1186/s40035-020-00193-3
31. REICHMANN, H., LEES, A., ROCHA, J. F., MAGALHAES, D., SOARES-DA-SILVA, P. and INVESTIGATORS, O., (2020). Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the OPTIPARK open-label study. Transl Neurodegener, 9 9. https://doi.org/10.1186/s40035-020-00187-1
32. ROGIN, J., RESNICK, T., STROM, L., BEN-MENACHEM, E., KOCHEN, S., BLUM, D., GAMA, H., SOARES-DA-SILVA, P., LI, Y. and GRINNELL, T., (2020). Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate. Acta Neurol Scand, 141 (5), 397-404. https://doi.org/10.1111/ane.13218
33. SALMANTON-GARCIA, J., KOEHLER, P., KINDO, A., FALCES-ROMERO, I., GARCIA-RODRIGUEZ, J., RACIL, Z., CHEN, S. C., KLIMKO, N., DESOUBEAUX, G., THOMPSON GR, III, BENITEZ-PENUELA, M. A., RODRIGUEZ, J. Y., SHEPPARD, D. C., HOENIGL, M., LE GOVIC, Y., BADALI, H., BADDLEY, J. W., CHANDER, J., INGRAM, P. R., PAKSTIS, D. L., MELLINGHOFF, S. C., ATICI, S., CESARO, S., CHAKRABARTI, A., DUPONT, D., GONZALEZ, G. M., HATVANI, L., HERBRECHT, R., KLYASOVA, G., LASS-FLORL, C., MARES, M., MULLANE, K., VINH, D. C., WISPLINGHOFF, H., LACKNER, M., CORNELY, O. A., SEIDEL, D. and GROUP, E. I. W., (2020). Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope(Ⓡ)-Global Registry for Emerging Fungal Infections. J Infect, 81 (5), 802-815. https://doi.org/10.1016/j.jinf.2020.08.015
34. SILVA, F., MALHEIRO, J., PESTANA, N., RIBEIRO, C., NUNES-CARNEIRO, D., MANDANELO, M., TAVARES, J., PEDROSO, S., ALMEIDA, M., SILVA-RAMOS, M., DIAS, L., MARTINS, S. and CASTRO HENRIQUES, A., (2020). Lower donated kidney volume is associated with increased risk of lower graft function and acute rejection at 1 year after living donor kidney-a retrospective study. Transpl Int, 33 (12), 1711-1722. https://doi.org/10.1111/tri.13740
35. SILVA, I., MAGALHAES-CARDOSO, M. T., FERREIRINHA, F., MOREIRA, S., COSTA, A. F., SILVA, D., VIEIRA, C., SILVA-RAMOS, M. and CORREIA-DE-SA, P., (2020). beta3 Adrenoceptor-induced cholinergic inhibition in human and rat urinary bladders involves the exchange protein directly activated by cyclic AMP 1 favoring adenosine release. Br J Pharmacol, 177 (7), 1589-1608. https://doi.org/10.1111/bph.14921
36. SILVA, T. B., BORGES, F., SERRAO, M. P. and SOARES-DA-SILVA, P., (2020). Liver says no: the ongoing search for safe catechol O-methyltransferase inhibitors to replace tolcapone. Drug Discov Today, 25 (10), 1846-54. https://doi.org/10.1016/j.drudis.2020.07.015
37. SILVA-RAMOS, M., SILVA, I., FARIA, M., FERREIRINHA, F. and CORREIA-DE-SA, P., (2020). Activation of Prejunctional P2x2/3 Heterotrimers by ATP Enhances the Cholinergic Tone in Obstructed Human Urinary Bladders. J Pharmacol Exp Ther, 372 (1), 63-72. https://doi.org/10.1124/jpet.119.261610
38. TEIXEIRA-SANTOS, L., ALBINO-TEIXEIRA, A. and PINHO, D., (2020). Neuroinflammation, oxidative stress and their interplay in neuropathic pain: Focus on specialized pro-resolving mediators and NADPH oxidase inhibitors as potential therapeutic strategies. Pharmacol Res, 162 105280. https://doi.org/10.1016/j.phrs.2020.105280
39. TORRES-COSTA, S., PENAS, S., CARNEIRO, A., SANTOS-SILVA, R., MOURA, R., BRANDAO, E., FALCAO-REIS, F. and FIGUEIRA, L., (2020). Idiopathic Acute Exudative Polymorphous Vitelliform Maculopathy: Insight into Imaging Features and Outcomes. Case Rep Ophthalmol Med, 2020 7254038. https://doi.org/10.1155/2020/7254038
40. TRINKA, E., ROCAMORA, R., CHAVES, J., MOREIRA, J., IKEDO, F., SOARES-DA-SILVA, P. and GROUP, B.-E. I. S., (2020). Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study. Epilepsia, 61 (10), 2129-2141. https://doi.org/10.1111/epi.16666
2019 (articles in alphabetic order)
1. AFONSO, J., ROCHA, C., LAGO, P., ARROJA, B., VIEIRA, A. I., DIAS, C. C. and MAGRO, F., (2019). Accuracy of a new rapid test assay for monitoring adalimumab levels. Journal of Crohns & Colitis, 13 S144-S144. <Go to ISI>://WOS:000460544500236
2. ARAUJO, A. M., MACHADO, H. S., FALCAO, A. C. and SOARES-DA-SILVA, P., (2019). Bioelectrical impedance analysis of body composition for the anesthetic induction dose of propofol in older patients. BMC Anesthesiol, 19 (1), 180. https://www.ncbi.nlm.nih.gov/pubmed/31604419
3. BANTLEON, F., SCHNEIDER, M., RICKEN, B., VELAYUTHAM, S., TRAPANI, D., AFONSO, J., MAGRO, F. and ABEL, A., (2019). Quantum blue anti-infliximab: development and evaluation of a point of care rapid test for measuring anti-infliximab antibodies in human serum. Journal of Crohns & Colitis, 13 S194-S195. <Go to ISI>://WOS:000460544501053
4. BARONE, V., BERTOLDO, G., MAGRO, F., BROCCANELLO, C., PUGLISI, I., BAGLIERI, A., CAGNIN, M., CONCHERI, G., SQUARTINI, A., PIZZEGHELLO, D., NARDI, S. and STEVANATO, P., (2019). Molecular and Morphological Changes Induced by Leonardite-based Biostimulant in Beta vulgaris L. Plants (Basel), 8 (6), https://www.ncbi.nlm.nih.gov/pubmed/31216763
5. BRAGANCA, B., NOGUEIRA-MARQUES, S., FERREIRINHA, F., FONTES-SOUSA, A. P. and CORREIA-DE-SA, P., (2019). The Ionotropic P2X4 Receptor has Unique Properties in the Heart by Mediating the Negative Chronotropic Effect of ATP While Increasing the Ventricular Inotropy. Front Pharmacol, 10 1103. https://www.ncbi.nlm.nih.gov/pubmed/31611793
6. BURISCH, J., KATSANOS, K. H., CHRISTODOULOU, D. K., BARROS, L., MAGRO, F., PEDERSEN, N., KJELDSEN, J., VEGH, Z., LAKATOS, P. L., ERIKSSON, C., HALFVARSON, J., FUMERY, M., GOWER-ROUSSEAU, C., BRINAR, M., CUKOVIC-CAVKA, S., NIKULINA, I., BELOUSOVA, E., MYERS, S., SEBASTIAN, S., KIUDELIS, G., KUPCINSKAS, L., SCHWARTZ, D., ODES, S., KAIMAKLIOTIS, I. P., VALPIANI, D., D'INCA, R., SALUPERE, R., ZAMMIT, S. C., ELLUL, P., DURICOVA, D., BORTLIK, M., GOLDIS, A., KIEVIT, H. A. L., TOCA, A., TURCAN, S., MIDJORD, J., NIELSEN, K. R., ANDERSEN, K. W., ANDERSEN, V., MISRA, R., AREBI, N., OKSANEN, P., COLLIN, P., DE CASTRO, L., HERNANDEZ, V., LANGHOLZ, E., MUNKHOLM, P. and GRP, E.-I., (2019). Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study. Journal of Crohns & Colitis, 13 (2), 198-208. <Go to ISI>://WOS:000459356300008
7. BURISCH, J., VARDI, H., SCHWARTZ, D., KRZNARIC, Z., LAKATOS, P. L., FUMERY, M., KUPCINSKAS, L., MAGRO, F., BELOUSOVA, E., OKSANEN, P., AREBI, N., LANGHOLZ, E., TURCAN, S., D'INCA, R., HERNANDEZ, V., VALPIANI, D., VEGH, Z., GIANNOTTA, M., KATSANOS, K. H., DURICOVA, D., NIELSEN, K. R., KIEVIT, H. A. L., ELLUL, P., SALUPERE, R., GOLDIS, A., KAIMAKLIOTIS, I., PEDERSEN, N., ANDERSEN, V., HALFVARSON, J., SEBASTIAN, S., DAHLERUP, J. F., MUNKHOLM, P., ODES, S. and EPI-IBD, (2019). Cost analysis in a prospective European population-based inception cohort: is there a cost-saving effect of biological therapy? Journal of Crohns & Colitis, 13 S9-S10. <Go to ISI>://WOS:000460544500016
8. BURISCH, J., ZAMMIT, S. C., ELLUL, P., TURCAN, S., DURICOVA, D., BORTLIK, M., ANDERSEN, K. W., ANDERSEN, V., KAIMAKLIOTIS, I. P., FUMERY, M., GOWER-ROUSSEAU, C., GIRARDIN, G., VALPIANI, D., GOLDIS, A., BRINAR, M., CUKOVIC-CAVKA, S., OKSANEN, P., COLLIN, P., BARROS, L., MAGRO, F., MISRA, R., AREBI, N., ERIKSSON, C., HALFVARSON, J., KIEVIT, H. A. L., PEDERSEN, N., KJELDSEN, J., MYERS, S., SEBASTIAN, S., KATSANOS, K. H., CHRISTODOULOU, D. K., MIDJORD, J., NIELSEN, K. R., KIUDELIS, G., KUPCINSKAS, L., NIKULINA, I., BELOUSOVA, E., SCHWARTZ, D., ODES, S., SALUPERE, R., CARMONA, A., PINEDA, J. R., VEGH, Z., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. and EPI, I. B. D. g., (2019). Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study. J Gastroenterol Hepatol, 34 (6), 996-1003. https://www.ncbi.nlm.nih.gov/pubmed/30562421
9. CABRAL, L., AFREIXO, V., MEIRELES, R., VAZ, M., FRADE, J. G., CHAVES, C., CAETANO, M., ALMEIDA, L. and PAIVA, J. A., (2019). Evaluation of Procalcitonin Accuracy for the Distinction Between Gram-Negative and Gram-Positive Bacterial Sepsis in Burn Patients. J Burn Care Res, 40 (1), 112-119. https://www.ncbi.nlm.nih.gov/pubmed/30481299
10. CABREIRA, V., SOARES-DA-SILVA, P. and MASSANO, J., (2019). Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review. Drugs, 79 (6), 593-608. https://www.ncbi.nlm.nih.gov/pubmed/30905034
11. CASTELLAO-SANTANA, L. M., YUMI ABIKO, P., AMBIEL, C. R., PEIXOTO, A. R., NORONHA-MATOS, J. B., CORREIA-DE-SA, P. and ALVES-DO-PRADO, W., (2019). Tetanic Facilitation of Neuromuscular Transmission by Adenosine A2A and Muscarinic M1 Receptors is Dependent on the Uptake of Choline via High-Affinity Transporters. Pharmacology, 103 (1-2), 38-49. https://www.ncbi.nlm.nih.gov/pubmed/30380560
12. DANESE, S., ALLEZ, M., VAN BODEGRAVEN, A. A., DOTAN, I., GISBERT, J. P., HART, A., LAKATOS, P. L., MAGRO, F., PEYRIN-BIROULET, L., SCHREIBER, S., TARABAR, D., VAVRICKA, S., HALFVARSON, J. and VERMEIRE, S., (2019). Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus. Digestive Diseases, 37 (4), 266-283. <Go to ISI>://WOS:000464379500002
13. DIAS, C. C., SANTIAGO, M., CORREIA, L., PORTELA, F., MINISTRO, P., LAGO, P., TRINDADE, E., FREITAS, A., MAGRO, F. and GEDII, (2019). Hospitalization trends of the Inflammatory Bowel Disease landscape: A nationwide overview of 16 years. Dig Liver Dis, 51 (7), 952-960. https://www.ncbi.nlm.nih.gov/pubmed/30826276
14. DOMENECH, E., PANES, J., HINOJOSA, J., ANNESE, V., MAGRO, F., STURNIOLO, G. C., BOSSA, F., FERNANDEZ, F., GONZALEZ-CONDE, B., GARCIA-SANCHEZ, V., DIGNASS, A., HERRERA, J. M., CABRIADA, J. L., GUARDIOLA, J., VECCHI, M., PORTELA, F., GINARD, D. and ULCEROSA, A. S. G. b. t. G. E. d. T. e. E. d. C. y. C., (2019). Corrigendum: Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial. J Crohns Colitis, 13 (6), 814. https://www.ncbi.nlm.nih.gov/pubmed/30951596
15. FERREIRA, J. J., LEES, A., ROCHA, J. F., POEWE, W., RASCOL, O. and SOARES-DA-SILVA, P., (2019). Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions. Eur J Neurol, 26 (7), 953-960. https://www.ncbi.nlm.nih.gov/pubmed/30681754
16. FONTES-SOUSA, A. P., SILVESTRE-FERREIRA, A. C., CARRETON, E., ESTEVES-GUIMARAES, J., MAIA-ROCHA, C., OLIVEIRA, P., LOBO, L., MORCHON, R., ARAUJO, F., SIMON, F. and MONTOYA-ALONSO, J. A., (2019). Exposure of humans to the zoonotic nematode Dirofilaria immitis in Northern Portugal. Epidemiol Infect, 147 e282. https://www.ncbi.nlm.nih.gov/pubmed/31793429
17. HAJIZADEH, H. S., HEIDARI, B., BERTOLDO, G., DELLA LUCIA, M. C., MAGRO, F., BROCCANELLO, C., BAGLIERI, A., PUGLISI, I., SQUARTINI, A., CAMPAGNA, G., CONCHERI, G., NARDI, S. and STEVANATO, P., (2019). Expression Profiling of Candidate Genes in Sugar Beet Leaves Treated with Leonardite-Based Biostimulant. High Throughput, 8 (4), https://www.ncbi.nlm.nih.gov/pubmed/31614507
18. HERNANDEZ, V., MARTINEZ-CADILLA, J., LANGHOLZ, E., CHRISTODOULOU, D., TURCAN, S., VALPIANI, D., LAKATOS, P. L., VEGH, Z., GOLDIS, A., BELOUSOVA, E., LADEFOGED, K., KIUDELIS, G., MCNAMARA, D., SHONOVA, O., KRZNARIC, Z., MAGRO, F., BJORNSSON, E. S., ALMER, S., FUMERY, M., DURICOVA, D., KIEVIT, A., KAIMAKLIOTIS, I., ELLUL, P., NIEWIADOMSKI, O., GIANNOTTA, M., ODES, S., PEDERSEN, N., DAHLERUP, J. F., SALUPERE, R., D'INCA, R., HALFVARSON, J., OKSANEN, P., AREBI, N., NIELSEN, K. R., ANDERSEN, V., SHAJI, S., MUNKHOLM, P., BURISCH, J. and EPI-IBD-GRP, (2019). Medical treatment and surgery in patients with elderly-onset inflammatory bowel disease: 3-year follow-up of Epi-IBD 2010-2011 cohorts. Journal of Crohns & Colitis, 13 S510-S511. <Go to ISI>://WOS:000460544503024
19. IGREJA, B., PIRES, N. M., WRIGHT, L. C. and SOARES-DA-SILVA, P., (2019). Effects of zamicastat treatment in a genetic model of salt-sensitive hypertension and heart failure. Eur J Pharmacol, 842 125-132. https://www.ncbi.nlm.nih.gov/pubmed/30401628
20. IGREJA, B., PIRES, N., LOUREIRO, A., WRIGHT, L. and SOARES-DA-SILVA, P., (2019). Cardiometabolic and Inflammatory Benefits of Sympathetic Down-Regulation with Zamicastat in Aged Spontaneously Hypertensive Rats. ACS Pharmacol Transl Sci, 2 (5), 353-360. https://www.ncbi.nlm.nih.gov/pubmed/32259069
21. LEAL, J., TEIXEIRA-SANTOS, L., PINHO, D., AFONSO, J., CARVALHO, J., DE LOURDES BASTOS, M., ALBINO-TEIXEIRA, A., FRAGA, S. and SOUSA, T., (2019). l-proline supplementation improves nitric oxide bioavailability and counteracts the blood pressure rise induced by angiotensin II in rats. Nitric Oxide, 82 1-11. https://www.ncbi.nlm.nih.gov/pubmed/30423454
22. LEES, A., FERREIRA, J. J., ROCHA, J. F., RASCOL, O., POEWE, W., GAMA, H. and SOARES-DA-SILVA, P., (2019). Safety Profile of Opicapone in the Management of Parkinson's Disease. J Parkinsons Dis, 9 (4), 733-740. https://www.ncbi.nlm.nih.gov/pubmed/31498127
23. LOPES, S., COSTA-SILVA, M., MAGINA, S., SILVA, M., MAGRO, F., AZEVEDO, F. and LISBOA, C., (2019). Concurrent Lip Chancre and Maculopapular Syphilides in a Patient under Anti-TNFalpha Therapy. Skinmed, 17 (5), 343-345. https://www.ncbi.nlm.nih.gov/pubmed/31782712
24. LOPES, S., GOMES, N., TRINDADE, E., AZEVEDO, F. and MAGINA, S., (2019). Hidradenitis suppurativa in a prepubertal girl. Acta Dermatovenerol Alp Pannonica Adriat, 28 (3), 139-141. https://www.ncbi.nlm.nih.gov/pubmed/31545394
25. LOPES, S., VIDE, J., COSTA-SILVA, M., AZEVEDO, F. and MAGINA, S., (2019). Awareness, knowledge, and practice patterns of general practitioner residents and specialists toward hidradenitis suppurativa: a survey study. Acta Dermatovenerol Alp Pannonica Adriat, 28 (2), 61-63. https://www.ncbi.nlm.nih.gov/pubmed/31233168
26. MAGRO, F. and ESTEVINHO, M. M., (2019). Moving from efficacy to effectiveness: budesonide multimatrix in ulcerative colitis. United European Gastroenterol J, 7 (9), 1153-1155. https://www.ncbi.nlm.nih.gov/pubmed/31700627
27. MAGRO, F., (2019). Anti-TNF treatment failure: drug levels, immunogenicity, or both? Lancet Gastroenterology & Hepatology, 4 (5), 326-327. <Go to ISI>://WOS:000463786300003
28. MAGRO, F., COELHO, R. and PEIXOTO, A., (2019). Can We Extrapolate Data from One Immune-Mediated Inflammatory Disease to Another One? Current Medicinal Chemistry, 26 (2), 248-258. <Go to ISI>://WOS:000461143200002
29. MAGRO, F., DIAS, C. C., PORTELA, F., MIRANDA, M., FERNANDES, S., BERNARDO, S., MINISTRO, P., LAGO, P., ROSA, I., PITA, I., CORREIA, L., RODRIGUES, P. P. and GEDII, (2019). Development and Validation of Risk Matrices Concerning Ulcerative Colitis Outcomes-Bayesian Network Analysis. J Crohns Colitis, 13 (4), 401-409. https://www.ncbi.nlm.nih.gov/pubmed/30329032
30. MAGRO, F., LOPES, J., BORRALHO, P., LOPES, S., COELHO, R., COTTER, J., CASTRO, F. D., SOUSA, H. T., SALGADO, M., ANDRADE, P., VIEIRA, A. I., FIGUEIREDO, P., CALDEIRA, P., SOUSA, A., DUARTE, M. A., AVILA, F., SILVA, J., MOLEIRO, J., MENDES, S., GIESTAS, S., MINISTRO, P., SOUSA, P., GONCALVES, R., GONCALVES, B., OLIVEIRA, A., ROSA, I., RODRIGUES, M., CHAGAS, C., DIAS, C. C., AFONSO, J., GEBOES, K., CARNEIRO, F. and PORTUGUESE, I. B. D. S. G., (2019). Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels. Gut, 68 (4), 594-603. https://www.ncbi.nlm.nih.gov/pubmed/29437913
31. MAGRO, F., LOPES, S., SILVA, M., COELHO, R., PORTELA, F., BRANQUINHO, D., CORREIA, L., FERNANDES, S., CRAVO, M., CALDEIRA, P., TAVARES DE SOUSA, H., PATITA, M., LAGO, P., RAMOS, J., AFONSO, J., REDONDO, I., MACHADO, P., PHILIP, G., LOPES, J. and CARNEIRO, F., (2019). Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab. Therap Adv Gastroenterol, 12 1756284819869141. https://www.ncbi.nlm.nih.gov/pubmed/31516554
32. MAGRO, F., LOPES, S., SILVA, M., COELHO, R., PORTELA, F., BRANQUINHO, D., CORREIA, L., FERNANDES, S., CRAVO, M., CALDEIRA, P., SOUSA, H. T., PATITA, M., LAGO, P., RAMOS, J., AFONSO, J., REDONDO, I., MACHADO, P., CORNILLIE, F., LOPES, J., CARNEIRO, F. and PORTUGUESE, I. B. D. G., (2019). Low Golimumab Trough Levels at Week 6 Are Associated With Poor Clinical, Endoscopic and Histological Outcomes in Ulcerative Colitis Patients: Pharmacokinetic and Pharmacodynamic Sub-analysis of the Evolution Study. J Crohns Colitis, 13 (11), 1387-1393. https://www.ncbi.nlm.nih.gov/pubmed/30989180
33. MAGRO, F., LOPES, S., SILVA, M., COELHO, R., PORTELA, F., BRANQUINHO, D., CORREIA, L., FERNANDES, S., CRAVO, M., CALDEIRA, P., SOUSA, H., PATITA, M., LAGO, P., RAMOS, J., AFONSO, J., REDONDO, I., MACHADO, P., PHILIP, G., LOPES, J. and CARNEIRO, F., (2019). Correlation between soluble suppression of tumorigenicity 2 (sST2) and endoscopic activity in patients with moderate to severe ulcerative colitis under golimumab treatment: results of the EVOLUTION study. Journal of Crohns & Colitis, 13 S363-S363. <Go to ISI>://WOS:000460544502059
34. MOCUMBI, A. O., STOTHARD, J. R., CORREIA-DE-SA, P. and YACOUB, M., (2019). Endomyocardial Fibrosis: an Update After 70 Years. Curr Cardiol Rep, 21 (11), 148. https://www.ncbi.nlm.nih.gov/pubmed/31758352
35. NORONHA-MATOS, J. B., CARDOSO, R., CALEJO, I., MAGALHÃES-CARDOSO, M. T., I., S., COSTA, M. A., FERREIRINHA, F., FREITAS, R., PELLETIER, J., SÉVIGNY, J. and CORREIA-DE-SÁ, P., (2019). NTPDase3 enzyme inhibition or gene silencing rescues the osteogenic potential of post-menopausal mesenchymal stem cells (MSCs) derived from bone marrow. Purinergic Signal, 14 (Suppl 1), S14-S15. https://link.springer.com/journal/11302/14/1/suppl
36. NUNES-CARNEIRO, D., MARQUES-PINTO, A., BRAGA, I., CABRAL, J. F., ALMEIDA, M., CAVADAS, V., DE ALMEIDA, R., CASTRO-HENRIQUES, A., FRAGA, A. and SILVA-RAMOS, M., (2019). Mini-incision Living Donor Nephrectomy and Trans-peritoneal Laparoscopic Nephrectomy: Will There Be a Place for New Evidence? Transplant Proc, 51 (5), 1555-1558. https://www.ncbi.nlm.nih.gov/pubmed/31155191
37. NUNES-CARNEIRO, D., MARQUES-PINTO, A., VEIGA, C., BRAGA, I., CABRAL, J. F., ALMEIDA, M., CAVADAS, V., CASTRO-HENRIQUES, A., ALMEIDA, R., FRAGA, A. and SILVA-RAMOS, M., (2019). Which One Is the Best for Living Donation: A Multiple-Artery Left Kidney Nephrectomy or a Right Kidney Nephrectomy? Transplant Proc, 51 (5), 1559-1562. https://www.ncbi.nlm.nih.gov/pubmed/31155192
38. PATINHA, D., CARVALHO, C., ABREU, C., CUNHA, O. M., MOTA, M. C., AFONSO, J., ALBINO-TEIXEIRA, A., DINIZ, C. and MORATO, M., (2019). Diabetes downregulates renal adenosine A2A receptors in an experimental model of hypertension. PLoS One, 14 (5), e0217552. https://www.ncbi.nlm.nih.gov/pubmed/31150459
39. PEREIRA-CASTRO, J., BRAS-SILVA, C. and FONTES-SOUSA, A. P., (2019). Novel insights into the role of urotensin II in cardiovascular disease. Drug Discov Today, 24 (11), 2170-2180. https://www.ncbi.nlm.nih.gov/pubmed/31430542
40. PINHEIRO, S. D., SERRAO, M. P., SILVA, T., BORGES, F. and SOARES-DA-SILVA, P., (2019). Pharmacodynamic evaluation of novel Catechol-O-methyltransferase inhibitors. Eur J Pharmacol, 847 53-60. https://www.ncbi.nlm.nih.gov/pubmed/30685433
41. PIRES, N. M., IGREJA, B., SERRAO, M. P., MATIAS, E. F., MOURA, E., ANTONIO, T., CAMPOS, F. L., BRION, L., BERTORELLO, A. and SOARES-DA-SILVA, P., (2019). Acute salt loading induces sympathetic nervous system overdrive in mice lacking salt-inducible kinase 1 (SIK1). Hypertens Res, 42 (8), 1114-1124. https://www.ncbi.nlm.nih.gov/pubmed/30894696
42. POUILLON, L., DANESE, S., HART, A., FIORINO, G., ARGOLLO, M., SELMI, C., CARLO-STELLA, C., LOEUILLE, D., COSTANZO, A., LOPEZ, A., VEGNI, E., RADICE, S., GILARDI, D., SOCHA, M., FAZIO, M., GONZALEZ-LORENZO, M., BONOVAS, S., MAGRO, F. and PEYRIN-BIROULET, L., (2019). Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients. Aliment Pharmacol Ther, 49 (9), 1181-1187. https://www.ncbi.nlm.nih.gov/pubmed/30932219
43. REIS, A., SANTOS, M., FURTADO, I., CRUZ, C., SA-COUTO, P., QUEIROS, A., ALMEIDA, L. and ROCHA, N., (2019). Disability and its clinical correlates in pulmonary hypertension measured through the World Health Organization Disability Assessment Schedule 2.0: a prospective, observational study. J Bras Pneumol, 45 (4), e20170355. https://www.ncbi.nlm.nih.gov/pubmed/31166372
44. RICKEN, B., SCHNEIDER, M., BANTLEON, F., VELAYUTHAM, S., TRAPANI, D., AFONSO, J., MAGRO, F. and ABEL, A., (2019). Quantum blue anti-adalimumab: development and evaluation of a point of care rapid test for measuring anti-adalimumab antibodies in human serum. Journal of Crohns & Colitis, 13 S166-S166. <Go to ISI>://WOS:000460544501005
45. ROCHA, C., AFONSO, J., LAGO, P., ARROJA, B., VIEIRA, A. I., DIAS, C. C. and MAGRO, F., (2019). Accuracy of the new rapid test for monitoring adalimumab levels. Therap Adv Gastroenterol, 12 1756284819828238. https://www.ncbi.nlm.nih.gov/pubmed/30833984
46. RODRIGUES, A. V., ALMEIDA, F. J. and VIEIRA-COELHO, M. A., (2019). Dimethyltryptamine: Endogenous Role and Therapeutic Potential. J Psychoactive Drugs, 51 (4), 299-310. https://www.ncbi.nlm.nih.gov/pubmed/31018803
47. ROSEIRA, J., MAGRO, F., FERNANDES, S., SIMOES, C., PORTELA, F., ISABEL, V. A., PATITA, M., LEAL, C., LAGO, P., CALDEIRA, P., GAGO, T., CURRAIS, P., SAMPAIO, A., DIAS, C., DE SOUSA, H. T. and GEDII, (2019). Sexual quality of life in inflammatory bowel disease: a multi-centre, national-level study. Journal of Crohns & Colitis, 13 S491-S492. <Go to ISI>://WOS:000460544502296
48. SANTIAGO, M., MAGRO, F., CORREIA, L., PORTELA, F., MINISTRO, P., LAGO, P. and DIAS, C. C., (2019). What forecasting the prevalence of inflammatory bowel disease may tell us about its evolution on a national scale. Therap Adv Gastroenterol, 12 1756284819860044. https://www.ncbi.nlm.nih.gov/pubmed/31467592
49. SILVA, T., MOHAMED, T., SHAKERI, A., RAO, P. P. N., SOARES DA SILVA, P., REMIAO, F. and BORGES, F., (2019). Repurposing nitrocatechols: 5-Nitro-alpha-cyanocarboxamide derivatives of caffeic acid and caffeic acid phenethyl ester effectively inhibit aggregation of tau-derived hexapeptide AcPHF6. Eur J Med Chem, 167 146-152. https://www.ncbi.nlm.nih.gov/pubmed/30771602
2018 (articles in alphabetical order)
1. ABREU, C. M., SOARES-DOS-REIS, R., MELO, P. N., RELVAS, J. B., GUIMARAES, J., SA, M. J., CRUZ, A. P. & MENDES PINTO, I. (2018). Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics. Front Mol Neurosci, 11 164. https://www.ncbi.nlm.nih.gov/pubmed/29867354
2. ADLBRECHT, C., BLANCO-VEREA, A., BOUZAS-MOSQUERA, M. C., BRION, M., BURTSCHER, M., CARBONE, F., CHANG, T. T., CHARMANDARI, E., CHEN, J. W., CORREIA-COSTA, L., DULLAART, R. P. F., ELEFTHERIADES, M., FERNANDEZ-FERNANDEZ, B., GOLIASCH, G., GREMMEL, T., GROENEVELD, M. E., HENRIQUE, A., HUELSMANN, M., JUNG, C., LICHTENAUER, M., MONTECUCCO, F., NICOLAIDES, N. C., NIESSNER, A., PALMEIRA, C., PIRKLBAUER, M., SANCHEZ-NINO, M. D., SOTIRIADIS, A., SOUSA, T., SULZGRUBER, P., VAN BEEK, A. P., VERONESE, N., WINTER, M. P., YEUNG, K. K. & BOUZAS-MOSQUERA, A. (2018). Research update for articles published in EJCI in 2016. Eur J Clin Invest, 48 (10), e13016. https://www.ncbi.nlm.nih.gov/pubmed/30099749
3. ARAUJO, A. M., MACHADO, H. S., FALCAO, A. C. & SOARES-DA-SILVA, P. (2018). Reliability of body-weight scalars on the assessment of propofol induction dose in obese patients. Acta Anaesthesiol Scand, 62 (4), 464-473. https://www.ncbi.nlm.nih.gov/pubmed/29159892
4. ARMANDO, I., ASICO, L. D., WANG, X., JONES, J. E., SERRAO, M. P., CUEVAS, S., GRANDY, D. K., SOARES-DA-SILVA, P. & JOSE, P. A. (2018). Antihypertensive effect of etamicastat in dopamine D2 receptor-deficient mice. Hypertens Res, 41 (7), 489-498. https://www.ncbi.nlm.nih.gov/pubmed/29654295
5. BARROS-BARBOSA, A. R., OLIVEIRA, A., LOBO, M. G., CORDEIRO, J. M. & CORREIA-DE-SA, P. (2018). Under stressful conditions activation of the ionotropic P2X7 receptor differentially regulates GABA and glutamate release from nerve terminals of the rat cerebral cortex. Neurochem Int, 112 81-95. https://www.ncbi.nlm.nih.gov/pubmed/29154812
6. BECKONERT, N. M., OPITZ, T., PITSCH, J., SOARES DA SILVA, P. & BECK, H. (2018). Polyamine Modulation of Anticonvulsant Drug Response: A Potential Mechanism Contributing to Pharmacoresistance in Chronic Epilepsy. J Neurosci, 38 (24), 5596-5605. https://www.ncbi.nlm.nih.gov/pubmed/29789377
7. BESSA-GONCALVES, M., BRAGANCA, B., MARTINS-DIAS, E., CORREIA-DE-SA, P. & FONTES-SOUSA, A. P. (2018). Is the adenosine A2B 'biased' receptor a valuable target for the treatment of pulmonary arterial hypertension? Drug Discov Today, 23 (6), 1285-1292. https://www.ncbi.nlm.nih.gov/pubmed/29747005
8. BICKER, J., ALVES, G., FORTUNA, A., SOARES-DA-SILVA, P. & FALCAO, A. (2018). In vitro assessment of the interactions of dopamine beta-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein. Eur J Pharm Sci, 117 35-40. https://www.ncbi.nlm.nih.gov/pubmed/29428540
9. BURISCH, J., KIUDELIS, G., KUPCINSKAS, L., KIEVIT, H. A. L., ANDERSEN, K. W., ANDERSEN, V., SALUPERE, R., PEDERSEN, N., KJELDSEN, J., D'INCA, R., VALPIANI, D., SCHWARTZ, D., ODES, S., OLSEN, J., NIELSEN, K. R., VEGH, Z., LAKATOS, P. L., TOCA, A., TURCAN, S., KATSANOS, K. H., CHRISTODOULOU, D. K., FUMERY, M., GOWER-ROUSSEAU, C., ZAMMIT, S. C., ELLUL, P., ERIKSSON, C., HALFVARSON, J., MAGRO, F. J., DURICOVA, D., BORTLIK, M., FERNANDEZ, A., HERNANDEZ, V., MYERS, S., SEBASTIAN, S., OKSANEN, P., COLLIN, P., GOLDIS, A., MISRA, R., AREBI, N., KAIMAKLIOTIS, I. P., NIKUINA, I., BELOUSOVA, E., BRINAR, M., CUKOVIC-CAVKA, S., LANGHOLZ, E., MUNKHOLM, P. & EPI, I. B. D. G. (2018). Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut, in press https://www.ncbi.nlm.nih.gov/pubmed/29363534
10. BURISCH, J., ZAMMIT, S. C., ELLUL, P., TURCAN, S., DURICOVA, D., BORTLIK, M., ANDERSEN, K. W., ANDERSEN, V., KAIMAKLIOTIS, I. P., FUMERY, M., GOWER-ROUSSEAU, C., GIRARDIN, G., VALPIANI, D., GOLDIS, A., BRINAR, M., CUKOVIC-CAVKA, S., OKSANEN, P., COLLIN, P., BARROS, L., MAGRO, F., MISRA, R., AREBI, N., ERIKSSON, C., HALFVARSON, J., KIEVIT, H. A. L., PEDERSEN, N., KJELDSEN, J., MYERS, S., SEBASTIAN, S., KATSANOS, K. H., CHRISTODOULOU, D. K., MIDJORD, J., NIELSEN, K. R., KIUDELIS, G., KUPCINSKAS, L., NIKULINA, I., BELOUSOVA, E., SCHWARTZ, D., ODES, S., SALUPERE, R., CARMONA, A., PINEDA, J. R., VEGH, Z., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. & EPI, I. B. D. G. (2018). Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study. J Gastroenterol Hepatol, in press https://www.ncbi.nlm.nih.gov/pubmed/30562421
11. CABRAL, L., AFREIXO, V., MEIRELES, R., VAZ, M., CHAVES, C., CAETANO, M., ALMEIDA, L. & PAIVA, J. A. (2018). Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients. Burns Trauma, 6 10. https://www.ncbi.nlm.nih.gov/pubmed/29610766
12. CABRAL, L., AFREIXO, V., MEIRELES, R., VAZ, M., MARQUES, M., TOURAIS, I., CHAVES, C., ALMEIDA, L. & PAIVA, J. A. (2018). Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients - a retrospective observational study. BMC Anesthesiol, 18 (1), 122. https://www.ncbi.nlm.nih.gov/pubmed/30185148
13. CHAPARRO, M., VERRETH, A., LOBATON, T., GRAVITO-SOARES, E., JULSGAARD, M., SAVARINO, E., MAGRO, F., AVNI BIRON, I., LOPEZ-SERRANO, P., CASANOVA, M. J., GOMPERTZ, M., VITOR, S., ARROYO, M., PUGLIESE, D., ZABANA, Y., VICENTE, R., AGUAS, M., BAR-GIL SHITRIT, A., GUTIERREZ, A., DOHERTY, G. A., FERNANDEZ-SALAZAR, L., MARTINEZ CADILLA, J., HUGUET, J. M., O'TOOLE, A., STASI, E., MANCENIDO MARCOS, N., VILLORIA, A., KARMIRIS, K., RAHIER, J. F., RODRIGUEZ, C., DIZ-LOIS PALOMARES, M., FIORINO, G., BENITEZ, J. M., PRINCIPI, M., NAFTALI, T., TAXONERA, C., MANTZARIS, G., SEBKOVA, L., IADE, B., LISSNER, D., FERRER BRADLEY, I., LOPEZ-SAN ROMAN, A., MARIN-JIMENEZ, I., MERINO, O., SIERRA, M., VAN DOMSELAAR, M., CAPRIOLI, F., GUERRA, I., PEIXE, P., PIQUERAS, M., RODRIGUEZ-LAGO, I., BER, Y., VAN HOEVE, K., TORRES, P., GRAVITO-SOARES, M., RUDBECK-RESDAL, D., BARTOLO, O., PEIXOTO, A., MARTIN, G., ARMUZZI, A., GARRE, A., DONDAY, M. G., MARTIN DE CARPI, F. J. & GISBERT, J. P. (2018). Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. Am J Gastroenterol, 113 (3), 396-403. https://www.ncbi.nlm.nih.gov/pubmed/29460920
14. CHARBIT-HENRION, F., PARLATO, M., HANEIN, S., DUCLAUX-LORAS, R., NOWAK, J., BEGUE, B., RAKOTOBE, S., BRUNEAU, J., FOURRAGE, C., ALIBEU, O., RIEUX-LAUCAT, F., LEVY, E., STOLZENBERG, M. C., MAZEROLLES, F., LATOUR, S., LENOIR, C., FISCHER, A., PICARD, C., ALOI, M., AMIL DIAS, J., BEN HARIZ, M., BOURRIER, A., BREUER, C., BRETON, A., BRONSKI, J., BUDERUS, S., CANANZI, M., COOPMAN, S., CREMILLEUX, C., DABADIE, A., DUMANT-FOREST, C., EGRITAS GURKAN, O., FABRE, A., FISCHER, A., GERMAN DIAZ, M., GONZALEZ-LAMA, Y., GOULET, O., GUARISO, G., GURCAN, N., HOMAN, M., HUGOT, J. P., JEZIORSKI, E., KARANIKA, E., LACHAUX, A., LEWINDON, P., LIMA, R., MAGRO, F., MAJOR, J., MALAMUT, G., MAS, E., MATTYUS, I., MEARIN, L. M., MELEK, J., NAVAS-LOPEZ, V. M., PAERREGAARD, A., PELATAN, C., PIGNEUR, B., PINTO PAIS, I., REBEUH, J., ROMANO, C., SIALA, N., STRISCIUGLIO, C., TEMPIA-CALIERA, M., TOUNIAN, P., TURNER, D., URBONAS, V., WILLOT, S., RUEMMELE, F. M. & CERF-BENSUSSAN, N. (2018). Diagnostic Yield of Next-Generation Sequencing in Very Early-Onset Inflammatory Bowel Diseases: A Multicenter Study. J Crohns Colitis, in press https://www.ncbi.nlm.nih.gov/pubmed/29788237
15. CHETCUTI ZAMMIT, S., ELLUL, P., GIRARDIN, G., VALPIANI, D., NIELSEN, K. R., OLSEN, J., GOLDIS, A., LAZAR, D., SHONOVA, O., NOVAKOVA, M., SEBASTIAN, S., WHITEHEAD, E., CARMONA, A., MARTINEZ-CADILLA, J., DAHLERUP, J. F., KIEVIT, A. L. H., THORSGAARD, N., KATSANOS, K. H., CHRISTODOULOU, D. K., MAGRO, F., SALUPERE, R., PEDERSEN, N., KJELDSEN, J., CARLSEN, K., IOANNIS, K., BERGEMALM, D., HALFVARSON, J., DURICOVA, D., BORTLIK, M., COLLIN, P., OKSANEN, P., KIUDELIS, G., KUPCINSKAS, L., KUDSK, K., ANDERSEN, V., O'MORAIN, C., BAILEY, Y., DORON, S., SHMUEL, O., ALMER, S., AREBI, N., MISRA, R., CUKOVIC-CAVKA, S., BRINAR, M., MUNKHOLM, P., VEGH, Z. & BURISCH, J. (2018). Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study. Eur J Gastroenterol Hepatol, 30 (11), 1297-1303. https://www.ncbi.nlm.nih.gov/pubmed/30134383
16. COSTA, R., MAGALHAES, L. M., GRACA, J., VIEIRA, M., GAMA, H., MOREIRA, J., ROCHA, J. F. & SOARES-DA-SILVA, P. (2018). Eslicarbazepine acetate exposure in pregnant women with epilepsy. Seizure, 58 72-74. https://www.ncbi.nlm.nih.gov/pubmed/29674237
17. COSTA, R., STEINHOFF, B., GAMA, H., IKEDO, F., ROCHA, J. F. & SOARES-DA-SILVA, P. (2018). Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged >/= 65 Years with Focal Seizures. Drugs Aging, 35 (12), 1109-1117. https://www.ncbi.nlm.nih.gov/pubmed/30387043
18. COSTA-SILVA, M., VIDE, J., LOPES, S., AZEVEDO, F. & MAGINA, S. (2018). Psoriasis and comorbidities: general practitioners’ awareness. Acta Dermatovenerologica Alpina, Pannonica et Adriatica, 27 5-7.
19. DIAS, C. C., PORTELA, F., FERNANDES, S., MINISTRO, P., LAGO, P., ROSA, I., CORREIA, L., MAGRO, F. & ON BEHALF, G. (2018). The timing of early therapeutic strategies has a significant impact on Crohn's disease prognosis. Dig Liver Dis, 50 (5), 462-468. https://www.ncbi.nlm.nih.gov/pubmed/29456097
20. DOMENECH, E., PANES, J., HINOJOSA, J., ANNESE, V., MAGRO, F., STURNIOLO, G. C., BOSSA, F., FERNANDEZ, F., GONZALEZ-CONDE, B., GARCIA-SANCHEZ, V., DIGNASS, A., HERRERA, J. M., CABRIADA, J. L., GUARDIOLA, J., VECCHI, M., PORTELA, F., GINARD, D. & ULCEROSA, A. S. G. B. T. G. E. D. T. E. E. D. C. Y. C. (2018). Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial. J Crohns Colitis, 12 (6), 687-694. https://www.ncbi.nlm.nih.gov/pubmed/29490024
21. ESTEVINHO, M. M., AFONSO, J., ROSA, I., LAGO, P., TRINDADE, E., CORREIA, L., DIAS, C. C., MAGRO, F. & GEDII (2018). Placebo Effect on the Health-related Quality of Life of Inflammatory Bowel Disease Patients: A Systematic Review With Meta-analysis. J Crohns Colitis, 12 (10), 1232-1244. https://www.ncbi.nlm.nih.gov/pubmed/30010736
22. FERREIRA, J. J., LEES, A. J., POEWE, W., RASCOL, O., ROCHA, J. F., KELLER, B. & SOARES-DA-SILVA, P. (2018). Effectiveness of opicapone and switching from entacapone in fluctuating Parkinson disease. Neurology, 90 (21), e1849-e1857. https://www.ncbi.nlm.nih.gov/pubmed/29695590
23. FERREIRO-IGLESIAS, R. & MAGRO, F. (2018). Young GI angle: Tips and tricks for an academic career. United European Gastroenterol J, 6 (6), 952-954. https://www.ncbi.nlm.nih.gov/pubmed/30023074
24. FIGUEIRA, L., FERREIRA, C., JANEIRO, C., SERRAO, P., FALCAO-REIS, F. & MOURA, D. (2018). Concentration gradient of noradrenaline from the periphery to the centre of the cornea - A clue to its origin. Exp Eye Res, 168 107-114. https://www.ncbi.nlm.nih.gov/pubmed/29339089
25. FIGUEIRA, L., JANEIRO, C., FERREIRINHA, F., SERRAO, P., PERESTRELO, S., FALCAO-REIS, F., CORREIA-DE-SA, P. & MOURA, D. (2018). Regulation of corneal noradrenaline release and topography of sympathetic innervation: Functional implications for adrenergic mechanisms in the human cornea. Exp Eye Res, 174 121-132. https://www.ncbi.nlm.nih.gov/pubmed/29803557
26. FONSECA, D. J. & VAZ DA SILVA, M. J. (2018). Cardiac channelopathies: The role of sodium channel mutations. Rev Port Cardiol, 37 (2), 179-199. https://www.ncbi.nlm.nih.gov/pubmed/29525288
27. GIDAL, B. E., JACOBSON, M. P., BEN-MENACHEM, E., CARRENO, M., BLUM, D., SOARES-DA-SILVA, P., FALCAO, A., ROCHA, F., MOREIRA, J., GRINNELL, T., LUDWIG, E., FIEDLER-KELLY, J., PASSARELL, J. & SUNKARANENI, S. (2018). Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate. Acta Neurol Scand, 138 (3), 203-211. https://www.ncbi.nlm.nih.gov/pubmed/29732549
28. GONCALVES, J., MAGRO, F., DANESE, S., LAKATOS, P. L. & BEN-HORIN, S. (2018). Editorial: antigenic response to CT-P13 and infliximab originator in IBD shows similar epitope recognition-evidence from basic science supports safe switching to biosimilars. Authors' reply. Aliment Pharmacol Ther, 48 (5), 575-576. https://www.ncbi.nlm.nih.gov/pubmed/30156326
29. GONCALVES, J., SANTOS, M., ACURCIO, R., IRIA, I., GOUVEIA, L., MATOS BRITO, P., CATARINA CUNHA-SANTOS, A., BARBAS, A., GALVAO, J., BARBOSA, I., AIRES DA SILVA, F., ALCOBIA, A., CAVACO, M., CARDOSO, M., DELGADO ALVES, J., CAREY, J. J., DORNER, T., EURICO FONSECA, J., PALMELA, C., TORRES, J., LIMA VIEIRA, C., TRABUCO, D., FIORINO, G., STRIK, A., YAVZORI, M., ROSA, I., CORREIA, L., MAGRO, F., D'HAENS, G., BEN-HORIN, S., LAKATOS, P. L. & DANESE, S. (2018). Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition. Aliment Pharmacol Ther, 48 (5), 507-522. https://www.ncbi.nlm.nih.gov/pubmed/29873091
30. HOLTKAMP, D., OPITZ, T., HEBEISEN, S., SOARES-DA-SILVA, P. & BECK, H. (2018). Effects of eslicarbazepine on slow inactivation processes of sodium channels in dentate gyrus granule cells. Epilepsia, 59 (8), 1492-1506. https://www.ncbi.nlm.nih.gov/pubmed/29953587
31. IGREJA, B., PIRES, N. M., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2018). Effects of zamicastat treatment in a genetic model of salt-sensitive hypertension and heart failure. Eur J Pharmacol, 842 125-132. https://www.ncbi.nlm.nih.gov/pubmed/30401628
32. JOZWIAK, S., VEGGIOTTI, P., MOREIRA, J., GAMA, H., ROCHA, F. & SOARES-DA-SILVA, P. (2018). Effects of adjunctive eslicarbazepine acetate on neurocognitive functioning in children with refractory focal-onset seizures. Epilepsy Behav, 81 1-11. https://www.ncbi.nlm.nih.gov/pubmed/29454255
33. KISS, L. E., BELIAEV, A., FERREIRA, H. S., ROSA, C. P., BONIFACIO, M. J., LOUREIRO, A. I., PIRES, N. M., PALMA, P. N. & SOARES-DA-SILVA, P. (2018). Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase. ChemMedChem, 13 (20), 2177-2188. https://www.ncbi.nlm.nih.gov/pubmed/30113139
34. KITAJIMA, T., MIZOTE, S., BONIFACIO, M. J., UMEMURA, T., YONEDA, K., MOSER, P., SOARES-DA-SILVA, P. & TANAKA, M. (2018). Inhibition of catechol-O-methyltransferase in the cynomolgus monkey by opicapone after acute and repeated administration. Neuropharmacology, 143 282-288. https://www.ncbi.nlm.nih.gov/pubmed/30290160
35. KRAUSS, G., BITON, V., HARVEY, J. H., ELGER, C., TRINKA, E., SOARES DA SILVA, P., GAMA, H., CHENG, H., GRINNELL, T. & BLUM, D. (2018). Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials. Epilepsy Res, 139 1-8. https://www.ncbi.nlm.nih.gov/pubmed/29127848
36. LEAL, J., TEIXEIRA-SANTOS, L., PINHO, D., AFONSO, J., CARVALHO, J., DE LOURDES BASTOS, M., ALBINO-TEIXEIRA, A., FRAGA, S. & SOUSA, T. (2018). l-proline supplementation improves nitric oxide bioavailability and counteracts the blood pressure rise induced by angiotensin II in rats. Nitric Oxide, 82 1-11. https://www.ncbi.nlm.nih.gov/pubmed/30423454
37. LOPES, S., ANDRADE, P., AFONSO, J., CUNHA, R., RODRIGUES-PINTO, E., RAMOS, I., MACEDO, G. & MAGRO, F. (2018). Monitoring Crohn's disease activity: endoscopy, fecal markers and computed tomography enterography. Therap Adv Gastroenterol, 11 1756284818769075. https://www.ncbi.nlm.nih.gov/pubmed/29760785
38. LOPES, S., ANDRADE, P., CUNHA, R. & MAGRO, F. (2018). Transmural healing in Crohn's disease: Beyond mural findings. Dig Liver Dis, 50 (1), 103-104. https://www.ncbi.nlm.nih.gov/pubmed/29089271
39. MAGRO, F. & ANTONIO, T. (2018) Fibrosis in ulcerative colitis. In R. F. (eds) Fibrostenotic Inflammatory Bowel Disease, Springer, Cham, 10 147-57
40. MAGRO, F. & SOUSA, H. T. (2018). Editorial: ulcerative colitis submucosal fibrosis and inflammation: more than just strictures. Aliment Pharmacol Ther, 47 (7), 1033-1034. https://www.ncbi.nlm.nih.gov/pubmed/29512912
41. MAGRO, F., ROCHA, C., VIEIRA, A. I., SOUSA, H. T., ROSA, I., LOPES, S., CARVALHO, J., DIAS, C. C. & AFONSO, J. (2018). The performance of Remicade(R)-optimized quantification assays in the assessment of Flixabi(R) levels. Therap Adv Gastroenterol, 11 1756284818796956. https://www.ncbi.nlm.nih.gov/pubmed/30263065
42. MCNULTY, P., PILCHER, R., RAMESH, R., NECUINIATE, R., HUGHES, A., FAREWELL, D., HOLMANS, P., JONES, L. & NETWORK, R. I. O. T. E. H. S. D. (2018). Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study. J Huntingtons Dis, 7 (3), 209-222. https://www.ncbi.nlm.nih.gov/pubmed/30103338
43. MELO, F. J. & MAGINA, S. (2018). Clinical management of Anti-TNF-alpha-induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: a systematic review. Int J Dermatol, 57 (12), 1521-1532. https://www.ncbi.nlm.nih.gov/pubmed/30028008
44. MENDES, P., MARTINHO, R., LEITE, S., MAIA-MOCO, L., LEITE-MOREIRA, A. F., LOURENCO, A. P. & MOREIRA-RODRIGUES, M. (2018). Chronic exercise induces pathological left ventricular hypertrophy in adrenaline-deficient mice. Int J Cardiol, 253 113-119. https://www.ncbi.nlm.nih.gov/pubmed/29306449
45. MIEHLKE, S., ACOSTA, M. B., BOUMA, G., CARPIO, D., MAGRO, F., MOREELS, T. & PROBERT, C. (2018). Oral budesonide in gastrointestinal and liver disease: A practical guide for the clinician. J Gastroenterol Hepatol, https://www.ncbi.nlm.nih.gov/pubmed/29603368
46. OLIVEIRA, A., MARTINHO, R., SERRAO, P. & MOREIRA-RODRIGUES, M. (2018). Epinephrine Released During Traumatic Events May Strengthen Contextual Fear Memory Through Increased Hippocampus mRNA Expression of Nr4a Transcription Factors. Front Mol Neurosci, 11 334. https://www.ncbi.nlm.nih.gov/pubmed/30319349
47. PEYRIN-BIROULET, L., BAUMGART, D. C., ARMUZZI, A., GIONCHETTI, P., SEBASTIAN, S., DANESE, S., MAGRO, F., HIGGINS, S., YAWORKSY, A., BANDERAS, B. & KACHROO, S. (2018). Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach. Dig Dis, 36 (5), 346-353. https://www.ncbi.nlm.nih.gov/pubmed/29969780
48. PITA, I. & MAGRO, F. (2018). Advanced imaging techniques for small bowel Crohn's disease: what does the future hold? Therap Adv Gastroenterol, 11 1756283X18757185. https://www.ncbi.nlm.nih.gov/pubmed/29467827
49. REIS, A., SANTOS, M., FURTADO, I., CRUZ, C., SA-COUTO, P., QUEIRÓS, A., ALMEIDA, L. & ROCHA, N. (2018). Disability and its clinical correlates in pulmonary hypertension measured through the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0): a prospective, observational study. J Bras Pneumol., 44 (6), 1-10.
50. REIS, A., SANTOS, M., VICENTE, M., FURTADO, I., CRUZ, C., MELO, A., CARVALHO, L., GONÇALVES, F., SA-COUTO, P. & ALMEIDA, L. (2018). Health-Related Quality of Life in Pulmonary Hypertension and Its Clinical Correlates: A Cross-Sectional Study. BioMed Research International, Article ID 3924517 https://www.hindawi.com/journals/bmri/2018/3924517/
51. SOUSA, H. T., BRITO, J. & MAGRO, F. (2018). New cross-sectional imaging in IBD. Curr Opin Gastroenterol, 34 (4), 194-207. https://www.ncbi.nlm.nih.gov/pubmed/29846256
52. TRINKA, E., BEN-MENACHEM, E., KOWACS, P. A., ELGER, C., KELLER, B., LOFFLER, K., ROCHA, J. F. & SOARES-DA-SILVA, P. (2018). Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study. Epilepsia, 59 (2), 479-491. https://www.ncbi.nlm.nih.gov/pubmed/29369348
53. TRINKA, E., ROCHA, J. F. & SOARES-DA-SILVA, P. (2018). Response: Comparing the dosages of lacosamide, eslicarbazepine acetate, and controlled-release carbamazepine in noninferiority epilepsy monotherapy trials: How much "fair" is "fair". Epilepsia, 59 (4), 900-901. https://www.ncbi.nlm.nih.gov/pubmed/29604066
54. VAZ, R. P., CARDOSO, A., SERRAO, P., PEREIRA, P. A. & MADEIRA, M. D. (2018). Chronic stress leads to long-lasting deficits in olfactory-guided behaviors, and to neuroplastic changes in the nucleus of the lateral olfactory tract. Horm Behav, 98 130-144. https://www.ncbi.nlm.nih.gov/pubmed/29277699
55. VIDE, J., OSORIO, F., COSTA-SILVA, M., LOPES, S., AZEVEDO, F., CAMILA DIAS, C., MAGINA, S. & MAGRO, F. (2018). Cutaneous Morbidity Among Inflammatory Bowel Disease Patients: A Cohort Study. J Crohns Colitis, 12 (4), 442-451. https://www.ncbi.nlm.nih.gov/pubmed/29300856
2017 (articles in alphabetical order)
1. ABREU, C., AFONSO, J., CAMILA DIAS, C., RUAS, R., SARMENTO, A. & MAGRO, F. (2017). Serial Tuberculosis Screening in Inflammatory Bowel Disease Patients Receiving Anti-TNFalpha Therapy. J Crohns Colitis, 11 (10), 1223-1229. https://www.ncbi.nlm.nih.gov/pubmed/28605520
2. ABREU, C., SARMENTO, A. & MAGRO, F. (2017). Screening, prophylaxis and counselling before the start of biological therapies: A practical approach focused on IBD patients. Dig Liver Dis, 49 (12), 1289-1297. https://www.ncbi.nlm.nih.gov/pubmed/28986117
3. AFONSO, J., DE SOUSA, H. T., ROSA, I., CARVALHO, J., DIAS, C. C. & MAGRO, F. (2017). Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays. Therap Adv Gastroenterol, 10 (9), 661-671. https://www.ncbi.nlm.nih.gov/pubmed/28932268
4. ARAUJO, A. M., MACHADO, H. S., FALCAO, A. C. & SOARES-DA-SILVA, P. (2017). Reliability of body-weight scalars on the assessment of propofol induction dose in obese patients. Acta Anaesthesiol Scand, in press https://www.ncbi.nlm.nih.gov/pubmed/29159892
5. BICKER, J., FORTUNA, A., ALVES, G., SOARES-DA-SILVA, P. & FALCAO, A. (2017). Elucidation of the Impact of P-glycoprotein and Breast Cancer Resistance Protein on the Brain Distribution of Catechol-O-Methyltransferase Inhibitors. Drug Metab Dispos, 45 (12), 1282-1291. https://www.ncbi.nlm.nih.gov/pubmed/28916530
6. BURISCH, J., VEGH, Z., KATSANOS, K. H., CHRISTODOULOU, D. K., LAZAR, D., GOLDIS, A., O'MORAIN, C., FERNANDEZ, A., PEREIRA, S., MYERS, S., SEBASTIAN, S., PEDERSEN, N., OLSE, J., RUBEK NIELSEN, K., SCHWARTZ, D., ODES, S., ALMER, S., HALFVARSON, J., TURK, N., CUKOVIC-CAVKA, S., NIKULINA, I., BELOUSOVA, E., DURICOVA, D., BORTLIK, M., SHONOVA, O., SALUPERE, R., BARROS, L., MAGRO, F., JONAITIS, L., KUPCINSKAS, L., TURCAN, S., KAIMAKLIOTIS, I., LADEFOGED, K., KUDSK, K., ANDERSEN, V., VIND, I., THORSGAARD, N., OKSANEN, P., COLLIN, P., DAL PIAZ, G., SANTINI, A., NIEWIADOMSKI, O., BELL, S., MOUM, B., AREBI, N., KJELDSEN, J., CARLSEN, K., LANGHOLZ, E., LAKATOS, P. L., MUNKHOLM, P., GERDES, L. U., DAHLERUP, J. F. & EPICOM STUDY, G. (2017). Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study. J Crohns Colitis, 11 (10), 1213-1222. https://www.ncbi.nlm.nih.gov/pubmed/28575481
7. CAVALCANTE, W. L. G., NORONHA-MATOS, J. B., TIMOTEO, M. A., FONTES, M. R. M., GALLACCI, M. & CORREIA-DE-SA, P. (2017). Neuromuscular paralysis by the basic phospholipase A2 subunit of crotoxin from Crotalus durissus terrificus snake venom needs its acid chaperone to concurrently inhibit acetylcholine release and produce muscle blockage. Toxicol Appl Pharmacol, 334 8-17. https://www.ncbi.nlm.nih.gov/pubmed/28867438
8. CERTAL, M., VINHAS, A., BARROS-BARBOSA, A., FERREIRINHA, F., COSTA, M. A. & CORREIA-DE-SA, P. (2017). ADP-Induced Ca(2+) Signaling and Proliferation of Rat Ventricular Myofibroblasts Depend on Phospholipase C-Linked TRP Channels Activation Within Lipid Rafts. J Cell Physiol, 232 (6), 1511-1526. https://www.ncbi.nlm.nih.gov/pubmed/27755650
9. CORREIA-SA, I., SERRAO, P., MARQUES, M. & VIEIRA-COELHO, M. A. (2017). Hypertrophic Scars: Are Vitamins and Inflammatory Biomarkers Related with the Pathophysiology of Wound Healing? Obes Surg, 27 (12), 3170-3178. https://www.ncbi.nlm.nih.gov/pubmed/28569361
10.COSTA PEREIRA, C., DURAES, C., COELHO, R., GRACIO, D., SILVA, M., PEIXOTO, A., LAGO, P., PEREIRA, M., CATARINO, T., PINHO, S., TEIXEIRA, J. P., MACEDO, G., ANNESE, V. & MAGRO, F. (2017). Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel Disease. PLoS One, 12 (1), e0169102. http://www.ncbi.nlm.nih.gov/pubmed/28052094
11.COSTA, S., CORREIA-DE-SA, P., PORTO, M. J. & CAINE, L. (2017). The Use of Laser Microdissection in Forensic Sexual Assault Casework: Pros and Cons Compared to Standard Methods. J Forensic Sci, 62 (4), 998-1006. https://www.ncbi.nlm.nih.gov/pubmed/28133731
12.DE VARGAS, L. D. S., GONCALVES, R., LARA, M. V. S., COSTA-FERRO, Z. S. M., SALAMONI, S. D., DOMINGUES, M. F., PIOVESAN, A. R., DE ASSIS, D. R., VINADE, L., CORRADO, A. P., ALVES-DO-PRADO, W., CORREIA-DE-SA, P., DA COSTA, J. C., IZQUIERDO, I., DAL BELO, C. A. & MELLO-CARPES, P. B. (2017). Methylprednisolone as a memory enhancer in rats: Effects on aversive memory, long-term potentiation and calcium influx. Brain Res, 1670 44-51. https://www.ncbi.nlm.nih.gov/pubmed/28606783
13.DIAS, C. C., PEREIRA RODRIGUES, P., FERNANDES, S., PORTELA, F., MINISTRO, P., MARTINS, D., SOUSA, P., LAGO, P., ROSA, I., CORREIA, L., MOURA SANTOS, P. & MAGRO, F. (2017). The risk of disabling, surgery and reoperation in Crohn's disease - A decision tree-based approach to prognosis. PLoS One, 12 (2), e0172165. https://www.ncbi.nlm.nih.gov/pubmed/28225800
14.DIAS, C. C., RODRIGUES, P. P., COELHO, R., SANTOS, P. M., FERNANDES, S., LAGO, P., CAETANO, C., RODRIGUES, A., PORTELA, F., OLIVEIRA, A., MINISTRO, P., CANCELA, E., VIEIRA, A. I., BAROSA, R., COTTER, J., CARVALHO, P., CREMERS, I., TRABULO, D., CALDEIRA, P., ANTUNES, A., ROSA, I., MOLEIRO, J., PEIXE, P., HERCULANO, R., GONCALVES, R., GONCALVES, B., SOUSA, H. T., CONTENTE, L., MORNA, H., LOPES, S., MAGRO, F. & ON BEHALF, G. (2017). Erratum: Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. J Crohns Colitis, 11 (4), 515. https://www.ncbi.nlm.nih.gov/pubmed/27927719
15.DIAS, C. C., RODRIGUES, P. P., COELHO, R., SANTOS, P. M., FERNANDES, S., LAGO, P., CAETANO, C., RODRIGUES, A., PORTELA, F., OLIVEIRA, A., MINISTRO, P., CANCELA, E., VIEIRA, A. I., BAROSA, R., COTTER, J., CARVALHO, P., CREMERS, I., TRABULO, D., CALDEIRA, P., ANTUNES, A., ROSA, I., MOLEIRO, J., PEIXE, P., HERCULANO, R., GONCALVES, R., GONCALVES, B., SOUSA, H. T., CONTENTE, L., MORNA, H., LOPES, S., MAGRO, F. & ON BEHALF, G. (2017). Development and Validation of Risk Matrices for Crohn's Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. J Crohns Colitis, 11 (4), 445-453. https://www.ncbi.nlm.nih.gov/pubmed/27683799
16.ELGER, C., KOEPP, M., TRINKA, E., VILLANUEVA, V., CHAVES, J., BEN-MENACHEN, E., KOWACS, P. A., GIL-NAGEL, A., MOREIRA, J., GAMA, H., ROCHA, J. F. & SOARES-DA-SILVA, P. (2017). Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies. CNS Neurosci Ther, 23 (12), 961-972. https://www.ncbi.nlm.nih.gov/pubmed/29030894
17.ESTEVINHO, M. M., AFONSO, J., ROSA, I., LAGO, P., TRINDADE, E., CORREIA, L., DIAS, C. C., MAGRO, F. & GEDII (2017). A Systematic Review and Meta-Analysis of 6-Thioguanine Nucleotide Levels and Clinical Remission in Inflammatory Bowel Disease. J Crohns Colitis, 11 (11), 1381-1392. https://www.ncbi.nlm.nih.gov/pubmed/28981590
18.FERREIRA DE OLIVEIRA, J. M. P., PACHECO, A. R., COUTINHO, L., OLIVEIRA, H., PINHO, S., ALMEIDA, L., FERNANDES, E. & SANTOS, C. (2017). Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models. Arch Toxicol, in press https://www.ncbi.nlm.nih.gov/pubmed/29270805
19.GAMA, H., VIEIRA, M., COSTA, R., GRACA, J., MAGALHAES, L. M. & SOARES-DA-SILVA, P. (2017). Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience. Drug Saf, 40 (12), 1231-1240. https://www.ncbi.nlm.nih.gov/pubmed/28752473
20.GOMES, T., GUIMARÃES, J., LEÃO, M., MOURA, C., GARRETT, C., AZEVEDO, E., MASSANO, J., OLIVEIRA, J. P. & CASTRO, P. (2017). Investigation of Genetic Aetiology in Neurodegenerative Ataxias: Recommendations from the Group of Neurogenetics of Centro Hospitalar São João, Portugal. Acta Med Port, 30 (6), 502-12.
21.GONCALVES, D., ALVES, G., FORTUNA, A., BONIFACIO, M. J., SOARES-DA-SILVA, P. & FALCAO, A. (2017). A single- and multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of opicapone, a novel COMT inhibitor, in rat. Neuropharmacology, 125 146-155. https://www.ncbi.nlm.nih.gov/pubmed/28734868
22.GONCALVES, D., ALVES, G., FORTUNA, A., SOARES-DA-SILVA, P. & FALCAO, A. (2017). Pharmacokinetics of opicapone, a third-generation COMT inhibitor, after single and multiple oral administration: A comparative study in the rat. Toxicol Appl Pharmacol, 323 9-15. https://www.ncbi.nlm.nih.gov/pubmed/28322896
23.IVERSEN, L., DAUDEN, E., SEGAERT, S., FREEMAN, K., MAGINA, S., RIGOPOULOS, D. & THACI, D. (2017). Reformulations of well-known active ingredients in the topical treatment of psoriasis vulgaris can improve clinical outcomes for patients. J Eur Acad Dermatol Venereol, 31 (8), 1271-1284. https://www.ncbi.nlm.nih.gov/pubmed/28419600
24.KOPYLOV, U., PAPAMICHAEL, K., KATSANOS, K., WATERMAN, M., BAR-GIL SHITRIT, A., BOYSEN, T., PORTELA, F., PEIXOTO, A., SZILAGYI, A., SILVA, M., MACONI, G., HAR-NOY, O., BOSSUYT, P., MANTZARIS, G., BARREIRO DE ACOSTA, M., CHAPARRO, M., CHRISTODOULOU, D. K., ELIAKIM, R., RAHIER, J. F., MAGRO, F., DROBNE, D., FERRANTE, M., SONNENBERG, E., SIEGMUND, B., MULS, V., THURM, T., YANAI, H., DOTAN, I., RAINE, T., LEVIN, A., ISRAELI, E., GHALIM, F., CARBONNEL, F., VERMEIRE, S., BEN-HORIN, S. & ROBLIN, X. (2017). Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study. Inflamm Bowel Dis, 23 (9), 1605-1613. https://www.ncbi.nlm.nih.gov/pubmed/28590343
25.KRAUSS, G., BITON, V., HARVEY, J. H., ELGER, C., TRINKA, E., SOARES DA SILVA, P., GAMA, H., CHENG, H., GRINNELL, T. & BLUM, D. (2017). Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials. Epilepsy Res, 139 1-8. https://www.ncbi.nlm.nih.gov/pubmed/29127848
26.LEES, A. J., FERREIRA, J., RASCOL, O., POEWE, W., ROCHA, J. F., MCCRORY, M., SOARES-DA-SILVA, P. & INVESTIGATORS, B.-S. (2017). Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. JAMA Neurol, 74 (2), 197-206. https://www.ncbi.nlm.nih.gov/pubmed/28027332
27.LEES, A. J., ROCHA, J. F. & SOARES-DA-SILVA, P. (2017). Concerns Regarding Opicapone as Adjunct to Levodopa Therapy-Reply. JAMA Neurol, 74 (7), 873. https://www.ncbi.nlm.nih.gov/pubmed/28531266
28.LEMOS, V., DE OLIVEIRA, R. M., NAIA, L., SZEGO, E., RAMOS, E., PINHO, S., MAGRO, F., CAVADAS, C., REGO, A. C., COSTA, V., OUTEIRO, T. F. & GOMES, P. (2017). The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes. Hum Mol Genet, 26 (21), 4105-4117. https://www.ncbi.nlm.nih.gov/pubmed/28973648
29.LOPES, S., ANDRADE, P., CONDE, S., LIBERAL, R., DIAS, C. C., FERNANDES, S., PINHEIRO, J., SIMOES, J. S., CARNEIRO, F., MAGRO, F. & MACEDO, G. (2017). Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence? Inflamm Bowel Dis, 23 (8), 1278-1284. https://www.ncbi.nlm.nih.gov/pubmed/28617757
30.LOPES, S., ANDRADE, P., CUNHA, R. & MAGRO, F. (2017). Transmural healing in Crohn's disease: Beyond mural findings. Dig Liver Dis, https://www.ncbi.nlm.nih.gov/pubmed/29089271
31.LOPES, S., ANDRADE, P., RODRIGUES-PINTO, E., AFONSO, J., MACEDO, G. & MAGRO, F. (2017). Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn's disease patients with anastomotic strictures. World J Gastroenterol, 23 (35), 6482-6490. https://www.ncbi.nlm.nih.gov/pubmed/29085198
32.LOPES, S., RODRIGUES-PINTO, E., ANDRADE, P., AFONSO, J., BARON, T. H., MAGRO, F. & MACEDO, G. (2017). Endoscopic balloon dilation of Crohn's disease strictures-safety, efficacy and clinical impact. World J Gastroenterol, 23 (41), 7397-7406. https://www.ncbi.nlm.nih.gov/pubmed/29151693
33.MAGALHAES, D., SOARES-DA-SILVA, P. & MAGRO, F. (2017). The effect of PRR ligands on the membrane potential of intestinal epithelial cells. Pharmacol Rep, 69 (5), 978-984. https://www.ncbi.nlm.nih.gov/pubmed/28837901
34.MAGRO, F., AFONSO, J., LOPES, S., COELHO, R., GONCALVES, R., CALDEIRA, P., LAGO, P., DE SOUSA, H. T., RAMOS, J., GONCALVES, A. R., MINISTRO, P., ROSA, I., MEIRA, T., ANDRADE, P., SOARES, J. B., CARVALHO, D., SOUSA, P., VIEIRA, A. I., LOPES, J., DIAS, C. C., GEBOES, K. & CARNEIRO, F. (2017). Clinical performance of an infliximab rapid quantification assay. Therap Adv Gastroenterol, 10 (9), 651-660. https://www.ncbi.nlm.nih.gov/pubmed/28932267
35.MAGRO, F., AFONSO, J., LOPES, S., COELHO, R., GONCALVES, R., CALDEIRA, P., LAGO, P., DE SOUSA, H. T., RAMOS, J., GONCALVES, A. R., MINISTRO, P., ROSA, I., VIEIRA, A. I., ANDRADE, P., SOARES, J. B., CARVALHO, D., SOUSA, P., MEIRA, T., LOPES, J., MOLEIRO, J., DIAS, C. C., FALCAO, A., GEBOES, K., CARNEIRO, F. & PORTUGUESE, I. B. D. S. G. (2017). Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation. EBioMedicine, 21 123-130. https://www.ncbi.nlm.nih.gov/pubmed/28629912
36.MAGRO, F., DIAS, C. C., COELHO, R., SANTOS, P. M., FERNANDES, S., CAETANO, C., RODRIGUES, A., PORTELA, F., OLIVEIRA, A., MINISTRO, P., CANCELA, E., VIEIRA, A. I., BAROSA, R., COTTER, J., CARVALHO, P., CREMERS, I., TRABULO, D., CALDEIRA, P., ANTUNES, A., ROSA, I., MOLEIRO, J., PEIXE, P., HERCULANO, R., GONCALVES, R., GONCALVES, B., TAVARES SOUSA, H., CONTENTE, L., MORNA, H. & LOPES, S. (2017). Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes. Inflamm Bowel Dis, 23 (2), 289-297. https://www.ncbi.nlm.nih.gov/pubmed/28107278
37.MAGRO, F., GIONCHETTI, P., ELIAKIM, R., ARDIZZONE, S., ARMUZZI, A., BARREIRO-DE ACOSTA, M., BURISCH, J., GECSE, K. B., HART, A. L., HINDRYCKX, P., LANGNER, C., LIMDI, J. K., PELLINO, G., ZAGOROWICZ, E., RAINE, T., HARBORD, M., RIEDER, F., EUROPEAN, C. S. & COLITIS, O. (2017). Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis, 11 (6), 649-670. https://www.ncbi.nlm.nih.gov/pubmed/28158501
38.MAGRO, F., LOPES, S., COELHO, R., COTTER, J., DIAS DE CASTRO, F., TAVARES DE SOUSA, H., SALGADO, M., ANDRADE, P., VIEIRA, A. I., FIGUEIREDO, P., CALDEIRA, P., SOUSA, A., DUARTE, M. A., AVILA, F., SILVA, J., MOLEIRO, J., MENDES, S., GIESTAS, S., MINISTRO, P., SOUSA, P., GONCALVES, R., GONCALVES, B., OLIVEIRA, A., CHAGAS, C., TORRES, J., DIAS, C. C., LOPES, J., BORRALHO, P., AFONSO, J., GEBOES, K., CARNEIRO, F. & PORTUGUESE, I. B. D. S. G. (2017). Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study. J Crohns Colitis, 11 (4), 435-444. https://www.ncbi.nlm.nih.gov/pubmed/27664275
39.MONTEIRO, A., MASSANO, J., LEAO, M., GARRETT, C. & GRUPO DE NEUROGENETICA DO CENTRO HOSPITALAR SAO, J. (2017). [Genetic Study of Primary Dystonias: Recommendations from the Centro Hospitalar Sao Joao Neurogenetics Group]. Acta Med Port, 30 (4), 340-346. https://www.ncbi.nlm.nih.gov/pubmed/28555563
40.MORATO, M., CORREIA-COSTA, L., SOUSA, T., COSME, D., SCHAEFER, F., AREIAS, J. C., GUERRA, A., AFONSO, A. C., BARROS, H., AZEVEDO, A. & ALBINO-TEIXEIRA, A. (2017). Longer duration of obesity is associated with a reduction in urinary angiotensinogen in prepubertal children. Pediatr Nephrol, 32 (8), 1411-1422. https://www.ncbi.nlm.nih.gov/pubmed/28337615
41.PEIXOTO, A., COELHO, R., MAIA, T., SARMENTO, A., MAGRO, F. & MACEDO, G. (2017). Chronic Granulomatous Disease Mimicking Colonic Crohn's Disease Successfully Treated with Infliximab. ACG Case Rep J, 4 e46. https://www.ncbi.nlm.nih.gov/pubmed/28377934
42.PORTELA, F., DIAS, C. C., CALDEIRA, P., CRAVO, M., DEUS, J., GONCALVES, R., LAGO, P., MORNA, H., PEIXE, P., RAMOS, J., SOUSA, H., TAVARES, L., VASCONCELOS, H., MAGRO, F. & MINISTRO, P. (2017). The who-when-why triangle of CAM use among Portuguese IBD patients. Dig Liver Dis, 49 (4), 388-396. https://www.ncbi.nlm.nih.gov/pubmed/28117198
43.ROCHA, J. F., SICARD, E., FAUCHOUX, N., FALCAO, A., SANTOS, A., LOUREIRO, A. I., PINTO, R., BONIFACIO, M. J., NUNES, T., ALMEIDA, L. & SOARES-DA-SILVA, P. (2017). Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics. Br J Clin Pharmacol, 83 (3), 540-553. https://www.ncbi.nlm.nih.gov/pubmed/27763682
44.SILVA, I., COSTA, A. F., MOREIRA, S., FERREIRINHA, F., MAGALHAES-CARDOSO, M. T., CALEJO, I., SILVA-RAMOS, M. & CORREIA-DE-SA, P. (2017). Inhibition of cholinergic neurotransmission by beta3-adrenoceptors depends on adenosine release and A1-receptor activation in human and rat urinary bladders. Am J Physiol Renal Physiol, 313 (2), F388-F403. https://www.ncbi.nlm.nih.gov/pubmed/28446460
45.VIDE, J. & MAGINA, S. (2017). Moderate to severe psoriasis treatment challenges through the era of biological drugs. An Bras Dermatol, 92 (5), 668-674. https://www.ncbi.nlm.nih.gov/pubmed/29166504
46.VIDE, J., OSORIO, F., COSTA-SILVA, M., LOPES, S., AZEVEDO, F., DIAS, C. C., MAGINA, S. & MAGRO, F. (2017). Cutaneous morbidity among inflammatory bowel disease patients: a cohort study. J Crohns Colitis, in press https://www.ncbi.nlm.nih.gov/pubmed/29300856
47.VIEIRA, C., FERREIRINHA, F., MAGALHAES-CARDOSO, M. T., SILVA, I., MARQUES, P. & CORREIA-DE-SA, P. (2017). Post-inflammatory Ileitis Induces Non-neuronal Purinergic Signaling Adjustments of Cholinergic Neurotransmission in the Myenteric Plexus. Front Pharmacol, 8 811. https://www.ncbi.nlm.nih.gov/pubmed/29167643
48.VIEIRA-SOUSA, E., CAVALEIRO, J., MOURAO, A. F., RODRIGUES, A. M., ALBINO-TEIXEIRA, A., PIMENTEL-SANTOS, F. M., OLIVEIRA-RAMOS, F., CANHAO, H., POLIDO-PEREIRA, J., FONSECA, J. E., PEREIRA DA SILVA, J. A., ROMEU, J. C., MELO GOMES, J., COSTA, L., GRACA, L., LEANDRO, M. J., SANTOS, M. J., MACHADO, P. M. & RAMIRO, S. (2017). Acta Reumatologica Portuguesa: perspectives in 2017. Acta Reumatol Port, 42 (2), 110-111. https://www.ncbi.nlm.nih.gov/pubmed/28693032
2016 (articles in alphabetical order)
1. ABREU, C., ALMEIDA, F., FERRAZ, R., DIAS, C. C., SARMENTO, A. & MAGRO, F. (2016). The tuberculin skin test still matters for the screening of latent Tuberculosis infections among Inflammatory Bowel Disease patients. Dig Liver Dis, 48 (12), 1438-1443. https://www.ncbi.nlm.nih.gov/pubmed/27599804
2. ABREU, C., CARVALHO, T., SARMENTO, A. & MAGRO, F. (2016). Stool Isolation of Nocardia nova in Two Immunomodulated Patients With Inflammatory Bowel Diseases. J Clin Gastroenterol, 50 (1), 92. http://www.ncbi.nlm.nih.gov/pubmed/26325188
3. ABREU, C., SARMENTO, A. & MAGRO, F. (2016). Reintroduction of Anti-TNFalpha Therapy After (or even During) Anti-TNFalpha-associated Tuberculosis in Immune-mediated Diseases. J Crohns Colitis, 10 (1), 120-1. http://www.ncbi.nlm.nih.gov/pubmed/26417047
4. AFONSO, J., LOPES, S., GONCALVES, R., CALDEIRA, P., LAGO, P., TAVARES DE SOUSA, H., RAMOS, J., GONCALVES, A. R., MINISTRO, P., ROSA, I., VIEIRA, A. I., COELHO, R., TAVARES, P., SOARES, J., SOUSA, A. L., CARVALHO, D., SOUSA, P., DA SILVA, J. P., MEIRA, T., SILVA FERREIRA, F., DIAS, C. C., CHOWERS, Y., BEN-HORIN, S., MAGRO, F. & ON BEHALF PORTUGUESE, I. B. D. S. G. (2016). Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays. Therap Adv Gastroenterol, 9 (6), 781-794. http://www.ncbi.nlm.nih.gov/pubmed/27803733
5. AFONSO, J., LOPES, S., GONCALVES, R., CALDEIRA, P., LAGO, P., TAVARES DE SOUSA, H., RAMOS, J., GONCALVES, A. R., MINISTRO, P., ROSA, I., VIEIRA, A. I., DIAS, C. C., MAGRO, F. & PORTUGUESE, I. B. D. S. G. (2016). Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays. Aliment Pharmacol Ther, 44 (7), 684-92. http://www.ncbi.nlm.nih.gov/pubmed/27507790
6. AGRA, R. M., AL-DAGHRI, N. M., BADIMON, L., BODI, V., CARBONE, F., CHEN, M., CUBEDO, J., DULLAART, R. P., EIRAS, S., GARCIA-MONZON, C., GARY, T., GNONI, A., GONZALEZ-RODRIGUEZ, A., GREMMEL, T., HAFNER, F., HAKALA, T., HUANG, B., ICKMANS, K., IRACE, C., KHOLOVA, I., KIMER, N., KYTO, V., MARZ, W., MIAZGOWSKI, T., MOLLER, S., MONTECUCCO, F., NICCOLI, G., NIJS, J., OZBEN, S., OZBEN, T., PAPASSOTIRIOU, I., PAPASTAMATAKI, M., REINA-COUTO, M., RIOS-NAVARRO, C., RITSCH, A., SABICO, S., SEETHO, I. W., SEVERINO, A., SIPILA, J., SOUSA, T., TASZAREK, A., TAURINO, F., TIETGE, U. J., TRIPOLINO, C., VERLOOP, W., VOSKUIL, M. & WILDING, J. P. (2016). Research update for articles published in EJCI in 2014. Eur J Clin Invest, 46 (10), 880-94. http://www.ncbi.nlm.nih.gov/pubmed/27571922
7. ALMEIDA, J. C., WACHA, A., GOMES, P. S., ALVES, L. C., FERNANDES, M. H. V., SALVADO, I. M. M. & FERNANDES, M. H. R. (2016). A biocompatible hybrid material with simultaneous calcium and strontium release capability for bone tissue repair. Materials Science and Engineering C, 62 429-38.
8. ALMEIDA, J. C., WACHA, A., GOMES, P. S., FERNANDES, M. H. R., FERNANDES, M. H. V. & SALVADO, I. M. M. (2016). PDMS-SiO2-TiO2-CaO hybrid materials - Cytocompatibility and nanoscale surface features. Materials Science and Engineering C, 64 74-86. http://www.sciencedirect.com/science/article/pii/S0928493116302466
9. ALVES, E., LUKOYANOV, N., SERRAO, P., MOURA, D. & MOREIRA-RODRIGUES, M. (2016). Epinephrine increases contextual learning through activation of peripheral beta2-adrenoceptors. Psychopharmacology (Berl), 233 (11), 2099-108. http://www.ncbi.nlm.nih.gov/pubmed/26935825
10.AMORIM-BARBOSA, T., SERRAO, M. P., BRANDAO, I. & VIEIRA-COELHO, M. A. (2016). Catechol-O-methyltransferase activity in erythrocytes from patients with eating disorders. Eat Weight Disord, 21 (2), 221-7. http://www.ncbi.nlm.nih.gov/pubmed/26296436
11.ANDRADE, C., BEATO, J., MONTEIRO, A., COSTA, A., PENAS, S., GUIMARAES, J., REIS, F. F. & GARRETT, C. (2016). Reply to Letter: Spectral-domain optical coherence tomography as a potential biomarker in Huntington's disease. Mov Disord, 31 (11), 1762-1763. http://www.ncbi.nlm.nih.gov/pubmed/27548531
12.ANDRADE, C., BEATO, J., MONTEIRO, A., COSTA, A., PENAS, S., GUIMARAES, J., REIS, F. F. & GARRETT, C. (2016). Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease. Mov Disord, 31 (3), 377-83. http://www.ncbi.nlm.nih.gov/pubmed/26853218
13.BARROS-BARBOSA, A. R., FERREIRINHA, F., OLIVEIRA, A., MENDES, M., LOBO, M. G., SANTOS, A., RANGEL, R., PELLETIER, J., SEVIGNY, J., CORDEIRO, J. M. & CORREIA-DE-SA, P. (2016). Adenosine A2A receptor and ecto-5'-nucleotidase/CD73 are upregulated in hippocampal astrocytes of human patients with mesial temporal lobe epilepsy (MTLE). Purinergic Signal, 12 (4), 719-734. https://www.ncbi.nlm.nih.gov/pubmed/27650530
14.BARROS-BARBOSA, A. R., FONSECA, A. L., GUERRA-GOMES, S., FERREIRINHA, F., SANTOS, A., RANGEL, R., LOBO, M. G., CORREIA-DE-SA, P. & CORDEIRO, J. M. (2016). Up-regulation of P2X7 receptor-mediated inhibition of GABA uptake by nerve terminals of the human epileptic neocortex. Epilepsia, 57 (1), 99-110. http://www.ncbi.nlm.nih.gov/pubmed/26714441
15.BELIAEV, A., FERREIRA, H. S., LEARMONTH, D. A., BONIFACIO, M. J., TORRAO, L., PIRES, N. M., SOARES-DA-SILVA, P. & KISS, L. E. (2016). Synthesis and structure-activity relationships of ionizable 1,3,4-oxadiazol-2(3H)-ones as peripherally selective FAAH inhibitors with improved aqueous solubility. Pure and Applied Chemistry, 88 (4), 341-347. <Go to ISI>://WOS:000377216400005
16.BICKER, J., ALVES, G., FORTUNA, A., SOARES-DA-SILVA, P. & FALCAO, A. (2016). A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates. Int J Pharm, 501 (1-2), 102-111. http://www.ncbi.nlm.nih.gov/pubmed/26836708
17.BRAGANCA, B., OLIVEIRA-MONTEIRO, N., FERREIRINHA, F., LIMA, P. A., FARIA, M., FONTES-SOUSA, A. P. & CORREIA-DE-SA, P. (2016). Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria. Front Pharmacol, 7 45. http://www.ncbi.nlm.nih.gov/pubmed/27014060
18.CAMPOS, S., MONTEIRO, J., VALENZUELA, B., GONCALINHO, H., DE PINHO, P. G., FRESCO, P., FELIX, L. & ANTUNES, L. (2016). Evidence of Different Propofol Pharmacokinetics under Short and Prolonged Infusion Times in Rabbits. Basic Clin Pharmacol Toxicol, 118 (6), 421-31. http://www.ncbi.nlm.nih.gov/pubmed/26551921
19.CARNEIRO, L. S., FONSECA, A. M., SERRAO, P., MOTA, M. P., VASCONCELOS-RAPOSO, J. & VIEIRA-COELHO, M. A. (2016). Impact of physical exercise on catechol-O-methyltransferase activity in depressive patients: A preliminary communication. J Affect Disord, 193 117-122. http://www.ncbi.nlm.nih.gov/pubmed/26773917
20.CARNEIRO, L. S., MOTA, M. P., VIEIRA-COELHO, M. A., ALVES, R. C., FONSECA, A. M. & VASCONCELOS-RAPOSO, J. (2016). Monoamines and cortisol as potential mediators of the relationship between exercise and depressive symptoms. Eur Arch Psychiatry Clin Neurosci, in press http://www.ncbi.nlm.nih.gov/pubmed/27484978
21.CARNEIRO, L. S., MOTA, M. P., VIEIRA-COELHO, M. A., ROSENBAUM, S., FONSECA, A. M. & VASCONCELOS-RAPOSO, J. (2016). Exercise for adults with depressive symptoms: Beyond the weight loss paradigm. Psychiatry Res, 246 364-365. http://www.ncbi.nlm.nih.gov/pubmed/27776332
22.CARVALHO, A., PELAEZ-VARGAS, A., HANSFORD, D. J., FERNANDES, M. H. & MONTEIRO, F. J. (2016). Effects of Line and Pillar Array Microengineered SiO2 Thin Films on the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells. Langmuir, 32 (4), 1091-100. http://www.ncbi.nlm.nih.gov/pubmed/26771563
23.CÉSAR, A., CALISTRU, A., PARDAL, J., MAGINA, S., MOTA, A. & AZEVEDO, F. (2016). Cutaneous Richter Syndrome mimicking a lower limb cellulitis infection - a case report and review of the literature. Dermatology Online Journal, 22 (5), http://www.escholarship.org/uc/item/0r05j1cc
24.COELHO, R., MAGRO, F., SILVA, M. & MACEDO, G. (2016). Early surgery in Crohn's disease patients with entero-urinary fistulas: does it change the prognosis? Scand J Gastroenterol, 51 (6), 679-83. http://www.ncbi.nlm.nih.gov/pubmed/26679346
25.COELHO, R., PEIXOTO, A., AMIL-DIAS, J., TRINDADE, E., CAMPOS, M., MAGINA, S., CHARBIT-HENRION, F., LENOIR, C., LATOUR, S., MAGRO, F. & MACEDO, G. (2016). Refractory monogenic Crohn's disease due to X-linked inhibitor of apoptosis deficiency. Int J Colorectal Dis, 31 (6), 1235-6. http://www.ncbi.nlm.nih.gov/pubmed/26584814
26.COELHO, R., SILVA, M., GASPAR, R., SILVA, R., PAIVA, D., LOPES, J., LOPES, S., LOPES, J. M., MAGRO, F. & MACEDO, G. (2016). "A book should not be judged by its cover": two cases of intestinal adenocarcinoma as the first manifestation of Crohn's disease. Int J Colorectal Dis, 31 (5), 1061-2. http://www.ncbi.nlm.nih.gov/pubmed/26410262
27.CORREIA-COSTA, L., COSME, D., NOGUEIRA-SILVA, L., MORATO, M., SOUSA, T., MOURA, C., MOTA, C., GUERRA, A., ALBINO-TEIXEIRA, A., AREIAS, J. C., SCHAEFER, F., LOPES, C., AFONSO, A. C. & AZEVEDO, A. (2016). Gender and obesity modify the impact of salt intake on blood pressure in children. Pediatr Nephrol, 31 (2), 279-88. http://www.ncbi.nlm.nih.gov/pubmed/26420679
28.CORREIA-COSTA, L., MORATO, M., SOUSA, T., COSME, D., GUIMARAES, J. T., GUERRA, A., SCHAEFER, F., AFONSO, A. C., AZEVEDO, A. & ALBINO-TEIXEIRA, A. (2016). Urinary fibrogenic cytokines ET-1 and TGF-beta1 are associated with urinary angiotensinogen levels in obese children. Pediatr Nephrol, 31 (3), 455-64. http://www.ncbi.nlm.nih.gov/pubmed/26482255
29.CORREIA-COSTA, L., SOUSA, T., MORATO, M., COSME, D., AFONSO, J., AREIAS, J. C., SCHAEFER, F., GUERRA, A., AFONSO, A. C., AZEVEDO, A. & ALBINO-TEIXEIRA, A. (2016). Oxidative stress and nitric oxide are increased in obese children and correlate with cardiometabolic risk and renal function. Br J Nutr, 116 (5), 805-15. http://www.ncbi.nlm.nih.gov/pubmed/27480380
30.CORREIA-COSTA, L., SOUSA, T., MORATO, M., COSME, D., AFONSO, J., MOURA, C., MOTA, C., AREIAS, J. C., GUERRA, A., SCHAEFER, F., CALDAS AFONSO, A., BARROS, H., ALBINO-TEIXEIRA, A. & AZEVEDO, A. (2016). Association of myeloperoxidase levels with cardiometabolic factors and renal function in prepubertal children. Eur J Clin Invest, 46 (1), 50-9. http://www.ncbi.nlm.nih.gov/pubmed/26541603
31.COSTA, F., SOUSA GOMES, P. & FERNANDES, M. H. (2016). Osteogenic and Angiogenic Response to Calcium Silicate-based Endodontic Sealers. J Endod, 42 (1), 113-9. http://www.ncbi.nlm.nih.gov/pubmed/26577874
32.COSTA, S., REINA-COUTO, M., ALBINO-TEIXEIRA, A. & SOUSA, T. (2016). Statins and oxidative stress in chronic heart failure. Rev Port Cardiol, 35 (1), 41-57. http://www.ncbi.nlm.nih.gov/pubmed/26763895
33.COSTA-RODRIGUES, J., CARMO, S., PERPETUO, I. P., MONTEIRO, F. J. & FERNANDES, M. H. (2016). Osteoclastogenic differentiation of human precursor cells over micro- and nanostructured hydroxyapatite topography. Biochim Biophys Acta, 1860 (4), 825-35. http://www.ncbi.nlm.nih.gov/pubmed/26801877
34.COSTA-RODRIGUES, J., REIS, S., CASTRO, A. & FERNANDES, M. H. (2016). Bone Anabolic Effects of Soluble Si: In Vitro Studies with Human Mesenchymal Stem Cells and CD14+ Osteoclast Precursors. Stem Cells Int, 2016 5653275. http://www.ncbi.nlm.nih.gov/pubmed/26798359
35.DIAS SCHALCH, T., PORTA SANTOS FERNANDES, K., COSTA-RODRIGUES, J., PEREIRA GARCIA, M., AGNELLI MESQUITA-FERRARI, R., KALIL BUSSADORI, S. & FERNANDES, M. H. (2016). Photomodulation of the osteoclastogenic potential of oral squamous carcinoma cells. J Biophotonics, 9 (11-12), 1136-1147. https://www.ncbi.nlm.nih.gov/pubmed/27089455
36.FALCAO, A., ROCHA, J. F., SANTOS, A., NUNES, T. & SOARES-DA-SILVA, P. (2016). Opicapone pharmacokinetics and pharmacodynamics comparison between healthy Japanese and matched white subjects. Clin Pharmacol Drug Dev, 5 (2), 150-61. https://www.ncbi.nlm.nih.gov/pubmed/27138028
37.FERREIRA, J. J., LEES, A., ROCHA, J. F., POEWE, W., RASCOL, O. & SOARES-DA-SILVA, P. (2016). Opicapone as an adjunct to levodopa in patients with Parkinson’s disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial. Lancet Neurol, 15 (2), 154-65. http://www.sciencedirect.com/science/article/pii/S1474442215003361
38.FIORINO, G., CORTES, P. N., ELLUL, P., FELICE, C., KARATZAS, P., SILVA, M., LAKATOS, P. L., BOSSA, F., UNGAR, B., SEBASTIAN, S., FURFARO, F., KARMIRIS, K., KATSANOS, K. H., MUSCAT, M., CHRISTODOULOU, D. K., MACONI, G., KOPYLOV, U., MAGRO, F., MANTZARIS, G. J., ARMUZZI, A., BOSCA-WATTS, M. M., BEN-HORIN, S., BONOVAS, S. & DANESE, S. (2016). Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study. Clin Gastroenterol Hepatol, 14 (10), 1426-1432 e1. http://www.ncbi.nlm.nih.gov/pubmed/27317850
39.GOMES, P. S., ZOMORODIAN, A., KWIATKOWSKI, L., LUTZE, R., BALKOWIEC, A., COLACO, B., PINHEIRO, V., FERNANDES, J. C., MONTEMOR, M. F. & FERNANDES, M. H. (2016). In vivo assessment of a new multifunctional coating architecture for improved Mg alloy biocompatibility. Biomed Mater, 11 (4), 045007. http://www.ncbi.nlm.nih.gov/pubmed/27508333
40.GONCALVES, E. M., OLIVEIRA, F. J., SILVA, R. F., NETO, M. A., FERNANDES, M. H., AMARAL, M., VALLET-REGI, M. & VILA, M. (2016). Three-dimensional printed PCL-hydroxyapatite scaffolds filled with CNTs for bone cell growth stimulation. J Biomed Mater Res B Appl Biomater, 104 (6), 1210-9. http://www.ncbi.nlm.nih.gov/pubmed/26089195
41.IGREJA, B., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2016). Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine beta-hydroxylase inhibitor. J Am Soc Hypertens, 10 (3), 207-16. http://www.ncbi.nlm.nih.gov/pubmed/26803288
42.LEITAO, A. F., FARIA, M. A., FAUSTINO, A. M., MOREIRA, R., MELA, P., LOUREIRO, L., SILVA, I. & GAMA, M. (2016). A Novel Small-Caliber Bacterial Cellulose Vascular Prosthesis: Production, Characterization, and Preliminary In Vivo Testing. Macromol Biosci, 16 (1), 139-50. http://www.ncbi.nlm.nih.gov/pubmed/26388180
43.LOPES, S., ANDRADE, P., AFONSO, J., RODRIGUES-PINTO, E., DIAS, C. C., MACEDO, G. & MAGRO, F. (2016). Correlation Between Calprotectin and Modified Rutgeerts Score. Inflamm Bowel Dis, 22 (9), 2173-81. http://www.ncbi.nlm.nih.gov/pubmed/27482974
44.MAGALHAES, D., CABRAL, J. M., SOARES-DA-SILVA, P. & MAGRO, F. (2016). Role of epithelial ion transports in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol, 310 (7), G460-76. http://www.ncbi.nlm.nih.gov/pubmed/26744474
45.MAGRO, F., COELHO, R., GUIMARAES, L. S., SILVA, M., PEIXOTO, A., LOPES, S. & MACEDO, G. (2016). Anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg? Scand J Gastroenterol, 51 (4), 511-2. http://www.ncbi.nlm.nih.gov/pubmed/26523855
46.MAGRO, F., LOPES, S. I., LOPES, J., PORTELA, F., COTTER, J., LOPES, S., MOREIRA, M. J., LAGO, P., PEIXE, P., ALBUQUERQUE, A., RODRIGUES, S., SILVA, M. R., MONTEIRO, P., LOPES, C., MONTEIRO, L., MACEDO, G., VELOSO, L., CAMILA, C., AFONSO, J., GEBOES, K., CARNEIRO, F. & PORTUGUESE, I. B. D. G. (2016). Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab. J Crohns Colitis, 10 (12), 1407-1416. https://www.ncbi.nlm.nih.gov/pubmed/27226417
47.MAGRO, F., RAMOS, J., CORREIA, L., LAGO, P., PEIXE, P., GONCALVES, A. R., RODRIGUES, A., VIEIRA, C., FERREIRA, D., PEREIRA SILVA, J., TULIO, M. A., SALGUEIRO, P. & FERNANDES, S. (2016). [Portuguese Consensus on the Diagnosis, Prevention and Treatment of Anaemia in Inflammatory Bowel Disease]. Acta Med Port, 29 (2), 144-56. http://www.ncbi.nlm.nih.gov/pubmed/27234956
48.MANE, N., VIAIS, R., MARTINEZ-CUTILLAS, M., GALLEGO, D., CORREIA-DE-SA, P. & JIMENEZ, M. (2016). Inverse gradient of nitrergic and purinergic inhibitory cotransmission in the mouse colon. Acta Physiol (Oxf), 216 (1), 120-31. http://www.ncbi.nlm.nih.gov/pubmed/26347033
49.MASSANO, J., LEAO, M., GARRETT, C. & GRUPO DE NEUROGENETICA DO CENTRO HOSPITALAR SAO, J. (2016). [Investigation of Genetic Etiology in Neurodegenerative Dementias: Recommendations from the Centro Hospitalar Sao Joao Neurogenetics Group]. Acta Med Port, 29 (10), 675-679. http://www.ncbi.nlm.nih.gov/pubmed/28103467
50.MEIRELES, M., MOURA, E., VIEIRA-COELHO, M. A., SANTOS-BUELGA, C., GONZALEZ-MANZANO, S., DUENAS, M., MATEUS, N., FARIA, A. & CALHAU, C. (2016). Flavonoids as dopaminergic neuromodulators. Mol Nutr Food Res, 60 (3), 495-501. http://www.ncbi.nlm.nih.gov/pubmed/26582321
51.MEURICE, E., BOUCHART, F., HORNEZ, J. C., LERICHE, A., HAUTCOEUR, D., LARDOT, V., CAMBIER, F., FERNANDES, M. H. & MONTEIRO, F. (2016). Osteoblastic cells colonization inside beta-TCP macroporous structures obtained by ice-templating. Journal of the European Ceramic Society, 36 (12), 2895-2901. <Go to ISI>://WOS:000378362800006
52.NORONHA-MATOS, J. B. & CORREIA-DE-SA, P. (2016). Mesenchymal Stem Cells Ageing: Targeting the "Purinome" to Promote Osteogenic Differentiation and Bone Repair. J Cell Physiol, 231 (9), 1852-61. http://www.ncbi.nlm.nih.gov/pubmed/26754327
53.PEDROSA, A. F., MAGINA, S., AZEVEDO, F. & LISBOA, C. (2016). Re-emergence of syphilis in the biological era. Int J Dermatol, 55 (12), e626-e628. https://www.ncbi.nlm.nih.gov/pubmed/27496611
54.PEREIRA, C., COELHO, R., GRACIO, D., DIAS, C., SILVA, M., PEIXOTO, A., LOPES, P., COSTA, C., TEIXEIRA, J. P., MACEDO, G. & MAGRO, F. (2016). DNA Damage and Oxidative DNA Damage in Inflammatory Bowel Disease. J Crohns Colitis, 10 (11), 1316-1323. http://www.ncbi.nlm.nih.gov/pubmed/27095753
55.PORTELA, F., LAGO, P., COTTER, J., GONCALVES, R., VASCONCELOS, H., MINISTRO, P., LOPES, S., EUSEBIO, M., MORNA, H., CRAVO, M., PEIXE, P., CREMMERS, I., SOUSA, H., DEUS, J., DUARTE, M., MAGRO, F., INVESTIGATORS, C. & GEDII (2016). Anaemia in Patients with Inflammatory Bowel Disease - A Nationwide Cross-Sectional Study. Digestion, 93 (3), 214-220. http://www.ncbi.nlm.nih.gov/pubmed/27022722
56.REBELO, T. S., NORONHA, J. P., GALESIO, M., SANTOS, H., DINIZ, M., SALES, M. G., FERNANDES, M. H. & COSTA-RODRIGUES, J. (2016). Testing the variability of PSA expression by different human prostate cancer cell lines by means of a new potentiometric device employing molecularly antibody assembled on graphene surface. Mater Sci Eng C Mater Biol Appl, 59 1069-78. http://www.ncbi.nlm.nih.gov/pubmed/26652466
57.RIEDER, F., LATELLA, G., MAGRO, F., YUKSEL, E. S., HIGGINS, P. D., DI SABATINO, A., DE BRUYN, J. R., RIMOLA, J., BRITO, J., BETTENWORTH, D., VAN ASSCHE, G., BEMELMAN, W., D'HOORE, A., PELLINO, G. & DIGNASS, A. U. (2016). European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease. J Crohns Colitis, 10 (8), 873-85. http://www.ncbi.nlm.nih.gov/pubmed/26928961
58.ROCHA, J. F., FERREIRA, J. J., FALCAO, A., SANTOS, A., PINTO, R., NUNES, T., ALMEIDA, L. & SOARES-DA-SILVA, P. (2016). Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease. Clin Pharmacol Drug Dev, 5 (3), 232-40. https://www.ncbi.nlm.nih.gov/pubmed/27163503
59.SALGADO, C. L., GRENHO, L., FERNANDES, M. H., COLACO, B. J. & MONTEIRO, F. J. (2016). Biodegradation, biocompatibility, and osteoconduction evaluation of collagen-nanohydroxyapatite cryogels for bone tissue regeneration. J Biomed Mater Res A, 104 (1), 57-70. http://www.ncbi.nlm.nih.gov/pubmed/26179958
60.SILVA-FERREIRA, F., AFONSO, J., PINTO-LOPES, P. & MAGRO, F. (2016). A Systematic Review on Infliximab and Adalimumab Drug Monitoring: Levels, Clinical Outcomes and Assays. Inflamm Bowel Dis, 22 (9), 2289-301. http://www.ncbi.nlm.nih.gov/pubmed/27508512
61.SILVA-RAMOS, M., SILVA, I., OLIVEIRA, J. C. & CORREIA-DE-SA, P. (2016). Increased Urinary Adenosine Triphosphate in Patients With Bladder Outlet Obstruction Due to Benign Prostate Hyperplasia. Prostate, 76 (15), 1353-63. http://www.ncbi.nlm.nih.gov/pubmed/27418113
62.SOARES-DA-SILVA, P., CABRAL, J. M., MAGALHAES, D., FRAGA, S. & MAGRO, F. (2016). Amine neurotransmitters, inflammation and epithelial sodium transport. Exp Physiol, 101 (4), 459-64. https://www.ncbi.nlm.nih.gov/pubmed/26548358
63.TORRES, T., FERREIRA, A., FERREIRA, P., HENRIQUES, M., LEITE, L., MAGINA, S., MARQUES-PINTO, G., OLIVEIRA, H., SOUSA-BASTO, A., BELLO, R. T., VARELA, P., MASSA, A., SELORES, M. & FILIPE, P. (2016). Portuguese Position Paper on the Use of Biosimilars in
64.Psoriasis. Acta Medica Portuguesa, 29 (9), 574-7. http://dx.doi.org/10.20344/amp.8118
65.VALENTE, T. A., SILVA, D. M., GOMES, P. S., FERNANDES, M. H., SANTOS, J. D. & SENCADAS, V. (2016). Effect of Sterilization Methods on Electrospun Poly(lactic acid) (PLA) Fiber Alignment for Biomedical Applications. ACS Appl Mater Interfaces, 8 (5), 3241-9. http://www.ncbi.nlm.nih.gov/pubmed/26756809
66.VIDE, J., MOREIRA, C., CUNHA, A. P., BALDAIA, H., MAGINA, S. & AZEVEDO, F. (2016). Generalized bullous fixed drug eruption due to bromhexine. Dermatology Online Journal, 22 (7), http://escholarship.org/uc/item/7nt074w4#page-1
2015 (articles in alphabetical order)
1. ABREU, C., ROCHA-PEREIRA, N., SARMENTO, A. & MAGRO, F. (2015). Nocardia infections among immunomodulated inflammatory bowel disease patients: A review. World J Gastroenterol, 21 (21), 6491-6498. http://www.ncbi.nlm.nih.gov/pubmed/26074688
2. ABREU, C., SANTOS, L. & MAGRO, F. (2015). Varicella Complicated by Severe Pneumonia and Shock in an Immunosuppressed Crohn's Disease Patient Under Azathioprine and Anti-Tumour Necrosis Factor Alpha. J Crohns Colitis, 9 (12), 1176-8. http://www.ncbi.nlm.nih.gov/pubmed/26351378
3. AMORIM-BARBOSA, T., SERRAO, M. P., BRANDAO, I. & VIEIRA-COELHO, M. A. (2015). Catechol-O-methyltransferase activity in erythrocytes from patients with eating disorders. Eat Weight Disord, in press http://www.ncbi.nlm.nih.gov/pubmed/26296436
4. ANDRADE, C., BARROS, P., CAMACHO, O., GARRETT, C. & GUIMARAES, J. (2015). Radiation-induced neurotoxicity: clinical and radiological improvement after hyperbaric oxygen therapy. Neurol Sci, 36 (6), 1057-9. http://www.ncbi.nlm.nih.gov/pubmed/25630455
5. ANDRADE, C., FARIA, O. & GUIMARAES, J. (2015). [Bilateral Optic Disc Edema Secondary to Amiodarone: Manifestation of an Iatrogenic Optic Neuropathy]. Acta Med Port, 28 (2), 256-9. http://www.ncbi.nlm.nih.gov/pubmed/26061517
6. BARROS, J., GRENHO, L., FERNANDES, M. H., MANUEL, C. M., MELO, L. F., NUNES, O. C., MONTEIRO, F. J. & FERRAZ, M. P. (2015). Anti-sessile bacterial and cytocompatibility properties of CHX-loaded nanohydroxyapatite. Colloids Surf B Biointerfaces, 130 305-14. http://www.ncbi.nlm.nih.gov/pubmed/25936560
7. BARROS-BARBOSA, A. R., LOBO, M. G., FERREIRINHA, F., CORREIA-DE-SA, P. & CORDEIRO, J. M. (2015). P2X7 receptor activation downmodulates Na-dependent high-affinity GABA and glutamate transport into rat brain cortex synaptosomes. Neuroscience, 306 74-90. http://www.ncbi.nlm.nih.gov/pubmed/26299340
8. BERTORELLO, A. M., PIRES, N., IGREJA, B., PINHO, M. J., VORKAPIC, E., WAGSATER, D., WIKSTROM, J., BEHRENDT, M., HAMSTEN, A., ERIKSSON, P., SOARES-DA-SILVA, P. & BRION, L. (2015). Increased Arterial Blood Pressure and Vascular Remodeling in Mice Lacking Salt-Inducible Kinase 1 (SIK1). Circ Res, 116 (4), 642-52. http://www.ncbi.nlm.nih.gov/pubmed/25556206
9. BONIFACIO, M. J., SOUSA, F., NEVES, M., PALMA, N., IGREJA, B., PIRES, N. M., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2015). Characterization of the interaction of the novel antihypertensive etamicastat with human dopamine-beta-hydroxylase: Comparison with nepicastat. Eur J Pharmacol, 751C 50-58. http://www.ncbi.nlm.nih.gov/pubmed/25641750
10. BONIFACIO, M. J., TORRAO, L., LOUREIRO, A. I., PALMA, P. N., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2015). Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat. Br J Pharmacol, 172 (7), 1739-52. http://www.ncbi.nlm.nih.gov/pubmed/25409768
11. BOOKER, S. A., PIRES, N., COBB, S., SOARES-DA-SILVA, P. & VIDA, I. (2015). Carbamazepine and oxcarbazepine, but not eslicarbazepine, enhance excitatory synaptic transmission onto hippocampal CA1 pyramidal cells through an antagonist action at adenosine A1 receptors. Neuropharmacology, 93C 103-115. http://www.ncbi.nlm.nih.gov/pubmed/25656478
12. BURISCH, J., VARDI, H., PEDERSEN, N., BRINAR, M., CUKOVIC-CAVKA, S., KAIMAKLIOTIS, I., DURICOVA, D., BORTLIK, M., SHONOVA, O., VIND, I., AVNSTROM, S., THORSGAARD, N., KRABBE, S., ANDERSEN, V., DAHLERUP, J. F., KJELDSEN, J., SALUPERE, R., OLSEN, J., NIELSEN, K. R., MANNINEN, P., COLLIN, P., KATSANOS, K. H., TSIANOS, E. V., LADEFOGED, K., LAKATOS, L., BAILEY, Y., O'MORAIN, C., SCHWARTZ, D., LUPINACCI, G., DE PADOVA, A., JONAITIS, L., KUPCINSKAS, L., TURCAN, S., BARROS, L., MAGRO, F., LAZAR, D., GOLDIS, A., NIKULINA, I., BELOUSOVA, E., FERNANDEZ, A., PINEDA, J. R., ALMER, S., HALFVARSON, J., TSAI, H. H., SEBASTIAN, S., FRIGER, M., GREENBERG, D., LAKATOS, P. L., LANGHOLZ, E., ODES, S., MUNKHOLM, P. & EPICOM, G. (2015). Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study. Inflamm Bowel Dis, 21 (1), 121-31. http://www.ncbi.nlm.nih.gov/pubmed/25437816
13. CABRAL, J. M., GRACIO, D., SOARES-DA-SILVA, P. & MAGRO, F. (2015). Short- and long-term regulation of intestinal Na+/H+ exchange by Toll-like receptors TLR4 and TLR5. Am J Physiol Gastrointest Liver Physiol, 309 (8), G703-15. http://www.ncbi.nlm.nih.gov/pubmed/26294670
14. CALVO, A. M., SANTOS, G. M., DIONISIO, T. J., MARQUES, M. P., BROZOSKI, D. T., LANCHOTE, V. L., FERNANDES, M. H., FARIA, F. A. & SANTOS, C. F. (2015). Quantification of piroxicam and 5'-hydroxypiroxicam in human plasma and saliva using liquid chromatography-tandem mass spectrometry following oral administration. J Pharm Biomed Anal, 120 212-220. http://www.ncbi.nlm.nih.gov/pubmed/26760238
15. CARDOSO, A. M., SCHETINGER, M. R., CORREIA-DE-SA, P. & SEVIGNY, J. (2015). Impact of ectonucleotidases in autonomic nervous functions. Auton Neurosci, 191 25-38. http://www.ncbi.nlm.nih.gov/pubmed/26008223
16. CARNEIRO, L. S., FONSECA, A. M., VIEIRA-COELHO, M. A., MOTA, M. P. & VASCONCELOS-RAPOSO, J. (2015). Effects of structured exercise and pharmacotherapy vs. pharmacotherapy for adults with depressive symptoms: A randomized clinical trial. J Psychiatr Res, 71 48-55. http://www.ncbi.nlm.nih.gov/pubmed/26522871
17. CERTAL, M., VINHAS, A., PINHEIRO, A. R., FERREIRINHA, F., BARROS-BARBOSA, A. R., SILVA, I., COSTA, M. A. & CORREIA-DE-SA, P. (2015). Calcium signaling and the novel anti-proliferative effect of the UTP-sensitive P2Y receptor in rat cardiac myofibroblasts. Cell Calcium, 58 (5), 518-33. http://www.ncbi.nlm.nih.gov/pubmed/26324417
18. COELHO, R., MAGRO, F., SILVA, M. & MACEDO, G. (2015). Early surgery in Crohn's disease patients with entero-urinary fistulas: does it change the prognosis? Scand J Gastroenterol, in press http://www.ncbi.nlm.nih.gov/pubmed/26679346
19. COELHO, R., PEIXOTO, A., AMIL-DIAS, J., TRINDADE, E., CAMPOS, M., MAGINA, S., CHARBIT-HENRION, F., LENOIR, C., LATOUR, S., MAGRO, F. & MACEDO, G. (2015). Refractory monogenic Crohn's disease due to X-linked inhibitor of apoptosis deficiency. Int J Colorectal Dis, in press http://www.ncbi.nlm.nih.gov/pubmed/26584814
20. CORREIA-COSTA, L., MORATO, M., SOUSA, T., COSME, D., GUIMARAES, J. T., GUERRA, A., SCHAEFER, F., AFONSO, A. C., AZEVEDO, A. & ALBINO-TEIXEIRA, A. (2015). Urinary fibrogenic cytokines ET-1 and TGF-beta1 are associated with urinary angiotensinogen levels in obese children. Pediatr Nephrol, in press http://www.ncbi.nlm.nih.gov/pubmed/26482255
21. CORREIA-COSTA, L., SOUSA, T., MORATO, M., COSME, D., AFONSO, J., MOURA, C., MOTA, C., AREIAS, J. C., GUERRA, A., SCHAEFER, F., AFONSO, A. C., BARROS, H., ALBINO-TEIXEIRA, A. & AZEVEDO, A. (2015). Association of myeloperoxidase levels with cardiometabolic factors and renal function in prepubertal children. Eur J Clin Invest, in press http://www.ncbi.nlm.nih.gov/pubmed/26541603
22. COSTA, F., SOUSA GOMES, P. & FERNANDES, M. H. (2015). Osteogenic and Angiogenic Response to Calcium Silicate-based Endodontic Sealers. J Endod, 42 (1), 113-9. http://www.ncbi.nlm.nih.gov/pubmed/26577874
23. DIAS, C. C., RODRIGUES, P. P., DA COSTA-PEREIRA, A. & MAGRO, F. (2015). Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. J Crohns Colitis, 9 (2), 156-63. http://www.ncbi.nlm.nih.gov/pubmed/25518058
24. DIGNASS, A. U., GASCHE, C., BETTENWORTH, D., BIRGEGARD, G., DANESE, S., GISBERT, J. P., GOMOLLON, F., IQBAL, T., KATSANOS, K., KOUTROUBAKIS, I., MAGRO, F., SAVOYE, G., STEIN, J., VAVRICKA, S., EUROPEAN, C. S. & COLITIS, O. (2015). European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis, 9 (3), 211-22. http://www.ncbi.nlm.nih.gov/pubmed/25518052
25. DOESER, A., DICKHOF, G., REITZE, M., UEBACHS, M., SCHAUB, C., PIRES, N. M., BONIFACIO, M. J., SOARES-DA-SILVA, P. & BECK, H. (2015). Targeting pharmacoresistant epilepsy and epileptogenesis with a dual-purpose antiepileptic drug. Brain, 138 (Pt 2), 371-87. http://www.ncbi.nlm.nih.gov/pubmed/25472797
26. FALCÃO, A., ROCHA, J. F., SANTOS, A., NUNES, T. & SOARES-DA-SILVA, P. (2015). Opicapone Pharmacokinetics andPharmacodynamics ComparisonBetween Healthy Japanese andMatched White Subjects. Clinical Pharmacologyin Drug Development, in press http://onlinelibrary.wiley.com/doi/10.1002/cpdd.213/epdf
27. FERRAZ, R., COSTA-RODRIGUES, J., FERNANDES, M. H., SANTOS, M. M., MARRUCHO, I. M., REBELO, L. P., PRUDENCIO, C., NORONHA, J. P., PETROVSKI, Z. & BRANCO, L. C. (2015). Antitumor Activity of Ionic Liquids Based on Ampicillin. ChemMedChem, 10 (9), 1480-3. http://www.ncbi.nlm.nih.gov/pubmed/26190053
28. FERREIRA, J. J., ROCHA, J. F., FALCAO, A., SANTOS, A., PINTO, R., NUNES, T. & SOARES-DA-SILVA, P. (2015). Effect of opicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity and motor fluctuations in patients with Parkinson's disease. Eur J Neurol, 22 (5), 815-e56. http://www.ncbi.nlm.nih.gov/pubmed/25649051
29. GONCALVES, A. P., CORDEIRO, J. M., MONTEIRO, J., LUCCHI, C., CORREIA-DE-SA, P. & VIDEIRA, A. (2015). Involvement of mitochondrial proteins in calcium signaling and cell death induced by staurosporine in Neurospora crassa. Biochim Biophys Acta, 1847 (10), 1064-1074. http://www.ncbi.nlm.nih.gov/pubmed/26004627
30. GONCALVES, D., ALVES, G., FORTUNA, A., SOARES-DA-SILVA, P. & FALCAO, A. (2015). Development of a liquid chromatography assay for the determination of opicapone and BIA 9-1079 in rat matrices. Biomed Chromatogr, 30 (3), 312-22. http://www.ncbi.nlm.nih.gov/pubmed/26147707
31. GONCALVES, P., MAGRO, F. & MARTEL, F. (2015). Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis, 21 (2), 453-67. http://www.ncbi.nlm.nih.gov/pubmed/25248003
32. HINDRYCKX, P., BAERT, F., HART, A., MAGRO, F., ARMUZZI, A., PEYRIN-BIROULET, L., CLINICAL TRIAL COMMITTEE CLINCOM OF THE EUROPEAN, C. S. & COLITIS, O. (2015). Clinical trials in ulcerative colitis: a historical perspective. J Crohns Colitis, 9 (7), 580-8. http://www.ncbi.nlm.nih.gov/pubmed/25913641
33. IGREJA, B., PIRES, N. M., BONIFACIO, M. J., LOUREIRO, A. I., FERNANDES-LOPES, C., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2015). Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat. Hypertens Res, 38 (1), 30-8. http://www.ncbi.nlm.nih.gov/pubmed/25298210
34. IGREJA, B., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2015). Sustained high blood pressure reduction with etamicastat, a peripheral selective dopamine beta-hydroxylase inhibitor. J Am Soc Hypertens, in press http://www.ncbi.nlm.nih.gov/pubmed/26803288
35. LAM, W. Y. & FRESCO, P. (2015). Medication Adherence Measures: An Overview. Biomed Res Int, 2015 217047. http://www.ncbi.nlm.nih.gov/pubmed/26539470
36. LEAO, M., SOARES, J., GOMES, S., RAIMUNDO, L., RAMOS, H., BESSA, C., QUEIROZ, G., DOMINGOS, S., PINTO, M., INGA, A., CIDADE, H. & SARAIVA, L. (2015). Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction. Life Sci, 142 60-65. http://www.ncbi.nlm.nih.gov/pubmed/26475964
37. LOUREIRO, A. I., BONIFACIO, M. J., FERNANDES-LOPES, C., PIRES, N., IGREJA, B., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2015). Role of P-glycoprotein and permeability upon the brain distribution and pharmacodynamics of etamicastat: a comparison with nepicastat. Xenobiotica, 45 (9), 828-39. http://www.ncbi.nlm.nih.gov/pubmed/25915108
38. LOUREIRO, A. I. & SOARES-DA-SILVA, P. (2015). Distribution and pharmacokinetics of etamicastat and its N-acetylated metabolite (BIA 5-961) in dog and monkey. Xenobiotica, 45 (10), 903-11. http://www.ncbi.nlm.nih.gov/pubmed/25869244
39. MACONI, G. & MAGRO, F. (2015). Comparing techniques to achieve high accuracy and low cost: how should we first diagnose Crohn's disease? J Comp Eff Res, 4 (2), 75-8. http://www.ncbi.nlm.nih.gov/pubmed/25825838
40. MAGRO, F., COELHO, R., GUIMARAES, L. S., SILVA, M., PEIXOTO, A., LOPES, S. & MACEDO, G. (2015). Ionizing radiation exposure is still increasing in Crohn's disease: Who should be blamed? Scand J Gastroenterol, 50 (10), 1214-25. http://www.ncbi.nlm.nih.gov/pubmed/25881793
41. MAGRO, F., COELHO, R., GUIMARAES, L. S., SILVA, M., PEIXOTO, A., LOPES, S. & MACEDO, G. (2015). Anti-TNF therapy and radiation exposure in Crohn's disease: chicken or egg? Scand J Gastroenterol, 51 (4), 511-2. http://www.ncbi.nlm.nih.gov/pubmed/26523855
42. MAGRO, F., RODRIGUES-PINTO, E., COELHO, R., ANDRADE, P., SANTOS-ANTUNES, J., LOPES, S., CAMILA-DIAS, C. & MACEDO, G. (2015). Response to Targownik. Am J Gastroenterol, 110 (2), 349-51. http://www.ncbi.nlm.nih.gov/pubmed/25646916
43. MAGRO, F., RODRIGUES-PINTO, E., COELHO, R., ANDRADE, P., SANTOS-ANTUNES, J., LOPES, S., CAMILA-DIAS, C. & MACEDO, G. (2015). Response to Irwin et al. Am J Gastroenterol, 110 (6), 933-5. http://www.ncbi.nlm.nih.gov/pubmed/26052772
44. MARCOS, R., BRAGANCA, B. & FONTES-SOUSA, A. P. (2015). Image Analysis or Stereology: Which to Choose for Quantifying Fibrosis? J Histochem Cytochem, 63 (9), 734-6. http://www.ncbi.nlm.nih.gov/pubmed/26033333
45. MARQUES, C., AMORIM, M. M., PEREIRA, J. O., GUARDAO, L., MARTINS, M. J., PINTADO, M. E., MOURA, D., CALHAU, C. & PINHEIRO, H. (2015). In vitro ACE-inhibitory peptide KGYGGVSLPEW facilitates noradrenaline release from sympathetic nerve terminals: Relationship with the lack of antihypertensive effect on spontaneous hypertensive rats. Peptides, 71 72-76. http://www.ncbi.nlm.nih.gov/pubmed/26116781
46. MEIRELES, M., MOURA, E., VIEIRA-COELHO, M. A., SANTOS-BUELGA, C., GONZALEZ-MANZANO, S., DUENAS, M., MATEUS, N., FARIA, A. & CALHAU, C. (2015). Flavonoids as dopaminergic neuromodulators. Mol Nutr Food Res, in press http://www.ncbi.nlm.nih.gov/pubmed/26582321
47. MENDES, C. E., PALOMBIT, K., VIEIRA, C., SILVA, I., CORREIA-DE-SA, P. & CASTELUCCI, P. (2015). The Effect of Ischemia and Reperfusion on Enteric Glial Cells and Contractile Activity in the Ileum. Dig Dis Sci, 60 (9), 2677-89. http://www.ncbi.nlm.nih.gov/pubmed/25917048
48. MORAIS, D. S., COELHO, J., LOPES, M. A., FERRAZ, M. P., GOMES, P., FERNANDES, M. H., SANTOS, J. D. & SOORAJ HUSSAIN, N. (2015). Microanalysis of Bioactive Samarium Doped Glass-Reinforced Hydroxyapatite. Microsc Microanal, 21 ( Suppl 5), 31-2. http://www.ncbi.nlm.nih.gov/pubmed/26227696
49. NAZARETH, N., MAGRO, F., APPELBERG, R., SILVA, J., GRACIO, D., COELHO, R., CABRAL, J. M., ABREU, C., MACEDO, G., BULL, T. J. & SARMENTO, A. (2015). Increased viability but decreased culturability of Mycobacterium avium subsp. paratuberculosis in macrophages from inflammatory bowel disease patients under Infliximab treatment. Med Microbiol Immunol, 204 (6), 647-56. http://www.ncbi.nlm.nih.gov/pubmed/25702170
50. NAZARETH, N., MAGRO, F., MACHADO, E., RIBEIRO, T. G., MARTINHO, A., RODRIGUES, P., ALVES, R., MACEDO, G. N., GRACIO, D., COELHO, R., ABREU, C., APPELBERG, R., DIAS, C., MACEDO, G., BULL, T. & SARMENTO, A. (2015). Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease. Med Microbiol Immunol, 204 (6), 681-92. http://www.ncbi.nlm.nih.gov/pubmed/25994082
51. ORESLAND, T., BEMELMAN, W. A., SAMPIETRO, G. M., SPINELLI, A., WINDSOR, A., FERRANTE, M., MARTEAU, P., ZMORA, O., KOTZE, P. G., ESPIN-BASANY, E., TIRET, E., SICA, G., PANIS, Y., FAERDEN, A. E., BIANCONE, L., ANGRIMAN, I., SERCLOVA, Z., DE BUCK VAN OVERSTRAETEN, A., GIONCHETTI, P., STASSEN, L., WARUSAVITARNE, J., ADAMINA, M., DIGNASS, A., ELIAKIM, R., MAGRO, F., D'HOORE, A., EUROPEAN, C. S. & COLITIS, O. (2015). European evidence based consensus on surgery for ulcerative colitis. J Crohns Colitis, 9 (1), 4-25. http://www.ncbi.nlm.nih.gov/pubmed/25304060
52. PEREIRA, C., GRACIO, D., TEIXEIRA, J. P. & MAGRO, F. (2015). Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease. Inflamm Bowel Dis, 21 (10), 2403-17. http://www.ncbi.nlm.nih.gov/pubmed/26193347
53. PINTO, R., L’HOSTIS, P., PATAT, A., HOMERY, M. C., FALCÃO, A., NUNES, T., ROCHA, J. F. & SOARES-DA-SILVA, P. (2015). Evaluation of Opicapone on CardiacRepolarization in a ThoroughQT/QTc Study. Clinical Pharmacologyin Drug Development, 4 (6), 454-52. http://onlinelibrary.wiley.com/doi/10.1002/cpdd.188/abstract
54. PIRES, N., BONIFACIO, M. J. & SOARES-DA-SILVA, P. (2015). Carbamazepine aggravates absence seizures in two dedicated mouse models. Pharmacological Reports, 67 (5), 986-995. http://www.sciencedirect.com/science/article/pii/S1734114015000468
55. PIRES, N. M., IGREJA, B., MOURA, E., WRIGHT, L. C., SERRAO, M. P. & SOARES-DA-SILVA, P. (2015). Blood pressure decrease in spontaneously hypertensive rats folowing renal denervation or dopamine beta-hydroxylase inhibition with etamicastat. Hypertens Res, 38 (9), 605-12. http://www.ncbi.nlm.nih.gov/pubmed/25854989
56. PIRES, N. M., LOUREIRO, A. I., IGREJA, B., LACROIX, P. & SOARES-DA-SILVA, P. (2015). Cardiovascular safety pharmacology profile of etamicastat, a novel peripheral selective dopamine-ss-hydroxylase inhibitor. Eur J Pharmacol, 750C 98-107. http://www.ncbi.nlm.nih.gov/pubmed/25641747
57. QUELHAS-SANTOS, J., SAMPAIO-MAIA, B., REMIÃO, F., SERRÃO, P., SOARES-SILVA, I., DESIR, G. V. & PESTANA, M. (2015). Assessment of renalase activity on catecholamines degradation. Open Hypertension Journal, 7 (1), 14-18. http://benthamopen.com/ABSTRACT/TOHYPERJ-7-14
58. QUELHAS-SANTOS, J., SERRÃO, M. P., SOARES-SILVA, I., FERNANDES-CERQUEIRA, C., SIMÕES-SILVA, L., PINHO, M. J., REMIÃO, F., SAMPAIO-MAIA, B., DESIR, G. V. & PESTANA, M. (2015). Renalase regulates peripheral and central dopaminergic activities. American Journal of Physiology - Renal Physiology, 308 (2), F84-F91. http://www.scopus.com/inward/record.url?eid=2-s2.0-84920992145&partnerID=40&md5=c76d0c483befdec1a85a233ddc7f9c84
59. RIBEIRO, M., DE MORAES, M. A., BEPPU, M. M., GARCIA, M. P., FERNANDES, M. H., MONTEIRO, F. J. & FERRAZ, M. P. (2015). Development of silk fibroin/nanohydroxyapatite composite hydrogels for bone tissue engineering. European Polymer Journal, 67 (0), 66-77. http://www.sciencedirect.com/science/article/pii/S0014305715001913
60. ROCHA, J. F., FERREIRA, J. J., FALCÃO, A., SANTOS, A., PINTO, R., NUNES, T., ALMEIDA, L. & SOARES-DA-SILVA, P. (2015). Effect of 3 Single-Dose Regimens of Opicapone on Levodopa Pharmacokinetics, Catechol-O-Methyltransferase Activity and Motor Response in Patients With Parkinson Disease. Clinical Pharmacology in Drug Development, in press http://onlinelibrary.wiley.com/doi/10.1002/cpdd.217/epdf
61. RODRIGUES, S., LOPES, S., MAGRO, F., CARDOSO, H., HORTA, E. V. A. M., MARQUES, M., MARIZ, E., BERNARDES, M., LOPES, J., CARNEIRO, F. & MACEDO, G. (2015). Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases. World J Gastroenterol, 21 (24), 7584-8. http://www.ncbi.nlm.nih.gov/pubmed/26140007
62. RUNA, M. J., MATHEW, M. T., FERNANDES, M. H. & ROCHA, L. A. (2015). First insight on the impact of an osteoblastic layer on the bio-tribocorrosion performance of Ti6Al4V hip implants. Acta Biomater, 12 341-51. http://www.ncbi.nlm.nih.gov/pubmed/25448346
63. SILVA, C., RAMALHO, C., LUZ, I., MONTEIRO, J. & FRESCO, P. (2015). Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention. Int J Clin Pharm, 37 (2), 327-34. http://www.ncbi.nlm.nih.gov/pubmed/25637404
64. SILVA, I., FERREIRINHA, F., MAGALHAES-CARDOSO, M. T., SILVA-RAMOS, M. & CORREIA-DE-SA, P. (2015). Activation of P2Y6 Receptors Facilitates Nonneuronal Adenosine Triphosphate and Acetylcholine Release from Urothelium with the Lamina Propria of Men with Bladder Outlet Obstruction. J Urol, 194 (4), 1146-54. http://www.ncbi.nlm.nih.gov/pubmed/26004864
65. SILVA, J. C., SAMPAIO, P., FERNANDES, M. H. & GOMES, P. S. (2015). The Osteogenic Priming of Mesenchymal Stem Cells is Impaired in Experimental Diabetes. J Cell Biochem, 116 (8), 1658-67. http://www.ncbi.nlm.nih.gov/pubmed/25704854
66. SILVA-RAMOS, M., SILVA, I., FARIA, M., MAGALHAES-CARDOSO, M. T., CORREIA, J., FERREIRINHA, F. & CORREIA-DE-SA, P. (2015). Impairment of ATP hydrolysis decreases adenosine A1 receptor tonus favoring cholinergic nerve hyperactivity in the obstructed human urinary bladder. Purinergic Signal, 11 (4), 595-606. http://www.ncbi.nlm.nih.gov/pubmed/26521170
67. SOARES, A. S., COSTA, V. M., DINIZ, C. & FRESCO, P. (2015). Inosine Strongly Enhances Proliferation of Human C32 Melanoma Cells through PLC-PKC-MEK1/2-ERK1/2 and PI3K Pathways. Basic Clin Pharmacol Toxicol, 116 (1), 25-36. http://www.ncbi.nlm.nih.gov/pubmed/24909096
68. SOARES, J. B., MARINHO, A. S., FERNANDES, D., MOREIRA GONCALVES, B., CAMILA-DIAS, C., GONCALVES, R., MAGRO, F., ASSOCIATION OF PORTUGUESE PATIENTS WITH, I. B. D. & PORTUGUESE STUDY GROUP OF, I. B. D. (2015). Assessing overall patient satisfaction in inflammatory bowel disease using structural equation modeling. Eur J Gastroenterol Hepatol, 27 (8), 941-50. http://www.ncbi.nlm.nih.gov/pubmed/25966672
69. SOARES-DA-SILVA, P., CABRAL, J. M., MAGALHAES, D., FRAGA, S. & MAGRO, F. (2015). Amine neurotransmitters, inflammation and epithelial sodium transport. Exp Physiol, in press http://www.ncbi.nlm.nih.gov/pubmed/26548358
70. SOUSA, J. B., VIEIRA-ROCHA, M. S., ARRIBAS, S. M., GONZALEZ, M. C., FRESCO, P. & DINIZ, C. (2015). Endothelial and Neuronal Nitric Oxide Activate Distinct Pathways on Sympathetic Neurotransmission in Rat Tail and Mesenteric Arteries. PLoS One, 10 (6), e0129224. http://www.ncbi.nlm.nih.gov/pubmed/26075386
71. SPERLING, M. R., ABOU-KHALIL, B., HARVEY, J., ROGIN, J. B., BIRABEN, A., GALIMBERTI, C. A., KOWACS, P. A., HONG, S. B., CHENG, H., BLUM, D., NUNES, T., SOARES-DA-SILVA, P. & STUDY, T. (2015). Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial. Epilepsia, 56 (2), 244-53. http://www.ncbi.nlm.nih.gov/pubmed/25528898
72. VAN DER WOUDE, C. J., ARDIZZONE, S., BENGTSON, M. B., FIORINO, G., FRASER, G., KATSANOS, K., KOLACEK, S., JUILLERAT, P., MULDERS, A. G., PEDERSEN, N., SELINGER, C., SEBASTIAN, S., STURM, A., ZELINKOVA, Z., MAGRO, F., EUROPEAN, C. S. & COLITIS, O. (2015). The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis, 9 (2), 107-24. http://www.ncbi.nlm.nih.gov/pubmed/25602023
73. VAZ-DA-SILVA, M., ROCHA, J. F., LACROIX, P., FALCAO, A., ALMEIDA, L. & SOARES-DA-SILVA, P. (2015). Cardiac safety profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor in non-human primates, human young and elderly healthy volunteers and hypertensive patients. IJC Metabolic & Endocrine, 7 10-24. http://www.sciencedirect.com/science/article/pii/S2214762415000134
74. VEGH, Z., BURISCH, J., PEDERSEN, N., KAIMAKLIOTIS, I., DURICOVA, D., BORTLIK, M., VINDING, K. K., AVNSTROM, S., OLSEN, J., NIELSEN, K. R., KATSANOS, K. H., TSIANOS, E. V., LAKATOS, L., SCHWARTZ, D., ODES, S., D'INCA, R., BELTRAMI, M., KIUDELIS, G., KUPCINSKAP, L., JUCOV, A., TURCAN, S., BARROS, L. F., MAGRO, F., LAZAR, D., GOLDIS, A., DE CASTRO, L., HERNANDEZ, V., NIEWIADOMSKI, O., BELL, S., LANGHOLZ, E., MUNKHOLM, P., LAKATOS, P. L. & EPICOM, G. (2015). Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort. J Crohns Colitis, 9 (9), 747-53. http://www.ncbi.nlm.nih.gov/pubmed/26055976
75. VIEIRA, L., SILVESTRE-FERREIRA, A. C., FONTES-SOUSA, A. P., BALREIRA, A. C., MORCHON, R., CARRETON, E., VILHENA, H., SIMON, F. & MONTOYA-ALONSO, J. A. (2015). Seroprevalence of heartworm (Dirofilaria immitis) in feline and canine hosts from central and northern Portugal. J Helminthol, 89 (5), 625-9. http://www.ncbi.nlm.nih.gov/pubmed/24824176
2014 (articles in alphabetical order)
1. AZEVEDO, A. R., DE SOUSA, H. M., MONTEIRO, J. A. & LIMA, A. R. (2014). Future perspectives of Smartphone applications for rheumatic diseases self-management. Rheumatol Int, 35 419-31. http://www.ncbi.nlm.nih.gov/pubmed/25168866
2. BARROS, J., COSTA-RODRIGUES, J., LOPES, M. A., PINA-VAZ, I. & FERNANDES, M. H. (2014). Response of Human Osteoblastic and Osteoclastic Cells to AH Plus and Pulp Canal Sealer Containing Quaternary Ammonium Polyethylenimine Nanoparticles. J Endod, 40 (8), 1149-55. http://www.ncbi.nlm.nih.gov/pubmed/25069923
3. BONIFACIO, M. J., SUTCLIFFE, J. S., TORRAO, L., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2014). Brain and peripheral pharmacokinetics of levodopa in the cynomolgus monkey following administration of opicapone, a third generation nitrocatechol COMT inhibitor. Neuropharmacology, 77 334-41. http://www.ncbi.nlm.nih.gov/pubmed/24148813
4. BURISCH, J., PEDERSEN, N., CUKOVI, X. C. S., BRINAR, M., KAIMAKLIOTIS, I., DURICOVA, D., SHONOVA, O., VIND, I., AVNSTROM, S., THORSGAARD, N., ANDERSEN, V., KRABBE, S., DAHLERUP, J. F., SALUPERE, R., NIELSEN, K. R., OLSEN, J., MANNINEN, P., COLLIN, P., TSIANOS, E. V., KATSANOS, K. H., LADEFOGED, K., LAKATOS, L., BJORNSSON, E., RAGNARSSON, G., BAILEY, Y., ODES, S., SCHWARTZ, D., MARTINATO, M., LUPINACCI, G., MILLA, M., DE PADOVA, A., D'INCA, R., BELTRAMI, M., KUPCINSKAS, L., KIUDELIS, G., TURCAN, S., TIGHINEANU, O., MIHU, I., MAGRO, F., BARROS, L. F., GOLDIS, A., LAZAR, D., BELOUSOVA, E., NIKULINA, I., HERNANDEZ, V., MARTINEZ-ARES, D., ALMER, S., ZHULINA, Y., HALFVARSON, J., AREBI, N., SEBASTIAN, S., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. & FOR THE, E.-G. (2014). East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut, 63 (4), 588-597. http://www.ncbi.nlm.nih.gov/pubmed/23604131
5. BURISCH, J., PEDERSEN, N., CUKOVIC-CAVKA, S., TURK, N., KAIMAKLIOTIS, I., DURICOVA, D., BORTLIK, M., SHONOVA, O., VIND, I., AVNSTROM, S., THORSGAARD, N., KRABBE, S., ANDERSEN, V., DAHLERUP, J. F., KJELDSEN, J., SALUPERE, R., OLSEN, J., NIELSEN, K. R., MANNINEN, P., COLLIN, P., KATSANOS, K. H., TSIANOS, E. V., LADEFOGED, K., LAKATOS, L., RAGNARSSON, G., BJORNSSON, E., BAILEY, Y., O'MORAIN, C., SCHWARTZ, D., ODES, S., GIANNOTTA, M., GIRARDIN, G., KIUDELIS, G., KUPCINSKAS, L., TURCAN, S., BARROS, L., MAGRO, F., LAZAR, D., GOLDIS, A., NIKULINA, I., BELOUSOVA, E., MARTINEZ-ARES, D., HERNANDEZ, V., ALMER, S., ZHULINA, Y., HALFVARSON, J., AREBI, N., TSAI, H. H., SEBASTIAN, S., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. & EPICOM, G. (2014). Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study. J Crohns Colitis, 8 (7), 607-16. http://www.ncbi.nlm.nih.gov/pubmed/24315795
6. BURISCH, J., PEDERSEN, N., CUKOVIC-CAVKA, S., TURK, N., KAIMAKLIOTIS, I., DURICOVA, D., SHONOVA, O., VIND, I., AVNSTROM, S., THORSGAARD, N., KRABBE, S., ANDERSEN, V., DAHLERUP JENS, F., KJELDSEN, J., SALUPERE, R., OLSEN, J., NIELSEN, K. R., MANNINEN, P., COLLIN, P., KATSANOS, K. H., TSIANOS, E. V., LADEFOGED, K., LAKATOS, L., BAILEY, Y., O'MORAIN, C., SCHWARTZ, D., ODES, S., MARTINATO, M., LOMBARDINI, S., JONAITIS, L., KUPCINSKAS, L., TURCAN, S., BARROS, L., MAGRO, F., LAZAR, D., GOLDIS, A., NIKULINA, I., BELOUSOVA, E., FERNANDEZ, A., HERNANDEZ, V., ALMER, S., ZHULINA, Y., HALFVARSON, J., TSAI, H. H., SEBASTIAN, S., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. & EPICOM, G. (2014). Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflamm Bowel Dis, 20 (1), 36-46. http://www.ncbi.nlm.nih.gov/pubmed/24252978
7. BURISCH, J., VEGH, Z., PEDERSEN, N., CUKOVIC-CAVKA, S., TURK, N., KAIMAKLIOTIS, I., DURICOVA, D., BORTLIK, M., SHONOVA, O., THORSGAARD, N., KRABBE, S., ANDERSEN, V., DAHLERUP, J. F., KJELDSEN, J., SALUPERE, R., OLSEN, J., NIELSEN, K. R., MANNINEN, P., COLLIN, P., KATSANOS, K. H., TSIANOS, E. V., LADEFOGED, K., RAGNARSSON, G., BJORNSSON, E., BAILEY, Y., O'MORAIN, C., SCHWARTZ, D., ODES, S., POLITI, P., SANTINI, A., KIUDELIS, G., KUPCINSKAS, L., TURCAN, S., MAGRO, F., BARROS, L., LAZAR, D., GOLDIS, A., NIKULINA, I., BELOUSOVA, E., SANROMAN, L., MARTINEZ-ARES, D., ALMER, S., ZHULINA, Y., HALFVARSON, J., AREBI, N., HOUSTON, Y., SEBASTIAN, S., LANGHOLZ, E., LAKATOS, P. L., MUNKHOLM, P. & EPICOM, G. (2014). Health care and patients' education in a European inflammatory bowel disease inception cohort: An ECCO-EpiCom study. J Crohns Colitis, 8 (8), 811-8. http://www.ncbi.nlm.nih.gov/pubmed/24439390
8. BURISCH, J., WEIMERS, P., PEDERSEN, N., CUKOVIC-CAVKA, S., VUCELIC, B., KAIMAKLIOTIS, I., DURICOVA, D., BORTLIK, M., SHONOVA, O., VIND, I., AVNSTROM, S., THORSGAARD, N., KRABBE, S., ANDERSEN, V., DAHLERUP, J. F., KJELDSEN, J., SALUPERE, R., OLSEN, J., NIELSEN, K. R., MANNINEN, P., COLLIN, P., KATSANOS, K. H., TSIANOS, E. V., LADEFOGED, K., LAKATOS, L., RAGNARSSON, G., BJORNSSON, E., BAILEY, Y., O'MORAIN, C., SCHWARTZ, D., ODES, S., VALPIANI, D., BONI, M. C., JONAITIS, L., KUPCINSKAS, L., TURCAN, S., BARROS, L., MAGRO, F., LAZAR, D., GOLDIS, A., NIKULINA, I., BELOUSOVA, E., FERNANDEZ, A., SANROMAN, L., ALMER, S., ZHULINA, Y., HALFVARSON, J., AREBI, N., DIGGORY, T., SEBASTIAN, S., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. & EPICOM, G. (2014). Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease - An ECCO-EpiCom study. J Crohns Colitis, 8 (9), 1030-42. http://www.ncbi.nlm.nih.gov/pubmed/24560877
9. CARNEIRO, I., TIMOTEO, M. A., SILVA, I., VIEIRA, C., BALDAIA, C., FERREIRINHA, F., SILVA-RAMOS, M. & CORREIA-DE-SA, P. (2014). Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium. Br J Pharmacol, 171 (14), 3404-19. http://www.ncbi.nlm.nih.gov/pubmed/24697602
10. CORREIA-SA, I., SERRAO, P., MARQUES, M. & VIEIRA-COELHO, M. A. (2014). Vitamin D and Inflammatory Biomarkers during Wound-Healing. Plast Reconstr Surg, 134 (4 Suppl 1), 68-9. http://www.ncbi.nlm.nih.gov/pubmed/25254772
11. COSTA, M., GARCIA, M., COSTA-RODRIGUES, J., COSTA, M. S., RIBEIRO, M. J., FERNANDES, M. H., BARROS, P., BARREIRO, A., VASCONCELOS, V. & MARTINS, R. (2014). Exploring bioactive properties of marine cyanobacteria isolated from the Portuguese coast: high potential as a source of anticancer compounds. Mar Drugs, 12 (1), 98-114. http://www.ncbi.nlm.nih.gov/pubmed/24384871
12. DE PAULA RAMOS, E., ANTONIO, M. B., AMBIEL, C. R., CORREIA-DE-SA, P. & ALVES-DO-PRADO, W. (2014). Paradoxical neostigmine-induced TOFfade: On the role of presynaptic cholinergic and adenosine receptors. Eur J Pharmacol, 723 389-96. http://www.ncbi.nlm.nih.gov/pubmed/24247035
13. DIGNASS, A., ELIAKIM, R., MAGRO, F., MAASER, C., CHOWERS, Y., GEBOES, K., MANTZARIS, G., REINISCH, W., COLOMBEL, J., VERMEIRE, S., TRAVIS, S., LINDSAY, J. O. & VAN ASSCHE, G. (2014). Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis (Spanish version). Rev Gastroenterol Mex, 79 (4), 263-289. http://www.ncbi.nlm.nih.gov/pubmed/25487134
14. DOESER, A., SOARES-DA-SILVA, P., BECK, H. & UEBACHS, M. (2014). The effects of eslicarbazepine on persistent Na(+) current and the role of the Na(+) channel beta subunits. Epilepsy Res, 108 (2), 202-11. http://www.ncbi.nlm.nih.gov/pubmed/24368131
15. DUNANT, Y. & CORDEIRO, J. M. (2014). Presynaptic k(+) channels, vesicular ca(2+)/h (+) antiport-synaptotagmin, and acetylcholinesterase, three mechanisms cutting short the cholinergic signal at neuromuscular and nerve-electroplaque junctions. J Mol Neurosci, 53 (3), 377-86. http://www.ncbi.nlm.nih.gov/pubmed/24390960
16. DURAO, S. F., GOMES, P. S., COLACO, B. J., SILVA, J. C., FONSECA, H. M., DUARTE, J. R., FELINO, A. C. & FERNANDES, M. H. (2014). The biomaterial-mediated healing of critical size bone defects in the ovariectomized rat. Osteoporos Int, 25 (5), 1535-45. http://www.ncbi.nlm.nih.gov/pubmed/24573401
17. ELIAKIM, R. & MAGRO, F. (2014). Imaging techniques in IBD and their role in follow-up and surveillance. Nat Rev Gastroenterol Hepatol, 11 (12), 722-36. http://www.ncbi.nlm.nih.gov/pubmed/25157623
18. FREITAS, E. & GUIMARAES, J. (2014). Neuromyelitis optica spectrum disorders associated with other autoimmune diseases. Rheumatol Int, 35 (2), 243-53. http://www.ncbi.nlm.nih.gov/pubmed/24952418
19. GONCALVES, A. P., CORDEIRO, J. M., MONTEIRO, J., MUNOZ, A., CORREIA-DE-SA, P., READ, N. D. & VIDEIRA, A. (2014). Activation of a TRP-like channel and intracellular Ca2+ dynamics during phospholipase-C-mediated cell death. J Cell Sci, 127 (Pt 17), 3817-3829. http://www.ncbi.nlm.nih.gov/pubmed/25037570
20. GRUNZE, H., KOTLIK, E., COSTA, R., NUNES, T., FALCAO, A., ALMEIDA, L. & SOARES-DA-SILVA, P. (2014). Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: Experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. J Affect Disord, 174C 70-82. http://www.ncbi.nlm.nih.gov/pubmed/25484179
21. GUIMARAES, J., VIEIRA-COELHO, M. A., MOURA, E., AFONSO, J., ROSAS, M. J., VAZ, R. & GARRETT, C. (2014). Urinary profile of catecholamines and metabolites in Parkinson patients with deep brain stimulation. Eur J Neurol, 21 (2), 353-6. http://www.ncbi.nlm.nih.gov/pubmed/23679894
22. KISS, L. E. & SOARES-DA-SILVA, P. (2014). Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility. J Med Chem, 57 (21), 8692-717. http://www.ncbi.nlm.nih.gov/pubmed/25080080
23. LANGNER, C., MAGRO, F., DRIESSEN, A., ENSARI, A., MANTZARIS, G. J., VILLANACCI, V., BECHEANU, G., BORRALHO NUNES, P., CATHOMAS, G., FRIES, W., JOURET-MOURIN, A., MESCOLI, C., DE PETRIS, G., RUBIO, C. A., SHEPHERD, N. A., VIETH, M., ELIAKIM, R. & GEBOES, K. (2014). The histopathological approach to inflammatory bowel disease: a practice guide. Virchows Arch, 464 (5), 511-27. http://www.ncbi.nlm.nih.gov/pubmed/24487791
24. LARANJEIRA, M. S., CARVALHO, A., PELAEZ-VARGAS, A., FERNANDES, M. H., HANSFORD, D. & MONTEIRO, F. J. (2014). Modulation of human dermal microvascular endothelial cells (HDMEC) and human gingival fibroblast (HGF) behaviors by micropatterned silica coating surfaces for zirconia dental implants applications. Sci. Technol. Adv. Mater., 15 (2), 025001 (11pp). http://iopscience.iop.org/1468-6996/15/2/025001/
25. LIMA, A., SOUSA, H., MONTEIRO, J., AZEVEDO, R., MEDEIROS, R. & SEABRA, V. (2014). Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers. Pharmacogenomics, 15 (12), 1611-35. http://www.ncbi.nlm.nih.gov/pubmed/25340735
26. LOUREIRO, A. I., JOAO BONIFACIO, M., FERNANDES-LOPES, C., IGREJA, B., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2014). Etamicastat, a new dopamine-ss-hydroxylase inhibitor, pharmacodynamics and metabolism in rat. Eur J Pharmacol, 740 285-94. http://www.ncbi.nlm.nih.gov/pubmed/25058908
27. LOUREIRO, A. I., ROCHA, J. F., FERNANDES-LOPES, C., NUNES, T., WRIGHT, L. C., ALMEIDA, L. & SOARES-DA-SILVA, P. (2014). Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine beta-hydroxylase inhibitor. Br J Clin Pharmacol, 77 (6), 1017-26. http://www.ncbi.nlm.nih.gov/pubmed/24168152
28. MAGINA, S., VIEIRA-COELHO, M. A., MOURA, E., SERRAO, M. P., PISCITELLI, F., MOURA, D. & DI MARZO, V. (2014). Effect of narrowband ultraviolet B treatment on endocannabinoid plasma levels in patients with psoriasis. Br J Dermatol, 171 (1), 198-201. http://www.ncbi.nlm.nih.gov/pubmed/24641781
29. MAGRO, F. & ABREU, C. (2014). Immunisations in Crohn’s disease: Who? Why? What? When? Best Practice & Research Clinical Gastroenterology, 28 (3), 485-96. http://www.sciencedirect.com/science/article/pii/S1521691814000511#
30. MAGRO, F. & ELIAKIM, R. (2014). Are we on our way to change our mode of thinking and treating inflammatory bowel disease patients? Ann Gastroenterol, 27 (4), 424-426. http://www.ncbi.nlm.nih.gov/pubmed/25330804
31. MAGRO, F., PEYRIN-BIROULET, L., SOKOL, H., ALDEGER, X., COSTA, A., HIGGINS, P. D., JOYCE, J. C., KATSANOS, K. H., LOPEZ, A., DE XAXARS, T. M., TOADER, E. & BEAUGERIE, L. (2014). Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III). J Crohns Colitis, 8 (1), 31-44. http://www.ncbi.nlm.nih.gov/pubmed/23721759
32. MAGRO, F., RODRIGUES-PINTO, E., COELHO, R., ANDRADE, P., SANTOS-ANTUNES, J., LOPES, S., CAMILA-DIAS, C. & MACEDO, G. (2014). Is it Possible to Change Phenotype Progression in Crohn's Disease in the Era of Immunomodulators? Predictive Factors of Phenotype Progression. Am J Gastroenterol, 109 (7), 1026-36. http://www.ncbi.nlm.nih.gov/pubmed/24796767
33. MAGRO, F., RODRIGUES-PINTO, E., LOPES, S. & MACEDO, G. (2014). Earlier need of infliximabintensification in Ulcerative Colitisthan in Crohn's disease. J Crohns Colitis, 8 (10), 1331-2. http://www.ncbi.nlm.nih.gov/pubmed/24690137
34. MAGRO, F., RODRIGUES-PINTO, E., SANTOS-ANTUNES, J., VILAS-BOAS, F., LOPES, S., NUNES, A., CAMILA-DIAS, C. & MACEDO, G. (2014). High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment. J Crohns Colitis, 8 (2), 129-36. http://www.ncbi.nlm.nih.gov/pubmed/23932786
35. MAGRO, F., SANTOS-ANTUNES, J., VILAS-BOAS, F., RODRIGUES-PINTO, E., COELHO, R., RIBEIRO, O. S., LOPES, S. & MACEDO, G. (2014). Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience. J Crohns Colitis, 8 (7), 617-25. http://www.ncbi.nlm.nih.gov/pubmed/24332869
36. MAGRO, F., SOARES, J. B. & FERNANDES, D. (2014). Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol, 20 (7), 4857-72. http://www.wjgnet.com/1007-9327/current.htm
37. MAGRO, F., SOUSA, P. & MINISTRO, P. (2014). C-reactive protein in Crohn's disease: how informative is it? Expert Rev Gastroenterol Hepatol, 8 (4), 393-408. http://www.ncbi.nlm.nih.gov/pubmed/24635486
38. MATA, D., OLIVEIRA, F. J., FERREIRA, N. M., ARAUJO, R. F., FERNANDES, A. J., LOPES, M. A., GOMES, P. S., FERNANDES, M. H. & SILVA, R. F. (2014). Processing strategies for smart electroconductive carbon nanotube-based bioceramic bone grafts. Nanotechnology, 25 (14), 145602. http://www.ncbi.nlm.nih.gov/pubmed/24622290
39. MATA, D., OLIVEIRA, F. J., FERRO, M., GOMES, P. S., FERNANDES, M. H., LOPES, M. A. & SILVA, R. F. (2014). Multifunctional Carbon Nanotube/Bioceramics Modulate the Directional Growth and Activity of Osteoblastic Cells. Journal of Biomedical Nanotechnology, 10 (5), 725-43. http://www.ingentaconnect.com/content/asp/jbn/2014/00000010/00000005/art00001
40. MOREIRA-RODRIGUES, M., GRACA, A. L., FERREIRA, M., AFONSO, J., SERRAO, P., MORATO, M., FERREIRINHA, F., CORREIA-DE-SA, P., EBERT, S. N. & MOURA, D. (2014). Attenuated Aortic Vasodilation and Sympathetic Prejunctional Facilitation in Epinephrine-Deficient Mice: Selective Impairment of beta2-Adrenoceptor Responses. J Pharmacol Exp Ther, 351 (2), 243-9. http://www.ncbi.nlm.nih.gov/pubmed/25161169
41. NAZARETH, N., MAGRO, F., SILVA, J., DURO, M., GRACIO, D., COELHO, R., APPELBERG, R., MACEDO, G. & SARMENTO, A. (2014). Infliximab therapy increases the frequency of circulating CD16+ monocytes and modifies macrophage cytokine response to bacterial infection. Clin Exp Immunol, 177 (3), 703-11. http://www.ncbi.nlm.nih.gov/pubmed/24816497
42. NORONHA-MATOS, J. B., COIMBRA, J., SA, E. S. A., ROCHA, R., MARINHAS, J., FREITAS, R., GUERRA-GOMES, S., FERREIRINHA, F., COSTA, M. A. & CORREIA-DE-SA, P. (2014). P2X7-induced zeiosis promotes osteogenic differentiation and mineralization of postmenopausal bone marrow-derived mesenchymal stem cells. FASEB J, 28 (12), 5208-22. http://www.ncbi.nlm.nih.gov/pubmed/25169056
43. OLIVEIRA, A., PINHO, D., ALBINO-TEIXEIRA, A., MEDEIROS, R., DINIS-OLIVEIRA, R. J. & CARVALHO, F. (2014). Morphine glucuronidation increases its analgesic effect in guinea pigs. Life Sci, 109 (2), 104-10. http://www.ncbi.nlm.nih.gov/pubmed/24968302
44. OLIVEIRA, L., COSTA, A. C., NORONHA-MATOS, J. B., SILVA, I., CAVALCANTE, W. L., TIMOTEO, M. A., CORRADO, A. P., DAL BELO, C. A., AMBIEL, C. R., ALVES-DO-PRADO, W. & CORREIA-DE-SA, P. (2014). Amplification of neuromuscular transmission by methylprednisolone involves activation of presynaptic facilitatory adenosine A receptors and redistribution of synaptic vesicles. Neuropharmacology, 89C 64-76. http://www.ncbi.nlm.nih.gov/pubmed/25220030
45. OSORIO, F., PEDROSA, A., AZEVEDO, F., FIGUEIREDO, P. & MAGINA, S. (2014). Cat-scratch disease during anti-tumor necrosis factor-alpha therapy: case report and review of the literature. Int J Dermatol, 53 (3), e182-3. http://www.ncbi.nlm.nih.gov/pubmed/23557494
46. PALMAS, R. A., MONTEIRO, J. & FRESCO, P. (2014). Analytical methods fortaxanes quantification in diluted formulations and biological samples and their applications in clinical practice. International Journal of Pharmacy and Pharmaceutical Sciences, 6 (6), 17-23. http://www.ijppsjournal.com/Vol6Issue6/8298.pdf
47. PEREIRA, C., LOPES-RODRIGUES, V., COUTINHO, I., NEVES, M. P., LIMA, R. T., PINTO, M., CIDADE, H., VASCONCELOS, M. H. & SARAIVA, L. (2014). Potential small-molecule activators of caspase-7 identified using yeast-based caspase-3 and -7 screening assays. Eur J Pharm Sci, 54 8-16. http://www.ncbi.nlm.nih.gov/pubmed/24398107
48. PEREIRA, C., MIGUEL MARTINS, L. & SARAIVA, L. (2014). LRRK2, but not pathogenic mutants, protects against HO stress depending on mitochondrial function and endocytosis in a yeast model. Biochim Biophys Acta, 1840 (6), 2025-2031. http://www.ncbi.nlm.nih.gov/pubmed/24576675
49. POPOV, S., TAKEMORI, H., TOKUDOME, T., MAO, Y., OTANI, K., MOCHIZUKI, PIRES, N., PINHO, M. J., FRANCO-CERECEDA, A., TORIELLI, L., FERRANDI, M., HAMSTEN, A., SOARES-DA-SILVA, P., ERIKSSON, P., BERTORELLO, A. M. & BRION, L. (2014). Lack of salt-inducible kinase 2 (SIK2) prevents the development of cardiac hypertrophy in response to chronic high-salt intake. PLoS ONE, 9 (4), e95771. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0095771
50. POTSCHKA, H., SOERENSEN, J., PEKCEC, A., LOUREIRO, A. & SOARES-DA-SILVA, P. (2014). Effect of eslicarbazepine acetate in the corneal kindling progression and the amygdala kindling model of temporal lobe epilepsy. Epilepsy Res, 108 (2), 212-22. http://www.ncbi.nlm.nih.gov/pubmed/24345645
51. QUINTAS, C., PINHO, D., PEREIRA, C., SARAIVA, L., GONCALVES, J. & QUEIROZ, G. (2014). Microglia P2Y6 receptors mediate nitric oxide release and astrocyte apoptosis. J Neuroinflammation, 11 (1), 141. http://www.ncbi.nlm.nih.gov/pubmed/25178395
52. RAHIER, J. F., MAGRO, F., ABREU, C., ARMUZZI, A., BEN-HORIN, S., CHOWERS, Y., COTTONE, M., DE RIDDER, L., DOHERTY, G., EHEHALT, R., ESTEVE, M., KATSANOS, K., LEES, C. W., MACMAHON, E., MOREELS, T., REINISCH, W., TILG, H., TREMBLAY, L., VEEREMAN-WAUTERS, G., VIGET, N., YAZDANPANAH, Y., ELIAKIM, R., COLOMBEL, J. F., ON BEHALF OF THE EUROPEAN, C. S. & COLITIS, O. (2014). Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis, 8 (6), 443-68. http://www.ncbi.nlm.nih.gov/pubmed/24613021
53. REBELO, T., COSTA-RODRIGUES, J., SANTOS, C., FERNANDES, M. H., NORONHA, J. & SALES, G. (2014). Novel Prostate Specific Antigen plastic antibody designed with charged binding sites for an improved protein binding and its application in a biosensor of potentiometric transduction. Electrochimica Acta, 132 142-150. http://ac.els-cdn.com/S0013468614006215/1-s2.0-S0013468614006215-main.pdf?_tid=3ca3244a-ca02-11e3-b28a-00000aab0f27&acdnat=1398159850_10c548418770fc09d1635d426e16a45a
54. REBELO, T. S. C. R., PEREIRA, C. M., SALES, M. F., NORONHA, J. P., COSTA-RODRIGUES, J., SILVA, F. & FERNANDES, M. H. (2014). Sarcosine oxidase composite screen-printed electrode for sarcosine determination in biological samples. Analytica Chimica Acta, 850 26-32. http://www.sciencedirect.com/science/article/pii/S0003267014009520
55. REINA-COUTO, M., CARVALHO, J., VALENTE, M. J., VALE, L., AFONSO, J., CARVALHO, F., BETTENCOURT, P., SOUSA, T. & ALBINO-TEIXEIRA, A. (2014). Impaired resolution of inflammation in human chronic heart failure. Eur J Clin Invest, 44 (6), 527-38. http://www.ncbi.nlm.nih.gov/pubmed/24673112
56. RIBEIRO, V., GARCIA, M., OLIVEIRA, R., GOMES, P. S., COLACO, B. & FERNANDES, M. H. (2014). Bisphosphonates induce the osteogenic gene expression in co-cultured human endothelial and mesenchymal stem cells. J Cell Mol Med, 18 (1), 27-37. http://www.ncbi.nlm.nih.gov/pubmed/24373581
57. RIEDER, F., DE BRUYN, J. R., PHAM, B. T., KATSANOS, K., ANNESE, V., HIGGINS, P. D., MAGRO, F. & DOTAN, I. (2014). Results of the 4th Scientific Workshop of the ECCO (Group II): Markers of intestinal fibrosis in inflammatory bowel disease. J Crohns Colitis, 8 (10), 1166-1178. http://www.ncbi.nlm.nih.gov/pubmed/24726695
58. ROCHA, J. F., FALCAO, A., SANTOS, A., PINTO, R., LOPES, N., NUNES, T., WRIGHT, L. C., VAZ-DA-SILVA, M. & SOARES-DA-SILVA, P. (2014). Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations. Eur J Clin Pharmacol, 70 (9), 1059-71. http://www.ncbi.nlm.nih.gov/pubmed/24925090
59. ROCHA, J. F., SANTOS, A., FALCAO, A., LOPES, N., NUNES, T., PINTO, R. & SOARES-DA-SILVA, P. (2014). Effect of moderate liver impairment on the pharmacokinetics of opicapone. Eur J Clin Pharmacol, 70 (3), 279-86. http://www.ncbi.nlm.nih.gov/pubmed/24271646
60. RODRIGUES, C., COSTA-RODRIGUES, J., CAPELAS, J. A. & FERNANDES, M. H. (2014). Behaviour of co-cultured human osteoclastic and osteoblastic cells exposed to endodontic sealers' extracts. Clin Oral Investig, 18 (2), 479-88. http://www.ncbi.nlm.nih.gov/pubmed/23604699
61. RODRIGUES, L. R., DE LARANJEIRA, M. S., FERNANDES, M. H., MONTEIRO, F. J. & DE CARVALHO ZAVAGLIA, C. A. (2014). HA/TCP scaffolds obtained by sucrose crystal leaching method: Preliminary in vitro evaluation. Materials Research, 17 (4), 811-16. http://www.scielo.br/scielo.php?pid=S1516-14392014000400003&script=sci_arttext
62. RODRIGUES-PINTO, E., MAGRO, F., PIMENTA, S., GUIMARAES, J. & MACEDO, G. (2014). Mimicry between intestinal Behcet's disease and inflammatory bowel disease. J Crohns Colitis, 8 (7), 714-5. http://www.ncbi.nlm.nih.gov/pubmed/24389388
63. SANTOS, J. M., BENITE-RIBEIRO, S. A., QUEIROZ, G. & DUARTE, J. A. (2014). The interrelation between aPKC and glucose uptake in the skeletal muscle during contraction and insulin stimulation. Cell Biochem Funct, 32 (8), 621-4. http://www.ncbi.nlm.nih.gov/pubmed/25529429
64. SANTOS-ANTUNES, J., ABREU, C., MAGRO, F., COELHO, R., VILAS-BOAS, F., ANDRADE, P., LOPES, S. & MACEDO, G. (2014). Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review. J Crohns Colitis, 8 (4), 326-30. http://www.ncbi.nlm.nih.gov/pubmed/24257435
65. SANTOS-ANTUNES, J., MAGRO, F. & MACEDO, G. (2014). Listeria monocytogenes bacteremia and CMV colitis in a patient with Ulcerative Colitis. J Crohns Colitis, 8 (3), 254-5. http://www.ncbi.nlm.nih.gov/pubmed/24183232
66. SANTOS-MORAIS, D., COELHO, J., FERRAZ, M. P., GOMES, P. S., FERNANDES, M. H., HUSSAIN, N. S., SANTOSA, J. D. & LOPESA, M. A. (2014). Samarium doped glass-reinforced hydroxyapatite with enhanced osteoblastic performance and antibacterial properties for bone tissue regeneration. Journal of Materials Chemistry B, 2 5872-81. http://pubs.rsc.org/en/Content/ArticleLanding/2014/TB/C4TB00484A#!divAbstract
67. SOARES, A. S., COSTA, V. M., DINIZ, C. & FRESCO, P. (2014). Combination of Cl-IB-MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR-dependent autophagy and mitotic catastrophe on human melanoma cells. J Cancer Res Clin Oncol, 140 (6), 921-935. http://www.ncbi.nlm.nih.gov/pubmed/24659394
68. SOARES, A. S., COSTA, V. M., DINIZ, C. & FRESCO, P. (2014). The combination of Cl-IB-MECA with paclitaxel: a new anti-metastatic therapeutic strategy for melanoma. Cancer Chemother Pharmacol, 74 (4), 847-60. http://www.ncbi.nlm.nih.gov/pubmed/25119183
69. SOARES, J., PEREIRA, N. A., MONTEIRO, A., LEAO, M., BESSA, C., DOS SANTOS, D. J., RAIMUNDO, L., QUEIROZ, G., BISIO, A., INGA, A., PEREIRA, C., SANTOS, M. M. & SARAIVA, L. (2014). Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. Eur J Pharm Sci, 66 138-47. http://www.ncbi.nlm.nih.gov/pubmed/25312347
70. SOUSA, J. B., FRESCO, P. & DINIZ, C. (2014). Endothelial dysfunction impairs vascular neurotransmission in tail arteries. Neurochem Int, 80C 7-13. http://www.ncbi.nlm.nih.gov/pubmed/25447765
71. SOUSA, J. B., VIEIRA-ROCHA, M. S., SA, C., FERREIRINHA, F., CORREIA-DE-SA, P., FRESCO, P. & DINIZ, C. (2014). Lack of endogenous adenosine tonus on sympathetic neurotransmission in spontaneously hypertensive rat mesenteric artery. PLoS One, 9 (8), e105540. http://www.ncbi.nlm.nih.gov/pubmed/25158061
72. TIMOTEO, M. A., CARNEIRO, I., SILVA, I., NORONHA-MATOS, J. B., FERREIRINHA, F., SILVA-RAMOS, M. & CORREIA-DE-SA, P. (2014). ATP released via pannexin-1 hemichannels mediates bladder overactivity triggered by urothelial P2Y6 receptors. Biochem Pharmacol, 87 (2), 371-9. http://www.ncbi.nlm.nih.gov/pubmed/24269631
73. VEGH, Z., BURISCH, J., PEDERSEN, N., KAIMAKLIOTIS, I., DURICOVA, D., BORTLIK, M., AVNSTROM, S., VINDING, K. K., OLSEN, J., NIELSEN, K. R., KATSANOS, K. H., TSIANOS, E. V., LAKATOS, L., SCHWARTZ, D., ODES, S., LUPINACCI, G., DE PADOVA, A., JONAITIS, L., KUPCINSKAS, L., TURCAN, S., TIGHINEANU, O., MIHU, I., BARROS, L. F., MAGRO, F., LAZAR, D., GOLDIS, A., FERNANDEZ, A., HERNANDEZ, V., NIEWIADOMSKI, O., BELL, S., LANGHOLZ, E., MUNKHOLM, P., LAKATOS, P. L. & EPICOM, G. (2014). Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis, 8 (11), 1506-15. http://www.ncbi.nlm.nih.gov/pubmed/24998983
74. VIDAL, H., GONÇALINHO, H., MONTEIRO, J., DAS NEVES, J., SARMENTO, B., DINIZ, C. & FRESCO, P. (2014). Development and validation of a rapid and simple reversed-phase HPLC method for the determination of gemcitabine in human plasma. International Journal of Pharmacy and Pharmaceutical Sciences, 6 (9), 59-65. http://innovareacademics.in/journals/index.php/ijpps/article/view/8447
75. VIEIRA, C., MAGALHÃES-CARDOSO, M. T., FERREIRINHA, F., SILVA, I., DIAS, A. S., PELLETIER, J., SÉVIGNY, J. & CORREIA-DE-SÁ, P. (2014). Feed-Forward Inhibition of CD73 and Upregulation of Adenosine Deaminase Contribute to the Loss of Adenosine Neuromodulation in Postinflammatory Ileitis. Mediators of Inflammation, 2014 (2014), Article ID 254640, 19 pages. http://www.hindawi.com/journals/mi/2014/254640/
76. VIEIRA, L., SILVESTRE-FERREIRA, A. C., FONTES-SOUSA, A. P., BALREIRA, A. C., MORCHON, R., CARRETON, E., VILHENA, H., SIMON, F. & MONTOYA-ALONSO, J. A. (2014). Seroprevalence of heartworm (Dirofilaria immitis) in feline and canine hosts from central and northern Portugal. J Helminthol, 89 (5), 625-9. http://www.ncbi.nlm.nih.gov/pubmed/24824176
2013 (articles in alphabetical order)
1. ABREU, C., MAGRO, F., SANTOS-ANTUNES, J., PILAO, A., RODRIGUES-PINTO, E., BERNARDES, J., BERNARDO, A., MAGINA, S., VILAS-BOAS, F., LOPES, S., MACEDO, G. & SARMENTO, A. (2013). Tuberculosis in anti-TNF-alpha treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population. J Crohns Colitis, 7 (10), e486-92. http://www.ncbi.nlm.nih.gov/pubmed/23583099
2. ABREU, C., MAGRO, F., VILAS-BOAS, F., LOPES, S., MACEDO, G. & SARMENTO, A. (2013). Listeria infection in patients on anti-TNF treatment: report of two cases and review of the literature. J Crohns Colitis, 7 (2), 175-82. http://www.ncbi.nlm.nih.gov/pubmed/22626505
3. AFONSO, J., PASSOS, C. P., COIMBRA, M. A., SILVA, C. M. & SOARES-DA-SILVA, P. (2013). Inhibitory effect of phenolic compounds from grape seeds (Vitis vinifera L.) on the activity of angiotensin I converting enzyme. Lwt-Food Science and Technology, 54 (1), 265-270. <Go to ISI>://000321991200039
4. ALMEIDA, L., NUNES, T., COSTA, R., ROCHA, J. F., VAZ-DA-SILVA, M. & SOARES-DA-SILVA, P. (2013). Etamicastat, a novel dopamine beta-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension. Clin Ther, 35 (12), 1983-96. http://www.ncbi.nlm.nih.gov/pubmed/24296323
5. ALMEIDA, L., ROCHA, J. F., FALCAO, A., PALMA, P. N., LOUREIRO, A. I., PINTO, R., BONIFACIO, M. J., WRIGHT, L. C., NUNES, T. & SOARES-DA-SILVA, P. (2013). Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel catechol-O-methyltransferase inhibitor, in healthy subjects: prediction of slow enzyme-inhibitor complex dissociation of a short-living and very long-acting inhibitor. Clinical pharmacokinetics, 52 (2), 139-51. http://www.ncbi.nlm.nih.gov/pubmed/23248072
6. ARAUJO, J. R., CORREIA-BRANCO, A., PEREIRA, A. C., PINHO, M. J., KEATING, E. & MARTEL, F. (2013). Oxidative stress decreases uptake of neutral amino acids in a human placental cell line (BeWo cells). Reprod Toxicol, 40 76-81. http://www.ncbi.nlm.nih.gov/pubmed/23806338
7. ARAUJO, J. R., CORREIA-BRANCO, A., RAMALHO, C., GONCALVES, P., PINHO, M. J., KEATING, E. & MARTEL, F. (2013). L-methionine placental uptake: characterization and modulation in gestational diabetes mellitus. Reprod Sci, 20 (12), 1492-507. http://www.ncbi.nlm.nih.gov/pubmed/23653387
8. BESSA, C., PEREIRA, C., LEAO, M., MACIEL, C., GOMES, S., GONCALVES, J., CORTE-REAL, M., COSTA, V. & SARAIVA, L. (2013). Using yeast to uncover the regulation of protein kinase Cdelta by ceramide. FEMS Yeast Res, 13 (7), 700-5. http://www.ncbi.nlm.nih.gov/pubmed/23937324
9. BURISCH, J., PEDERSEN, N., CUKOVIC-CAVKA, S., BRINAR, M., KAIMAKLIOTIS, I., DURICOVA, D., SHONOVA, O., VIND, I., AVNSTROM, S., THORSGAARD, N., ANDERSEN, V., KRABBE, S., DAHLERUP, J. F., SALUPERE, R., NIELSEN, K. R., OLSEN, J., MANNINEN, P., COLLIN, P., TSIANOS, E. V., KATSANOS, K. H., LADEFOGED, K., LAKATOS, L., BJORNSSON, E., RAGNARSSON, G., BAILEY, Y., ODES, S., SCHWARTZ, D., MARTINATO, M., LUPINACCI, G., MILLA, M., DE PADOVA, A., D'INCA, R., BELTRAMI, M., KUPCINSKAS, L., KIUDELIS, G., TURCAN, S., TIGHINEANU, O., MIHU, I., MAGRO, F., BARROS, L. F., GOLDIS, A., LAZAR, D., BELOUSOVA, E., NIKULINA, I., HERNANDEZ, V., MARTINEZ-ARES, D., ALMER, S., ZHULINA, Y., HALFVARSON, J., AREBI, N., SEBASTIAN, S., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. & FOR THE, E.-G. (2013). East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut, http://www.ncbi.nlm.nih.gov/pubmed/23604131
10. BURISCH, J., PEDERSEN, N., CUKOVIC-CAVKA, S., TURK, N., KAIMAKLIOTIS, I., DURICOVA, D., BORTLIK, M., SHONOVA, O., VIND, I., AVNSTROM, S., THORSGAARD, N., KRABBE, S., ANDERSEN, V., DAHLERUP, J. F., KJELDSEN, J., SALUPERE, R., OLSEN, J., NIELSEN, K. R., MANNINEN, P., COLLIN, P., KATSANOS, K. H., TSIANOS, E. V., LADEFOGED, K., LAKATOS, L., RAGNARSSON, G., BJORNSSON, E., BAILEY, Y., O'MORAIN, C., SCHWARTZ, D., ODES, S., GIANNOTTA, M., GIRARDIN, G., KIUDELIS, G., KUPCINSKAS, L., TURCAN, S., BARROS, L., MAGRO, F., LAZAR, D., GOLDIS, A., NIKULINA, I., BELOUSOVA, E., MARTINEZ-ARES, D., HERNANDEZ, V., ALMER, S., ZHULINA, Y., HALFVARSON, J., AREBI, N., TSAI, H. H., SEBASTIAN, S., LAKATOS, P. L., LANGHOLZ, E., MUNKHOLM, P. & FOR THE, E.-G. (2013). Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe - An ECCO-EpiCom study. J Crohns Colitis, http://www.ncbi.nlm.nih.gov/pubmed/24315795
11. CABRAL, J. M., SOARES-DA-SILVA, P. & MAGRO, F. (2013). Short- and long-term regulation of intestinal Na+/H+ exchange activity associated with TLR2 receptor activation is independent of nuclear factor-kappaB signaling. J Pharmacol Exp Ther, 346 (3), 453-64. http://www.ncbi.nlm.nih.gov/pubmed/23845891
12. CORDEIRO, J. M., BODA, B., GONCALVES, P. P. & DUNANT, Y. (2013). Synaptotagmin 1 is required for vesicular Ca(2)(+)/H(+)-antiport activity. J Neurochem, 126 (1), 37-46. http://www.ncbi.nlm.nih.gov/pubmed/23607712
13. CORREIA-DE-SA, P., NORONHA-MATOS, J. B., TIMOTEO, M. A., FERREIRINHA, F., MARQUES, P., SOARES, A. M., CARVALHO, C., CAVALCANTE, W. L. & GALLACCI, M. (2013). Bothropstoxin-I reduces evoked acetylcholine release from rat motor nerve terminals: radiochemical and real-time video-microscopy studies. Toxicon, 61 16-25. http://www.ncbi.nlm.nih.gov/pubmed/23142504
14. CORREIA-SA, I., DE-SOUSA-LOPES, H., MARTINS, M. J., AZEVEDO, I., MOURA, E. & VIEIRA-COELHO, M. A. (2013). Effects of raftilose on serum biochemistry and liver morphology in rats fed with normal or high-fat diet. Mol Nutr Food Res, 57 (8), 1468-72. http://www.ncbi.nlm.nih.gov/pubmed/23653231
15. COSTA, J., MAGRO, F., CALDEIRA, D., ALARCAO, J., SOUSA, R. & VAZ-CARNEIRO, A. (2013). Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis, 19 (10), 2098-110. http://www.ncbi.nlm.nih.gov/pubmed/23860567
16. COSTA-RODRIGUES, J., REIS, S., TEIXEIRA, S., LOPES, S. & FERNANDES, M. H. (2013). Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity. FEBS J, 280 (20), 5052-64. http://www.ncbi.nlm.nih.gov/pubmed/23937530
17. DIAS, C. C., RODRIGUES, P. P., DA COSTA-PEREIRA, A. & MAGRO, F. (2013). Clinical prognostic factors for disabling Crohn's disease: a systematic review and meta-analysis. World J Gastroenterol, 19 (24), 3866-71. http://www.ncbi.nlm.nih.gov/pubmed/23840127
18. DURAES, C., MACHADO, J. C., PORTELA, F., RODRIGUES, S., LAGO, P., CRAVO, M., MINISTRO, P., MARQUES, M., CREMERS, I., FREITAS, J., COTTER, J., TAVARES, L., MATOS, L., MEDEIROS, I., SOUSA, R., RAMOS, J., DEUS, J., CALDEIRA, P., CHAGAS, C., DUARTE, M. A., GONCALVES, R., LOUREIRO, R., BARROS, L., BASTOS, I., CANCELA, E., MORAES, M. C., MOREIRA, M. J., VIEIRA, A. I. & MAGRO, F. (2013). Phenotype-genotype profiles in Crohn's disease predicted by genetic markers in autophagy-related genes (GOIA study II). Inflamm Bowel Dis, 19 (2), 230-9. http://www.ncbi.nlm.nih.gov/pubmed/22573572
19. ELGER, C., BIALER, M., FALCAO, A., VAZ-DA-SILVA, M., NUNES, T., ALMEIDA, L. & SOARES-DA-SILVA, P. (2013). Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers. Epilepsia, 54 (8), 1453-61. http://www.ncbi.nlm.nih.gov/pubmed/23758485
20. EUSEBIO, N., PINHEIRO, T., AMORIM, A. A., GAMBOA, F., SARAIVA, L., GUSMAO, L., AMORIM, A. & ARAUJO, R. (2013). SNaPaer: a practical single nucleotide polymorphism multiplex assay for genotyping of Pseudomonas aeruginosa. PLoS One, 8 (6), e66083. http://www.ncbi.nlm.nih.gov/pubmed/23776608
21. FALCAO, A., LIMA, R., SOUSA, R., NUNES, T. & SOARES-DA-SILVA, P. (2013). Bioequivalence of eslicarbazepine acetate from two different sources of its active product ingredient in healthy subjects. Drugs in R&D, 13 (2), 137-43. http://www.ncbi.nlm.nih.gov/pubmed/23677811
22. FALCAO, A., PINTO, R., NUNES, T. & SOARES-DA-SILVA, P. (2013). Effect of repeated administration of eslicarbazepine acetate on the pharmacokinetics of simvastatin in healthy subjects. Epilepsy research, 106 (1-2), 244-9. http://www.ncbi.nlm.nih.gov/pubmed/23726291
23. FALCAO, A., VAZ-DA-SILVA, M., GAMA, H., NUNES, T., ALMEIDA, L. & SOARES-DA-SILVA, P. (2013). Effect of eslicarbazepine acetate on the pharmacokinetics of a combined ethinylestradiol/levonorgestrel oral contraceptive in healthy women. Epilepsy Res, 105 (3), 368-76. http://www.ncbi.nlm.nih.gov/pubmed/23570863
24. FERNANDES-CERQUEIRA, C., SAMPAIO-MAIA, B., QUELHAS-SANTOS, J., MOREIRA-RODRIGUES, M., SIMOES-SILVA, L., BLAZQUEZ-MEDELA, A. M., MARTINEZ-SALGADO, C., LOPEZ-NOVOA, J. M. & PESTANA, M. (2013). Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome. Biomed Res Int, 2013 397391. http://www.ncbi.nlm.nih.gov/pubmed/23956981
25. FERREIRA, R. S., DA SILVA COQUEIRO, R., BARBOSA, A. R., PINHEIRO, P. A. & FERNANDES, M. H. (2013). Relationship between BMI and physical performance among older adults. Geriatr Nurs, 34 (6), 465-8. http://www.ncbi.nlm.nih.gov/pubmed/23993659
26. FORTUNA, A., ALVES, G., SOARES-DA-SILVA, P. & FALCAO, A. (2013). Pharmacokinetics, brain distribution and plasma protein binding of carbamazepine and nine derivatives: new set of data for predictive in silico ADME models. Epilepsy research, 107 (1-2), 37-50. http://www.ncbi.nlm.nih.gov/pubmed/24050973
27. GIL-NAGEL, A., ELGER, C., BEN-MENACHEM, E., HALASZ, P., LOPES-LIMA, J., GABBAI, A. A., NUNES, T., FALCAO, A., ALMEIDA, L. & DA-SILVA, P. S. (2013). Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies. Epilepsia, 54 (1), 98-107. http://www.ncbi.nlm.nih.gov/pubmed/22882018
28. GOMES, P., SIMAO, S., LEMOS, V., AMARAL, J. S. & SOARES-DA-SILVA, P. (2013). Loss of oxidative stress tolerance in hypertension is linked to reduced catalase activity and increased c-Jun NH2-terminal kinase activation. Free Radic Biol Med, 56 112-22. http://www.ncbi.nlm.nih.gov/pubmed/23220262
29. GONCALVES, D., ALVES, G., FORTUNA, A., SOARES-DA-SILVA, P. & FALCAO, A. (2013). An HPLC-DAD method for the simultaneous quantification of opicapone (BIA 9-1067) and its active metabolite in human plasma. The Analyst, 138 (8), 2463-9. http://www.ncbi.nlm.nih.gov/pubmed/23476919
30. GUERRA, L. & FRESCO, P. (2013). Characterization of pharmacy services in Portuguese prisons: a national survey. International Journal of Prisoner Health, 9 (4), 187-95. http://www.emeraldinsight.com/journals.htm?articleid=17099982&show=abstract
31. GUIMARAES, J., MOURA, E., SILVA, E., AGUIAR, P., GARRETT, C. & VIEIRA-COELHO, M. A. (2013). Locus coeruleus is involved in weight loss in a rat model of Parkinson's disease: an effect reversed by deep brain stimulation. Brain Stimul, 6 (6), 845-55. http://www.ncbi.nlm.nih.gov/pubmed/23849716
32. GUIMARAES, J., VIEIRA-COELHO, M. A., MOURA, E., AFONSO, J., ROSAS, M. J., VAZ, R. & GARRETT, C. (2013). Urinary profile of catecholamines and metabolites in Parkinson patients with deep brain stimulation. Eur J Neurol, http://www.ncbi.nlm.nih.gov/pubmed/23679894
33. GUIMARAES, J., VIEIRA-COELHO, M. A., MOURA, E., ROSAS, M. J., VAZ, R. & GARRETT, C. (2013). Follow-up of renal function in Parkinson patients with bilateral deep brain stimulation. Parkinsonism Relat Disord, 19 (9), 836-7. http://www.ncbi.nlm.nih.gov/pubmed/23714358
34. HUFNAGEL, A., BEN-MENACHEM, E., GABBAI, A. A., FALCAO, A., ALMEIDA, L. & SOARES-DA-SILVA, P. (2013). Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study. Epilepsy Res, 103 (2-3), 262-9. http://www.ncbi.nlm.nih.gov/pubmed/22871333
35. LARANJEIRA, M. S., FERNANDES, M. H. & MONTEIRO, F. J. (2013). Response of monocultured and co-cultured human microvascular endothelial cells and mesenchymal stem cells to macroporous granules of nanostructured-hydroxyapatite agglomerates. J Biomed Nanotechnol, 9 (9), 1594-606. http://www.ncbi.nlm.nih.gov/pubmed/23980507
36. LEAO, M., GOMES, S., PEDRAZA-CHAVERRI, J., MACHADO, N., SOUSA, E., PINTO, M., INGA, A., PEREIRA, C. & SARAIVA, L. (2013). Alpha-mangostin and gambogic acid as potential inhibitors of the p53-MDM2 interaction revealed by a yeast approach. J Nat Prod, 76 (4), 774-8. http://www.ncbi.nlm.nih.gov/pubmed/23540934
37. LEAO, M., GOMES, S., SOARES, J., BESSA, C., MACIEL, C., CIRIBILLI, Y., PEREIRA, C., INGA, A. & SARAIVA, L. (2013). Novel simplified yeast-based assays of regulators of p53-MDMX interaction and p53 transcriptional activity. FEBS J, 280 (24), 6498-507. http://www.ncbi.nlm.nih.gov/pubmed/24119020
38. LEAO, M., PEREIRA, C., BISIO, A., CIRIBILLI, Y., PAIVA, A. M., MACHADO, N., PALMEIRA, A., FERNANDES, M. X., SOUSA, E., PINTO, M., INGA, A. & SARAIVA, L. (2013). Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach. Biochem Pharmacol, 85 (9), 1234-45. http://www.ncbi.nlm.nih.gov/pubmed/23428467
39. LIMA, C. F., GARRETT, C. & CASTRO, S. L. (2013). Not all sounds sound the same: Parkinson's disease affects differently emotion processing in music and in speech prosody. J Clin Exp Neuropsychol, 35 (4), 373-92. http://www.ncbi.nlm.nih.gov/pubmed/23477505
40. LOPES, P., GARCIA, M. P., FERNANDES, M. H. & FERNANDES, M. H. (2013). Properties and osteoblast cytocompatibility of self-curing acrylic cements modified by glass fillers. J Biomater Appl, 28 (4), 498-513. http://www.ncbi.nlm.nih.gov/pubmed/22918184
41. LOPES, P. P., GARCIA, M. P., FERNANDES, M. H. & FERNANDES, M. H. (2013). Acrylic formulations containing bioactive and biodegradable fillers to be used as bone cements: properties and biocompatibility assessment. Mater Sci Eng C Mater Biol Appl, 33 (3), 1289-99. http://www.ncbi.nlm.nih.gov/pubmed/23827574
42. LOPES, P. P., SILVA, M. S. & FERNANDES, M. H. (2013). Influence of ibuprofen addition on the properties of a bioactive bone cement. J Mater Sci Mater Med, 24 (8), 2067-76. http://www.ncbi.nlm.nih.gov/pubmed/23677434
43. LOUREIRO, A. I., FERNANDES-LOPES, C., BONIFACIO, M. J., WRIGHT, L. C. & SOARES-DA-SILVA, P. (2013). N-Acetylation of Etamicastat, a Reversible Dopamine-beta-Hydroxylase Inhibitor. Drug metabolism and disposition: the biological fate of chemicals, 41 (12), 2081-6. http://www.ncbi.nlm.nih.gov/pubmed/24013186
44. LOUREIRO, A. I., ROCHA, J. F., FERNANDES-LOPES, C., NUNES, T., WRIGHT, L. C., ALMEIDA, L. & SOARES-DA-SILVA, P. (2013). Human Disposition, Metabolism and Excretion of Etamicastat, a Reversible Peripherally Selective Dopamine ss-Hydroxylase Inhibitor. Br J Clin Pharmacol, http://www.ncbi.nlm.nih.gov/pubmed/24168152
45. MAGINA, S., MOURA, E., SERRAO, M. P., MOURA, D. & VIEIRA-COELHO, M. A. (2013). Catechol-O-methyltransferase activity is higher in psoriasis patients and is down-regulated by narrowband ultraviolet B treatment. Eur J Dermatol, 23 (1), 49-52. http://www.ncbi.nlm.nih.gov/pubmed/23399536
46. MAGRO, F., LANGNER, C., DRIESSEN, A., ENSARI, A., GEBOES, K., MANTZARIS, G. J., VILLANACCI, V., BECHEANU, G., BORRALHO NUNES, P., CATHOMAS, G., FRIES, W., JOURET-MOURIN, A., MESCOLI, C., DE PETRIS, G., RUBIO, C. A., SHEPHERD, N. A., VIETH, M., ELIAKIM, R., EUROPEAN SOCIETY OF, P., EUROPEAN, C. S. & COLITIS, O. (2013). European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis, 7 (10), 827-51. http://www.ncbi.nlm.nih.gov/pubmed/23870728
47. MAGRO, F., SANTOS-ANTUNES, J., ALBUQUERQUE, A., VILAS-BOAS, F., MACEDO, G. N., NAZARETH, N., LOPES, S., SOBRINHO-SIMOES, J., TEIXEIRA, S., DIAS, C. C., CABRAL, J., SARMENTO, A. & MACEDO, G. (2013). Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens. Inflamm Bowel Dis, 19 (8), 1710-6. http://www.ncbi.nlm.nih.gov/pubmed/23574759
48. MAGRO, F., SANTOS-ANTUNES, J., VILAS-BOAS, F., RODRIGUES-PINTO, E., COELHO, R., RIBEIRO, O. S., LOPES, S. & MACEDO, G. (2013). Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience. J Crohns Colitis, http://www.ncbi.nlm.nih.gov/pubmed/24332869
49. MORAIS, P., FERREIRA, O., MAGINA, S., SILVA, C., LEAO, M., MAIA, A. & AZEVEDO, F. (2013). Classic Ehlers-Danlos syndrome: case report and brief review of literature. Acta Dermatovenerol Croat, 21 (2), 118-22. http://www.ncbi.nlm.nih.gov/pubmed/24001420
50. MORAIS, P., MAGINA, S., REIS, A., PINTO, H., AMIL DIAS, J., RODRIGUES, M., SILVA, G., AZEVEDO, F. & GUIMARÃES, H. (2013). Reticular hemangioma of the lower extremity associated with congenital structural anomalies: therapeutic approach. Med Cutan Iber Lat Am, 41 (1), 38-42. http://www.medigraphic.com/pdfs/cutanea/mc-2013/mc131g.pdf
51. MORTE, M. I., CARREIRA, B. P., FALCAO, M. J., AMBROSIO, A. F., SOARES-DA-SILVA, P., ARAUJO, I. M. & CARVALHO, C. M. (2013). Evaluation of neurotoxic and neuroprotective pathways affected by antiepileptic drugs in cultured hippocampal neurons. Toxicology in vitro : an international journal published in association with BIBRA, 27 (8), 2193-202. http://www.ncbi.nlm.nih.gov/pubmed/24055897
52. MUNZ, M., AMORIM, M. J., FARIA, M., VICENTE, C., PINTO, A., MONTEIRO, J., LEITE-MOREIRA, A. F. & AGUAS, A. P. (2013). Cardiac venous arterialization in acute myocardial infarction: how great is the benefit? Interact Cardiovasc Thorac Surg, 16 (3), 307-13. http://www.ncbi.nlm.nih.gov/pubmed/23203313
53. NUNES, T., ROCHA, J. F., FALCAO, A., ALMEIDA, L. & SOARES-DA-SILVA, P. (2013). Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers. Epilepsia, 54 (1), 108-16. http://www.ncbi.nlm.nih.gov/pubmed/22812691
54. OLIVEIRA, R., DORIA, S., MADUREIRA, C., LIMA, V., ALMEIDA, C., PINHO, M. J., RAMALHO, C., MATOSO, E., BARROS, A., CARREIRA, I. M. & MOURA, C. P. (2013). Inv21p12q22del21q22 and intellectual disability. Gene, 517 (1), 120-4. http://www.ncbi.nlm.nih.gov/pubmed/23266646
55. OSORIO, F., LEAO, M., AZEVEDO, F. & MAGINA, S. (2013). Lamellar ichthyosis due to ALOX12B mutation. Actas Dermosifiliogr, 104 (5), 443-4. http://www.ncbi.nlm.nih.gov/pubmed/23083690
56. PANES, J., BOUHNIK, Y., REINISCH, W., STOKER, J., TAYLOR, S. A., BAUMGART, D. C., DANESE, S., HALLIGAN, S., MARINCEK, B., MATOS, C., PEYRIN-BIROULET, L., RIMOLA, J., ROGLER, G., VAN ASSCHE, G., ARDIZZONE, S., BA-SSALAMAH, A., BALI, M. A., BELLINI, D., BIANCONE, L., CASTIGLIONE, F., EHEHALT, R., GRASSI, R., KUCHARZIK, T., MACCIONI, F., MACONI, G., MAGRO, F., MARTIN-COMIN, J., MORANA, G., PENDSE, D., SEBASTIAN, S., SIGNORE, A., TOLAN, D., TIELBEEK, J. A., WEISHAUPT, D., WIARDA, B. & LAGHI, A. (2013). Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis, 7 (7), 556-85. http://www.ncbi.nlm.nih.gov/pubmed/23583097
57. PAPOUTSAKI, M., OSORIO, F., MORAIS, P., TORRES, T., MAGINA, S., CHIMENTI, S. & COSTANZO, A. (2013). Infliximab in psoriasis and psoriatic arthritis. BioDrugs, 27 Suppl 1 13-23. http://www.ncbi.nlm.nih.gov/pubmed/23990278
58. PATINHA, D., FASCHING, A., PINHO, D., ALBINO-TEIXEIRA, A., MORATO, M. & PALM, F. (2013). Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors. Am J Physiol Renal Physiol, 304 (5), F614-22. http://www.ncbi.nlm.nih.gov/pubmed/23283998
59. PELAEZ-VARGAS, A., GALLEGO-PEREZ, D., CARVALHO, A., FERNANDES, M. H., HANSFORD, D. J. & MONTEIRO, F. J. (2013). Effects of density of anisotropic microstamped silica thin films on guided bone tissue regeneration--in vitro study. J Biomed Mater Res B Appl Biomater, 101 (5), 762-9. http://www.ncbi.nlm.nih.gov/pubmed/23359600
60. PEREIRA, C. & SARAIVA, L. (2013). Interference of aging media on the assessment of yeast chronological life span by propidium iodide staining. Folia Microbiol (Praha), 58 (1), 81-4. http://www.ncbi.nlm.nih.gov/pubmed/22828896
61. PETRAUSKAITE, O., GOMES PDE, S., FERNANDES, M. H., JUODZBALYS, G., STUMBRAS, A., MAMINSKAS, J., LIESIENE, J. & CICCIU, M. (2013). Biomimetic mineralization on a macroporous cellulose-based matrix for bone regeneration. Biomed Res Int, 2013 452750. http://www.ncbi.nlm.nih.gov/pubmed/24163816
62. PINHEIRO, A. R., PARAMOS-DE-CARVALHO, D., CERTAL, M., COSTA, C., MAGALHAES-CARDOSO, M. T., FERREIRINHA, F., COSTA, M. A. & CORREIA-DE-SA, P. (2013). Bradykinin-induced Ca2+ signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation. Cell Commun Signal, 11 70. http://www.ncbi.nlm.nih.gov/pubmed/24047499
63. PINHEIRO, A. R., PARAMOS-DE-CARVALHO, D., CERTAL, M., COSTA, M. A., COSTA, C., MAGALHAES-CARDOSO, M. T., FERREIRINHA, F., SEVIGNY, J. & CORREIA-DE-SA, P. (2013). Histamine induces ATP release from human subcutaneous fibroblasts, via pannexin-1 hemichannels, leading to Ca2+ mobilization and cell proliferation. J Biol Chem, 288 (38), 27571-83. http://www.ncbi.nlm.nih.gov/pubmed/23918924
64. PINHO, D., QUINTAS, C., SARDO, F., CARDOSO, T. M. & QUEIROZ, G. (2013). Purinergic modulation of norepinephrine release and uptake in rat brain cortex: contribution of glial cells. J Neurophysiol, 110 (11), 2580-91. http://www.ncbi.nlm.nih.gov/pubmed/24027106
65. PINTO, V., PINHO, M. J. & SOARES-DA-SILVA, P. (2013). Renal amino acid transport systems and essential hypertension. FASEB J, 27 (8), 2927-38. http://www.ncbi.nlm.nih.gov/pubmed/23616567
66. PORTELA, A., VASCONCELOS, M., FERNANDES, M. H., GARCIA, M., SILVA, A., GABRIEL, J., GARTNER, F., AMORIM, I. & CAVALHEIRO, J. (2013). Highly focalised thermotherapy using a ferrimagnetic cement in the treatment of a melanoma mouse model by low temperature hyperthermia. Int J Hyperthermia, 29 (2), 121-32. http://www.ncbi.nlm.nih.gov/pubmed/23418916
67. ROCHA, J. F., ALMEIDA, L., FALCAO, A., PALMA, P. N., LOUREIRO, A. I., PINTO, R., BONIFACIO, M. J., WRIGHT, L. C., NUNES, T. & SOARES-DA-SILVA, P. (2013). Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following multiple dose administration in healthy subjects. Br J Clin Pharmacol, 76 (5), 763-75. http://www.ncbi.nlm.nih.gov/pubmed/23336248
68. ROCHA-PEREIRA, C., ARRIBAS, S. M., FRESCO, P., GONZALEZ, M. C., GONCALVES, J. & DINIZ, C. (2013). Impaired inhibitory function of presynaptic A1-adenosine receptors in SHR mesenteric arteries. J Pharmacol Sci, 122 (2), 59-70. http://www.ncbi.nlm.nih.gov/pubmed/23782593
69. ROCHA-PEREIRA, C., SOUSA, J. B., VIEIRA-ROCHA, M. S., FRESCO, P., GONCALVES, J. & DINIZ, C. (2013). Differential inhibition of noradrenaline release mediated by inhibitory A(1)-adenosine receptors in the mesenteric vein and artery from normotensive and hypertensive rats. Neurochem Int, 62 (4), 399-405. http://www.ncbi.nlm.nih.gov/pubmed/23416044
70. RODRIGUES, C., COSTA-RODRIGUES, J., CAPELAS, J. A. & FERNANDES, M. H. (2013). Long-term dose- and time-dependent effects of endodontic sealers in human in vitro osteoclastogenesis. J Endod, 39 (6), 833-8. http://www.ncbi.nlm.nih.gov/pubmed/23683288
71. RODRIGUES, C., COSTA-RODRIGUES, J., CAPELAS, J. A. & FERNANDES, M. H. (2013). Behaviour of co-cultured human osteoclastic and osteoblastic cells exposed to endodontic sealers' extracts. Clin Oral Investig, http://www.ncbi.nlm.nih.gov/pubmed/23604699
72. RODRIGUES, S. C., SALGADO, C. L., SAHU, A., GARCIA, M. P., FERNANDES, M. H. & MONTEIRO, F. J. (2013). Preparation and characterization of collagen-nanohydroxyapatite biocomposite scaffolds by cryogelation method for bone tissue engineering applications. J Biomed Mater Res A, 101 (4), 1080-94. http://www.ncbi.nlm.nih.gov/pubmed/23008173
73. SANTOS-ANTUNES, J., ABREU, C., MAGRO, F., COELHO, R., VILAS-BOAS, F., ANDRADE, P., LOPES, S. & MACEDO, G. (2013). Disseminated cutaneous herpes simplex infection in a patient with Crohn's disease under azathioprine and steroids: First case report and literature review. J Crohns Colitis, http://www.ncbi.nlm.nih.gov/pubmed/24257435
74. SILVA, C., FRESCO, P., MONTEIRO, J. & RAMA, A. C. (2013). Online drug databases: a new method to assess and compare inclusion of clinically relevant information. Int J Clin Pharm, 35 (4), 560-9. http://www.ncbi.nlm.nih.gov/pubmed/23729318
75. SILVA, R., CARMO, H., VILAS-BOAS, V., DE PINHO, P. G., DINIS-OLIVEIRA, R. J., CARVALHO, F., SILVA, I., CORREIA-DE-SA, P., BASTOS MDE, L. & REMIAO, F. (2013). Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells. Toxicol Lett, 217 (1), 34-41. http://www.ncbi.nlm.nih.gov/pubmed/23220037
76. SILVA-RAMOS, M., SILVA, I., OLIVEIRA, O., FERREIRA, S., REIS, M. J., OLIVEIRA, J. C. & CORREIA-DE-SA, P. (2013). Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome. PLoS One, 8 (5), e64696. http://www.ncbi.nlm.nih.gov/pubmed/23741373
77. SIMAO, S., GOMES, P., PINHO, M. J. & SOARES-DA-SILVA, P. (2013). Identification of SLC26A transporters involved in the Cl(-)/HCO(3)(-) exchange in proximal tubular cells from WKY and SHR. Life Sci, 93 (12-14), 435-40. http://www.ncbi.nlm.nih.gov/pubmed/23933130
78. SIMOES-SILVA, L., MOREIRA-RODRIGUES, M., QUELHAS-SANTOS, J., FERNANDES-CERQUEIRA, C., PESTANA, M., SOARES-SILVA, I. & SAMPAIO-MAIA, B. (2013). Intestinal and renal guanylin peptides system in hypertensive obese mice. Exp Biol Med (Maywood), 238 (1), 90-7. http://www.ncbi.nlm.nih.gov/pubmed/23479768
79. SOARES, A. S., COSTA, V. M., DINIZ, C. & FRESCO, P. (2013). Potentiation of cytotoxicity of paclitaxel in combination with Cl-IB-MECA in human C32 metastatic melanoma cells: A new possible therapeutic strategy for melanoma. Biomed Pharmacother, 67 (8), 777-89. http://www.ncbi.nlm.nih.gov/pubmed/24035253
80. SOUTEIRO, P., VIEIRA-COELHO, M. A., SERRAO, M. P. & MAGINA, S. (2013). Catechol-O-methyltransferase activity in psoriasis patients treated with psoralen plus ultraviolet A therapy. Photodermatol Photoimmunol Photomed, 29 (5), 227-32. http://www.ncbi.nlm.nih.gov/pubmed/24001377
81. STEIN, J., BAGER, P., BEFRITS, R., GASCHE, C., GUDEHUS, M., LEREBOURS, E., MAGRO, F., MEARIN, F., MITCHELL, D., OLDENBURG, B. & DANESE, S. (2013). Anaemia management in patients with inflammatory bowel disease: routine practice across nine European countries. Eur J Gastroenterol Hepatol, 25 (12), 1456-63. http://www.ncbi.nlm.nih.gov/pubmed/24100539
82. VIDEIRA, I. F., MOURA, D. F. & MAGINA, S. (2013). Mechanisms regulating melanogenesis. An Bras Dermatol, 88 (1), 76-83. http://www.ncbi.nlm.nih.gov/pubmed/23539007
83. ZOMORODIAN, A., GARCIA, M. P., MOURA E SILVA, T., FERNANDES, J. C., FERNANDES, M. H. & MONTEMOR, M. F. (2013). Corrosion resistance of a composite polymeric coating applied on biodegradable AZ31 magnesium alloy. Acta Biomater, 9 (10), 8660-70. http://www.ncbi.nlm.nih.gov/pubmed/23454214